🏷

Classifications

ICIMD (Inherited Metabolic Disorders)

👪

Inheritance

1

Autosomal recessive inheritance HP:0000007

Reported AREXT2 families show biallelic inheritance, including homozygous complex alleles and compound heterozygous variants. Unaffected heterozygous relatives support recessive segregation for those alleles. A heterozygous EXT2 variant must be interpreted for its specific pathogenic mechanism; it is not automatically a dominant hereditary multiple exostoses diagnosis.

Autosomal recessive inheritance

Show evidence (3 references)

PMID:26246518 SUPPORT Human Clinical

"In short, we have unravelled the genetic basis of a new recessive disorder, seizures-scoliosis-macrocephaly syndrome."

The paper's own conclusion that the disorder is recessive.

PMID:26246518 SUPPORT Human Clinical

"To confirm the autosomal-recessive mode of inheritance, all available family members were genotyped."

Documents the segregation analysis behind that conclusion.

PMID:30075207 SUPPORT Human Clinical

"Segregation analysis by Sanger sequencing confirmed homozygous by descent autosomal recessive transmission of this mutation."

Independent confirmation of recessive transmission in a second family.

?

Discussions and Knowledge Gaps

11

How should the reported urinary HS result be interpreted when its value exceeds the paper’s own 99th-percentile reference boundary?

INTERPRETATION OPEN interpretation_arext2_hs_reference_conflict

Attached to

biochemical#Heparan sulfate diagnosis#Glycosaminoglycan measurement pathophysiology#Impaired Heparan Sulfate Biosynthesis

Gupta reports dried-blood-spot HS 12 nmol/L, serum 4.46 ng/mL and urine 0.5 mg/mmol creatinine, calling all low. Table 1 instead gives first-percentile values 12.0, 7.06 and 0.014, and a urinary 99th percentile of 0.292. Serum is below its first percentile and dried blood spot equals it, but the stated urine value is above the 99th. The full source table was fetched and inspected; this is an internal value/interpretation conflict, not evidence that a cache is missing text. No number, unit or direction is silently repaired. These peripheral measures do not establish uniform tissue HS depletion.

Show evidence (2 references)

PMID:30997052 SUPPORT Human Clinical

"Biochemical screening for mucopolysaccharidoses was performed in view of the coarse facial features and revealed low levels of heparan sulfate in dried blood spot (12 nmol/L), serum (4.46 ng/mL), and urine (0.5 mg/mmol creatinine) specimens (Reference ranges given in Table 1)."

The narrative supplies the observed values and its low-level interpretation.

PMID:30997052 SUPPORT Human Clinical

"| 99%ile | 96.1 | 53.89 | 0.292 |"

The last column of Table 1 is urine HS in mg/mmol creatinine; 0.292 is its stated 99th-percentile boundary.

Which aspects of the proposed HS-dependent neural-development pathway operate in human AREXT2, and which are allele- or species-specific?

HUMAN MODEL MISMATCH OPEN mismatch_arext2_neural_models

Attached to

pathophysiology#Disrupted HS-Dependent FGF and Wnt Signaling pathophysiology#Altered Neural Patterning and Connectivity phenotypes#Macrocephaly phenotypes#Global developmental delay phenotypes#Intellectual disability phenotypes#Delayed speech and language development

The founding authors explicitly use Ext-model neural-patterning and axon-guidance findings to explain developmental delay and macrocephaly, so qualified causal paths are represented. Zebrafish experiments establish Fgf/Wnt dependence, with selected Hh outcomes preserved; they do not directly assay human circuits, head growth or language. Mouse null embryonic arrest differs from viable patient complex alleles and does not establish human null lethality. Patient fibroblasts and variant reconstruction are informative proximal models, not evidence that no cellular model exists. The unresolved issue is translational fidelity and feature-specific mediation, not absence of a published hypothesis.

Show evidence (3 references)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT INDIRECT Other

"these studies help explain why SSM patients are alive but have macrocephaly and are severely delayed in their developmental course."

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The authors explicitly connect the model-based neural-development explanation to macrocephaly and severe developmental delay in the founding family.

PMID:21892940 SUPPORT Model Organism

"In contrast, Hh dependent signaling is apparently unaffected in the ext2 mutants; Hh targeted gene expression is not reduced, the Hh inhibitor cyclopamine is not more affective in the mutants and Hh dependent cell differentiation in the retina and in the myotome are normal in ext2 mutants."

Selected fish Hh assays were preserved; this constrains a universal morphogen-signaling claim without proving every Hh-dependent function normal.

PMID:16236767 SUPPORT Model Organism

"Homozygous mutant embryos developed normally until embryonic day 6.0, when they became growth arrested and failed to gastrulate, pointing to the early essential role for heparan sulfate in developing embryos."

This documents mouse null-allele developmental arrest. It neither tests human biallelic null viability nor excludes partial mechanistic use of other Ext models.

Which neural or neuromuscular processes explain seizure type, status susceptibility, hypotonia, tremor and gait abnormalities beyond the established EXT2 etiology?

KNOWLEDGE GAP OPEN gap_arext2_seizure_types_and_tone

Attached to

phenotypes#Seizure phenotypes#Focal-onset seizure phenotypes#Bilateral tonic-clonic seizure with generalized onset phenotypes#Status epilepticus phenotypes#Hypotonia phenotypes#Tremor phenotypes#Broad-based gait

The genetic cause of the defining seizure-developmental syndrome is retained, but the sources do not establish the circuit mechanisms selecting focal versus generalized seizures or progression to status. Status-associated brain injury explains a specific acquired motor deficit, not baseline hypotonia or the broad-based gait in a different sibling. Hypotonia is absent in the Gupta proband; central versus peripheral contributions were not resolved in the reviewed families. A coarse tremor lacks physiological classification, and a broad-based gait alone does not establish cerebellar degeneration. These are unresolved mediators/localizations rather than a requirement for complete pathway reconstruction.

Show evidence (3 references)

PMID:30997052 REFUTE Human Clinical

"However, skeletal issues such as scoliosis and decreased bone density and muscular issues such as hypotonia, observed with this disorder, were not observed in our patient."

The Gupta proband lacked hypotonia despite biallelic EXT2 variants; tone abnormalities are variable.

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"his gait is stiff with out-toeing on a broad base."

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The description establishes the gait finding without a cerebellar diagnosis.

PMID:30997052 SUPPORT Human Clinical

"EEG was abnormal and revealed occipital midline spike and waves consistent with focal seizures."

The authors interpret the occipital-midline discharges as consistent with focal seizures; the EEG finding is also recorded separately as a readout.

What explains early regression and behavioral variability when the same EXT2/NDST1 genotype occurs in twins with different severity?

KNOWLEDGE GAP OPEN gap_arext2_regression_behavior

Attached to

phenotypes#Developmental regression phenotypes#Autism phenotypes#Aggressive behavior phenotypes#Motor stereotypy phenotypes#Sleep disturbance

Gupta’s verbal/social regression at 27 months preceded seizures at ten years, so the seizure-injury route cannot explain that episode. The proband had voltage-gated potassium-channel antibodies and a reported transient immunotherapy response, but the study does not establish an autoimmune cause of the entire phenotype. Both twins carried the same EXT2 pair and monoallelic NDST1 VUS, making its proposed modifier effect unproven. Autism, aggression, rocking and nonspecific sleep difficulty are documented, but no experiment attributes each to a particular HS-dependent circuit. The twin’s narrative Asperger diagnosis and negative Autism table cell are preserved as a terminology inconsistency.

Show evidence (3 references)

PMID:30997052 SUPPORT Human Clinical

"Developmental regression of verbal and social skills along with cognitive decline was reported at 27 months."

This dates regression in the Gupta proband, whose seizures began at 10 years; the source does not establish seizures as the cause of this earlier decline.

PMID:30997052 SUPPORT Human Clinical

"Her fraternal twin sister has Asperger syndrome (diagnosed at 3 years of age), mild motor delays, and a history of cognitive and speech delays, which had improved over time."

The narrative describes an autism-spectrum diagnosis in the milder twin, although Table 2 marks her Autism row negative. Preserve the stated diagnosis and this narrative/table terminology discrepancy.

PMID:30997052 SUPPORT Human Clinical

"She had aggressive behavior toward self and others, rocking stereotypies and sleep difficulty, which improved over time."

This reports behavior and its course without proving its molecular attribution.

Why do EXT2 families differ in head-size direction, and which developmental processes cause their individual craniofacial findings?

KNOWLEDGE GAP OPEN gap_arext2_head_and_facial_pattern

Attached to

phenotypes#Microcephaly phenotypes#Hypertelorism phenotypes#Coarse facial features phenotypes#High forehead phenotypes#Prominent forehead phenotypes#Long philtrum phenotypes#Preauricular pit phenotypes#Broad nasal tip phenotypes#Flat forehead

The founding authors offer a model-based neural explanation for macrocephaly, which is represented. It does not establish the mechanism of postnatal microcephaly in the El-Bazzal brothers or prove an allele-specific residual-HS threshold. Facial traits are distinct observations, not interchangeable consequences of head size. General HS-dependent morphogenesis is plausible, but the reviewed human reports do not map orbital spacing, forehead dimensions, philtral length, preauricular pits or nasal shape to a defined neural-crest or skeletal process. Coarse facies do not demonstrate lysosomal storage.

Show evidence (2 references)

PMID:30075207 SUPPORT Human Clinical

"We report a consanguineous family where 2 boys presented with developmental delay, hypotonia, microcephaly, seizures, gastro-intestinal abnormalities, osteopenia, and neurological regression."

Documents microcephaly in a family with the same recessive disorder.

PMID:30997052 SUPPORT Human Clinical

"The patient is a 14‐year‐old female evaluated through the Mayo Clinic Department of Clinical Genomics for developmental delay, autism, epilepsy, and distinctive craniofacial features including macrocephaly, prominent tall forehead, hypertelorism, long hypoplastic philtrum, bilateral preauricular..."

The quote establishes a broad nasal tip; no assumption about nostril orientation is needed.

Does abnormal cartilage differentiation explain the variable human spinal curves and bone density, or only the modeled exostosis route?

HUMAN MODEL MISMATCH OPEN gap_arext2_skeletal_variability

Attached to

pathophysiology#Abnormal Chondrocyte Differentiation phenotypes#Scoliosis phenotypes#Kyphosis phenotypes#Osteopenia phenotypes#Overlapping toe phenotypes#Multiple exostoses phenotypes#Cervical segmentation defect

The Ext2 mouse study provides a qualified cartilage-differentiation route to exostoses, and Gentile explicitly proposes genotype dependence in the human exostosis-positive family. That evidence does not establish that the same cartilage lesion causes scoliosis, kyphosis, reduced bone density or overlapping toes. Human growth-plate morphology, the effects of mobility and nutrition, and anatomic thresholds were not separated. Scoliosis narrative/table disagreement and absent skeletal findings in Gupta prevent a uniform-frequency claim. A supported model mechanism is retained; translation to each other skeletal feature remains unresolved. The cervical segmentation defect is a developmental anatomical observation, not proof of the later cartilage-differentiation mechanism.

Show evidence (4 references)

PMID:16236767 SUPPORT INDIRECT Model Organism

"Significantly, all of the mice showed multiple abnormalities in cartilage differentiation, including disorganization of chondrocytes in long bones and premature hypertrophy in costochondral cartilage."

This refers to heterozygous Ext2-null mice. It supports a partial-loss cartilage mechanism while differing from the human biallelic missense genotypes.

PMID:30288735 SUPPORT INDIRECT Other

"Our finding expands the clinical and molecular spectrum of the AREXT2 syndrome and suggests a possible genotype/phenotype correlation in the development of the exostoses."

Gentile proposes genotype dependence in the recessive family; it does not establish the same cellular threshold as the mouse or a dominant HME cohort.

PMID:30997052 REFUTE Human Clinical

"However, skeletal issues such as scoliosis and decreased bone density and muscular issues such as hypotonia, observed with this disorder, were not observed in our patient."

A biallelic EXT2 patient without scoliosis, which is why the feature is not treated as obligate.

+ 1 more reference

Which upstream processes cause malrotation, hiatus hernia and motility/feeding abnormalities, beyond their supported local complications?

KNOWLEDGE GAP OPEN gap_arext2_gastrointestinal_origins

Attached to

phenotypes#Gastrointestinal dysmotility phenotypes#Gastroesophageal reflux phenotypes#Constipation phenotypes#Feeding difficulties phenotypes#Dysphagia phenotypes#Diarrhea phenotypes#Volvulus phenotypes#Intestinal malrotation phenotypes#Hiatus hernia phenotypes#Encopresis phenotypes#Nausea phenotypes#Polyhydramnios

Case-level motility-to-vomiting and reflux-to-ulceration relations are represented. General anatomical evidence additionally supports qualified malrotation-to-volvulus in II-5 and hiatus-hernia-to-reflux in II-1. The general studies do not establish those patients’ mesenteric dimensions, hernia subtype or pressure measurements, and none explains why EXT2 variants would cause their structural abnormalities. The reports do not establish whether the upstream dysmotility is enteric-neural, smooth-muscle or secondary to other disability. Constipation followed by diarrhea in II-1 is longitudinal variation, not an inevitable progression. Dysphagia and tube feeding do not identify oral versus pharyngeal versus esophageal dysfunction. Encopresis and nausea lack physiological attribution. Polyhydramnios in II-5’s pregnancy is not proven to result from impaired fetal swallowing. The remaining uncertainty concerns upstream attribution and patient-specific mediation, not whether malrotation or hiatus hernia can have those local complications.

Show evidence (6 references)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"He too suffers from dysfunctional gastrointestinal motility"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. II-3 had dysfunctional gastrointestinal motility with easy vomiting and documented reflux.

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"While chronic constipation was a feature in early life, diarrhea has been a feature lately."

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. II-1 had later diarrhea following early constipation. These are different timepoints.

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"At four days of age, he was diagnosed with intestinal volvulus, which required surgical intervention."

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Neonatal intestinal volvulus in II-5 required surgery; the report does not establish whether EXT2 directly caused the anatomical predisposition.

+ 3 more references

Which renal and other visceral observations are intrinsic to EXT2 dysfunction, and which reflect comorbidity or secondary injury?

KNOWLEDGE GAP OPEN gap_arext2_renal_vascular_visceral

Attached to

phenotypes#Abnormal renal physiology phenotypes#Hematuria phenotypes#Proteinuria phenotypes#Hypertension phenotypes#Cerebral hemorrhage phenotypes#Ventricular septal defect phenotypes#Abnormal liver physiology phenotypes#Bilateral cryptorchidism phenotypes#Precocious puberty phenotypes#Extremities cold to touch

Renal findings require special attribution: II-3 had hemolytic uremic syndrome and dialysis, so renal failure is not direct proof of an EXT2 glomerular lesion. Hematuria and proteinuria in another sibling remain unexplained; the reports do not establish altered renal HS as their cause. Brain hemorrhage lacks timing and vascular mechanism, and must not be equated automatically with II-4’s status-associated injury. Hypertension, unspecified hepatic dysfunction, ventricular septal defects, bilateral cryptorchidism and precocious puberty are clinically documented but lack feature-specific physiological or developmental attribution in the reviewed sources. Maternal gestational hypertension is excluded from the child phenotype. Cold extremities do not establish vasospasm, neuropathy or impaired circulation as the causal route.

Show evidence (5 references)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"he developed hemolytic uremic syndrome and required peritoneal dialysis."

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. This names a renal comorbidity and treatment in II-3; it does not establish EXT2 deficiency as the cause of hemolytic uremic syndrome.

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Brain hemorrhage + + Circulation Cold extremities Cold extremities"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Brain hemorrhage was recorded in II-3 and II-4; the table does not establish timing or a vascular mechanism, including its relation to status-associated injury.

PMID:30997052 SUPPORT Human Clinical

"There is clinical heterogeneity in this disorder, with two of four patients with biallelic EXT2 alterations noted to have a ventricular septal defect.1"

Gupta summarizes two affected individuals among the four founding siblings; this is a selected family denominator, not syndrome-wide prevalence.

+ 2 more references

What explains ocular alignment, acne and sleep apnea without assigning unmeasured nerve, skin or respiratory mechanisms?

KNOWLEDGE GAP OPEN gap_arext2_ocular_skin_apnea

Attached to

phenotypes#Strabismus phenotypes#Exotropia phenotypes#Acne phenotypes#Sleep apnea

The reports document ocular deviations and corrective surgery, but do not distinguish ocular motor nerve, muscle or central-control causes. Zebrafish eye-field or optic-tract findings are not proof of the same lesion in human strabismus. Acne-prone sensitive skin has no demonstrated HS-dependent cutaneous mechanism. Sleep apnea in the founding table is not classified as central or obstructive; it cannot be placed downstream of a particular brainstem or airway lesion.

Show evidence (3 references)

PMID:30997052 SUPPORT Human Clinical

"She underwent surgery for strabismus bilaterally at the age of 5 years."

The reported diagnosis supports strabismus without selecting an unspecified narrower deviation.

PMID:30997052 SUPPORT Human Clinical

"Additional features include sensitive skin prone to acne and gastro‐intestinal problems such as constipation and gastroesophageal reflux."

The skin observation supports acne without a specific lesion subtype.

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Sleep apnea + Tremor Coarse Seizures, onset (years) +, 2.5 +, 4-5 +, 2-3 +, 5"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Sleep apnea was recorded in II-5 without central/obstructive classification.

How should the nonsense/splice candidate be interpreted without assuming either a confirmed AREXT2 diagnosis or universal human null lethality?

INTERPRETATION OPEN interpretation_arext2_candidate_nonmissense

Attached to

genetic#EXT2

The 2021 radiogenomics series describes one possible AREXT2 patient with maternal p.Trp79Ter and paternal c.1404+2T>C variants, but explicitly requests functional work and leaves syndrome attribution unclear. Its short stature, congenital heart disease, hearing loss, hemimegalencephaly and bilateral iris coloboma therefore remain scoped candidate findings rather than automatically entering the confirmed AREXT2 phenotype set. The whole 15-patient skeletal-dysplasia cohort is not an AREXT2 denominator. PMID:35045016 is a later title-only accessible record; without its case text, patient identity and follow-up conclusions are not assumed.

Show evidence (2 references)

PMID:34092239 SUPPORT Other

"It is unclear whether patient 13 has AREXT2 thus, functional work is required."

The authors explicitly leave this candidate diagnosis unresolved and request functional work; this is diagnostic interpretation rather than a measured phenotype.

PMID:34092239 SUPPORT Human Clinical

"Patient 13 presented with SD (short stature, macrocephaly, and scoliosis) with non-skeletal syndromal features (congenital heart disease and hearing loss)."

These observations belong to the explicitly uncertain candidate case.

Could restoring HS biosynthesis improve clinically relevant outcomes without toxic or mistimed excess?

EMERGING HYPOTHESIS OPEN hypothesis_arext2_replacement_therapy

Attached to

pathophysiology#Impaired Heparan Sulfate Biosynthesis

Enzyme or HS administration was proposed in the clinical papers; no disease-modifying intervention experiment is presented in the reviewed cases. The founding author explicitly cautions about genotype, possible toxicity of excess HS and developmental timing. These proposals are not clinical trial results, measured datasets or established treatments.

Show evidence (2 references)

PMID:30997052 SUPPORT Other

"The findings described above could allow for a better characterization of distinct features of such clinically variable and nonspecific phenotypes and may also provide potential strategies for therapeutic intervention by enzyme replacement therapy or administration of heparan sulfate to the patients."

This is a therapeutic proposal, not observed treatment efficacy.

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Other

"it is not clear if excess heparan sulfate is toxic to cells."

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The author identifies toxicity uncertainty in the same proposed replacement-therapy discussion.

⚙

Pathophysiology

7

Reduced EXT2 Protein Availability

The founding homozygous complex p.Met87Arg/p.Arg95Cys allele reduces EXT2 abundance in cultured patient fibroblasts and reconstructed COS-7/HEK293 cells. Each substitution contributes, with the larger effect from p.Arg95Cys and the greatest decrease when both are present. These protein-expression experiments do not establish an activity fraction for every AREXT2 allele.

EXT2 hgnc:3513

Experimental models

Founding-family patient fibroblast culture PRIMARY CELL CULTURE Immunoblotting measures reduced EXT2 abundance in cultured patient fibroblasts.

COS-7 and HEK293 EXT2 variant reconstruction CELL LINE Changing the encoded residues lowers EXT2 protein abundance, with the largest decrease for the double-substitution construct.

Animal models

Ext2-null mouse Mouse fails to recapitulate Complete null loss differs from the residual-expression complex allele in the founding patients.

Downstream

Impaired Heparan Sulfate Biosynthesis Reduced EXT2 availability compromises the EXT1/EXT2 biosynthetic complex. The founding study proposes impaired HS synthesis; complete absence of polymerization or uniformly short chains in human tissues was not measured.

Reduced NDST1 Protein Stability Loss of available EXT2 is proposed to reduce stabilization or processing of its interacting protein NDST1. The founding cells show protein/transcript discordance, supported by independent coexpression work; the exact degradation route remains unresolved.

Seizure The founding genetic and functional study attributes the seizure-developmental syndrome to the complex EXT2 allele. This broad etiologic relation is retained with unresolved epileptogenic intermediates; the separate neural-patterning hypothesis is not treated as a demonstrated seizure circuit.

Show evidence (2 references)

PMID:26246518 SUPPORT In Vitro

"We also performed an in vitro assay to determine which mutation has a larger effect on protein expression and observed reduced EXT2 expression in constructs expressing either one of the mutations but a greater reduction when both residues were mutated."

Constructs carrying either substitution lowered protein abundance; the double-substitution construct lowered it further. These are substitutions on the same complex allele, and the assay does not directly quantify residual glycosyltransferase activity.

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT In Vitro

"We observed diminished EXT2 protein expression relative to a healthy EXT2-WT control (P<0.001)"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Cultured patient fibroblasts showed reduced EXT2 protein. This is an in-vitro patient-derived assay, not a tissue-wide concentration measurement.

Reduced NDST1 Protein Stability

Mechanism confidence: Provisional

Absence of NDST1 protein despite preserved transcript in the founding patient fibroblasts suggests post-translational loss. Independent EXT2/NDST1 coexpression experiments show altered NDST1 abundance, glycosylation and HS sulfation, but do not identify the exact degradation or trafficking step in AREXT2.

Experimental models

Founding-family patient fibroblast culture PRIMARY CELL CULTURE Patient fibroblast protein and transcript comparisons identify NDST1 discordance.

Downstream

Impaired Heparan Sulfate Biosynthesis NDST1 loss is proposed to impair the sulfation component of HS biosynthesis, alongside reduced EXT2 polymerization capacity. The patient study did not directly assay sulfation; independent enzyme-expression perturbations establish that NDST1 abundance can change HS structure.

Show evidence (2 references)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT In Vitro

"Our findings indicate that cellular NDST1 protein levels are abolished in patient whole cell lysates"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. NDST1 immunoblot signal was absent in cultured patient-cell lysates; the corresponding transcript was not reduced. The assay measures protein abundance rather than direct EXT2 catalytic kinetics.

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT INDIRECT Other

"suggesting the absence of NDST1 protein expression is a product of an error in post-translational modification"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The authors infer post-translational instability or processing from protein/transcript discordance; protein turnover and the exact compartment were not directly measured.

Impaired Heparan Sulfate Biosynthesis

Mechanism confidence: Provisional

EXT1/EXT2 form the HS chain-polymerization machinery, with NDST1 contributing N-sulfation. AREXT2 is interpreted as impaired HS biosynthesis with residual function. Patient blood measurements provide limited biochemical support, but do not quantify tissue-wide polymer abundance, chain length or sulfation, and the urine interpretation conflicts with its reference table.

heparan sulfate proteoglycan biosynthetic process GO:0015012 ↓ DECREASED

Golgi apparatus GO:0005794

Downstream

Disrupted HS-Dependent FGF and Wnt Signaling Reduced HS can alter growth-factor presentation and signaling. The human hypothesis is supported by ext2 zebrafish Fgf/Wnt perturbations; receptor-complex stability and ligand transport are alternatives, not established patient intermediates.

Abnormal Chondrocyte Differentiation Partial Ext2 loss disrupts cartilage differentiation in mice. This is retained as a qualified shared mechanism for the exostosis-positive AREXT2 family, not proof that it causes scoliosis or osteopenia in every genotype.

Show evidence (2 references)

PMID:18337501 SUPPORT Other

"During polymerization of the HS chain, carried out by a complex of the exostosin proteins EXT1 and EXT2, the first modification enzyme, glucosaminyl N-deacetylase/N-sulfotransferase (NDST), introduces N-sulfate groups into the growing polymer."

Background biochemistry distinguishes chain polymerization from NDST-dependent modification.

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT INDIRECT Other

"both variants contribute to decreased EXT2 expression potentially destabilizing the protein, disrupting heparan sulfate biosynthesis, and probably other developmental cascades requiring EXT2 for propagation, such as FGF and Wnt signalling"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The founding-study discussion proposes this causal sequence; FGF/Wnt activity was not measured in the patients.

Disrupted HS-Dependent FGF and Wnt Signaling

Mechanism confidence: Provisional

Fgf and Wnt signaling are affected in ext2 zebrafish embryos. Reduced Fgf target-gene expression precedes later midbrain-hindbrain patterning changes; Wnt11/Wnt5b partial inhibition gives greater abnormalities in mutants. Hh target expression and selected differentiation assays were preserved. The founding human study proposes involvement of these pathways without direct patient signaling assays.

Animal models

Zebrafish ext2 dackel mutant Zebrafish partially recapitulates Direct fish experiments establish Fgf/Wnt sensitivity to ext2 deficiency.

Downstream

Altered Neural Patterning and Connectivity Reduced developmental signaling is proposed to disturb neural patterning. In fish, reduced Fgf signaling precedes abnormal midbrain-hindbrain signaling; the authors cautiously interpret this as a possible cause, not a complete reconstruction of human brain development.

Show evidence (3 references)

PMID:21892940 SUPPORT INDIRECT Model Organism

"In the ext2 mutants, Fgf signaling is shown to be affected during nervous system development and reduction of Fgf ligands in the mutants affects tail development."

The ext2 zebrafish model demonstrates altered developmental Fgf signaling; the tail experiment is not a human skeletal or neural phenotype.

PMID:21892940 SUPPORT INDIRECT Model Organism

"Also, Wnt signaling is affected in the ext2 mutants, as shown by a stronger phenotype in ext2 mutants injected with morpholinos that partially block translation of Wnt11 or Wnt5b, compared to injected wild type embryos."

Morpholino sensitization supports a Wnt signaling role in ext2 fish, not a measured Wnt deficit in AREXT2 patients.

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT INDIRECT Other

"both variants contribute to decreased EXT2 expression potentially destabilizing the protein, disrupting heparan sulfate biosynthesis, and probably other developmental cascades requiring EXT2 for propagation, such as FGF and Wnt signalling"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The founding-study discussion proposes this causal sequence; FGF/Wnt activity was not measured in the patients.

Altered Neural Patterning and Connectivity

Mechanism confidence: Provisional

Insufficient or mistimed HS-dependent signaling may impair brain patterning, axon guidance and circuit development. This source-proposed pathway explains developmental impairment and macrocephaly provisionally; no patient brain assay establishes the detailed circuit lesion or why other families have microcephaly.

Downstream

Global developmental delay The authors explicitly connect deficient HS-dependent neural development to severe developmental delay; motor and cognitive domains are affected in the clinical reports.

Intellectual disability The proposed disturbance of neural development provides a qualified explanation for the founding family’s cognitive impairment. It is not a measured IQ-to-pathway association.

Delayed speech and language development Impaired neural development is a qualified explanation for the language component of the developmental phenotype; the source documents minimal expressive speech in the founding family but does not isolate a language-specific circuit.

Macrocephaly The founding-study discussion explicitly links altered HS-dependent brain-size/structure development to macrocephaly. This does not explain the opposite head-size direction in the El-Bazzal family.

Show evidence (2 references)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT INDIRECT Other

"while residual levels of heparan sulfate facilitate some cellular functions, they are not sufficient for proper neural development including brain morphology and midline axon guidance"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The authors use Ext-model evidence to propose impaired neural development in human partial-loss disease. This is a translational hypothesis, not patient brain histology.

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT INDIRECT Other

"these studies help explain why SSM patients are alive but have macrocephaly and are severely delayed in their developmental course."

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The authors explicitly connect the model-based neural-development explanation to macrocephaly and severe developmental delay in the founding family.

Abnormal Chondrocyte Differentiation

Mechanism confidence: Provisional

Heterozygous Ext2-null mice show disorganized chondrocytes and premature hypertrophy. This supplies a plausible partial-loss cartilage mechanism for the exostosis-positive AREXT2 family, while allele, dosage and tissue thresholds differ and have not been tested in its patients.

Animal models

Ext2-null mouse Mouse partially recapitulates The heterozygous arm reproduces abnormal cartilage differentiation relevant to the proposed skeletal route.

Downstream

Multiple exostoses Abnormal cartilage differentiation is linked to ectopic bone growth in the Ext2 mouse model. The Gentile family establishes the human manifestation and proposes genotype dependence; the modeled causal route remains provisional for recessive AREXT2.

Show evidence (2 references)

PMID:16236767 SUPPORT INDIRECT Model Organism

"Significantly, all of the mice showed multiple abnormalities in cartilage differentiation, including disorganization of chondrocytes in long bones and premature hypertrophy in costochondral cartilage."

This refers to heterozygous Ext2-null mice. It supports a partial-loss cartilage mechanism while differing from the human biallelic missense genotypes.

PMID:30288735 SUPPORT INDIRECT Other

"Our finding expands the clinical and molecular spectrum of the AREXT2 syndrome and suggests a possible genotype/phenotype correlation in the development of the exostoses."

Gentile proposes genotype dependence in the recessive family; it does not establish the same cellular threshold as the mouse or a dominant HME cohort.

Seizure-Associated Brain Injury

In founding patient II-4, a four-hour seizure at age five caused significant brain injury, followed by right hemiplegia and loss of walking. This acquired route is separate from baseline developmental impairment and from the Gupta proband’s regression before epilepsy.

Downstream

Hemiplegia The documented seizure-associated brain injury was followed by right hemiplegia in II-4.

Inability to walk II-4 lost independent walking after the injury and remained wheelchair dependent; the report gives no more detailed motor-pathway localization.

Developmental regression Loss of a previously acquired walking skill after status-associated brain injury accounts for a motor-regression component in II-4. It does not explain all neurological regression across families.

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"During one episode at the age of five, she had a four-hour long seizure and sustained significant brain injury. She was rendered hemiplegic on the right side, and has been wheelchair bound since that event."

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. II-4 sustained brain injury during a four-hour seizure, followed by right hemiplegia and wheelchair dependence; this clinical attribution supports a secondary injury route.

⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.

●

Phenotypes

62

Blood 1

Cerebral hemorrhage HP:0001342

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Brain hemorrhage + + Circulation Cold extremities Cold extremities"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Brain hemorrhage was recorded in II-3 and II-4; the table does not establish timing or a vascular mechanism, including its relation to status-associated injury.

Cardiovascular 2

Ventricular septal defect HP:0001629

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"There is clinical heterogeneity in this disorder, with two of four patients with biallelic EXT2 alterations noted to have a ventricular septal defect.1"

Gupta summarizes two affected individuals among the four founding siblings; this is a selected family denominator, not syndrome-wide prevalence.

Hypertension HP:0000822

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Hypertension + Hematuria + +, Kidney failure Proteinuria + + Wide-based gait + Loss of ambulation"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Hypertension in II-1 appears in the patient clinical findings section, distinct from the separate maternal gestational hypertension row.

Digestive 13

Gastroesophageal reflux HP:0002020

Sequelae: Esophageal ulceration

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"Additional features include sensitive skin prone to acne and gastro‐intestinal problems such as constipation and gastroesophageal reflux."

Names both gastrointestinal problems in the patient described in detail.

Constipation HP:0002019

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"Additional features include sensitive skin prone to acne and gastro‐intestinal problems such as constipation and gastroesophageal reflux."

Names constipation among the gastrointestinal features.

Feeding difficulties HP:0011968

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Dysphagia + Tube-fed Low bone density + + + Sensitive skin + + + +"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The clinical table records dysphagia in II-1 and tube feeding in II-4. Empty cells are unavailable information, not negatives.

Gastrointestinal dysmotility HP:0002579

Sequelae: Vomiting

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"He too suffers from dysfunctional gastrointestinal motility"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. II-3 had dysfunctional gastrointestinal motility with easy vomiting and documented reflux.

Vomiting HP:0002013

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"tends to vomit easily and has documented gastroesophageal reflux."

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Easy vomiting was described in II-3 in the context of gastrointestinal dysmotility.

Diarrhea HP:0002014

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"While chronic constipation was a feature in early life, diarrhea has been a feature lately."

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. II-1 had later diarrhea following early constipation. These are different timepoints.

Volvulus HP:0002580

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"At four days of age, he was diagnosed with intestinal volvulus, which required surgical intervention."

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Neonatal intestinal volvulus in II-5 required surgery; the report does not establish whether EXT2 directly caused the anatomical predisposition.

Dysphagia HP:0002015

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Dysphagia + Tube-fed Low bone density + + + Sensitive skin + + + +"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The founding clinical table explicitly records dysphagia; tube feeding in a different sibling is retained without assuming its precise swallowing mechanism.

Intestinal malrotation HP:0002566

Sequelae: Volvulus

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Bowel malrotation + + Volvulus + Encopresis + Morning nausea + + + + Regression + +"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The founding clinical table records bowel malrotation in II-3 and II-5. The bowel rotational defect is distinct from the volvulus complication.

Hiatus hernia HP:0002036

Sequelae: Gastroesophageal reflux

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Hiatus hernia + Bowel dysfunction + + + Hypertension + Hematuria + +, Kidney failure"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Hiatus hernia was recorded in II-1. Coexisting reflux does not by itself prove the hernia caused all reflux in this syndrome.

Nausea HP:0002018

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Morning nausea + + + + Regression + + Dysphagia + Tube-fed Low bone density + + +"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Morning nausea was recorded for all four founding siblings, not assessed as a population frequency.

Abnormal liver physiology HP:0031865

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Hepatic dysfunction + Bowel malrotation + + Volvulus + Encopresis + Morning nausea + + + +"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The table records hepatic dysfunction in II-5 but does not specify biochemical or histological type. A broad physiological term avoids inventing a liver lesion.

Esophageal ulceration HP:0004791

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Significant gastroesophageal reflux and associated ulceration of the esophagus were documented."

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Esophageal ulceration accompanied significant reflux in founding patient II-1.

Endocrine 1

Precocious puberty HP:0000826

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Precocious puberty + Scoliosis + + + Hiatus hernia + Bowel dysfunction + + +"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Precocious puberty was recorded in II-5; hormonal evaluation and central/peripheral classification were not provided.

Eye 3

Hypertelorism HP:0000316

Show evidence (1 reference)

PMID:26246518 SUPPORT Human Clinical

"Herein, we describe a consanguineous family of four sibs with a novel disorder, which we designate as seizures-scoliosis-macrocephaly syndrome, characterised by seizures, intellectual disability, hypotonia, scoliosis, macrocephaly, hypertelorism and renal dysfunction."

Records hypertelorism among the defining features.

Strabismus HP:0000486

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"She underwent surgery for strabismus bilaterally at the age of 5 years."

The reported diagnosis supports strabismus without selecting an unspecified narrower deviation.

Exotropia HP:0000577

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Circulation Cold extremities Cold extremities Strabismus +, left eye +, exotropia Hypotonia + + + +"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Exotropia is specifically recorded in II-5; the broad strabismus entry remains appropriate for the other cases without a specified deviation.

Genitourinary 4

Abnormal renal physiology HP:0012211

Show evidence (2 references)

PMID:26246518 SUPPORT Human Clinical

"Herein, we describe a consanguineous family of four sibs with a novel disorder, which we designate as seizures-scoliosis-macrocephaly syndrome, characterised by seizures, intellectual disability, hypotonia, scoliosis, macrocephaly, hypertelorism and renal dysfunction."

Records renal dysfunction among the defining features.

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"he developed hemolytic uremic syndrome and required peritoneal dialysis."

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. This names a renal comorbidity and treatment in II-3; it does not establish EXT2 deficiency as the cause of hemolytic uremic syndrome.

Bilateral cryptorchidism HP:0008689

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Features seen in all affected individuals include: moderate intellectual disability, seizure disorder with onset between two and five years of age, hypotonia, scoliosis, macrocephaly, coarse facies, bilateral cryptorchidism in males, long hypoplastic philtrum, and hypertelorism."

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The three affected males in the founding family had bilateral cryptorchidism; this is not a syndrome-wide frequency.

Hematuria HP:0000790

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Hematuria + +, Kidney failure Proteinuria + + Wide-based gait + Loss of ambulation"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Hematuria was recorded in II-1 and II-3; the latter also had renal failure and hemolytic uremic syndrome.

Proteinuria HP:0000093

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Proteinuria + + Wide-based gait + Loss of ambulation Overlapping toes + +"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Proteinuria was recorded in II-1 and II-3; no protein selectivity or quantified excretion is provided.

Head and Neck 9

Macrocephaly HP:0000256

Show evidence (2 references)

PMID:26246518 SUPPORT Human Clinical

"Herein, we describe a consanguineous family of four sibs with a novel disorder, which we designate as seizures-scoliosis-macrocephaly syndrome, characterised by seizures, intellectual disability, hypotonia, scoliosis, macrocephaly, hypertelorism and renal dysfunction."

Records macrocephaly in the family that named the syndrome.

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Macrocephaly + + + + Cryptorchidism + + + Precocious puberty + Scoliosis + + + Hiatus hernia +"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. All four are labeled macrocephalic in the founding clinical table, although one listed circumference is at the 90th percentile. The table and narrative diagnoses are preserved without redefining the quantitative HPO threshold.

Microcephaly HP:0000252

Show evidence (1 reference)

PMID:30075207 SUPPORT Human Clinical

"We report a consanguineous family where 2 boys presented with developmental delay, hypotonia, microcephaly, seizures, gastro-intestinal abnormalities, osteopenia, and neurological regression."

Documents microcephaly in a family with the same recessive disorder.

Coarse facial features HP:0000280

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"Biochemical screening for mucopolysaccharidoses was performed in view of the coarse facial features and revealed low levels of heparan sulfate in dried blood spot (12 nmol/L), serum (4.46 ng/mL), and urine (0.5 mg/mmol creatinine) specimens (Reference ranges given in Table 1)."

Records the coarse facies and the screening it prompted in the same sentence.

Flat forehead HP:0004425

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

Gupta Table 2 summarizes the two El-Bazzal brothers in columns 5 and 6, both marked Flat; their ages at examination are 8 and 6 years. This is secondary reporting of those same patients, not two new observations or a syndrome-wide frequency. The four preceding empty cells do not establish absence in the founding family.

High forehead HP:0000348

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"The patient is a 14‐year‐old female evaluated through the Mayo Clinic Department of Clinical Genomics for developmental delay, autism, epilepsy, and distinctive craniofacial features including macrocephaly, prominent tall forehead, hypertelorism, long hypoplastic philtrum, bilateral preauricular..."

The height component of the reported prominent tall forehead supports this finding.

Prominent forehead HP:0011220

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"The patient is a 14‐year‐old female evaluated through the Mayo Clinic Department of Clinical Genomics for developmental delay, autism, epilepsy, and distinctive craniofacial features including macrocephaly, prominent tall forehead, hypertelorism, long hypoplastic philtrum, bilateral preauricular..."

Prominence and height are both explicitly described; this records prominence.

Long philtrum HP:0000343

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"The patient is a 14‐year‐old female evaluated through the Mayo Clinic Department of Clinical Genomics for developmental delay, autism, epilepsy, and distinctive craniofacial features including macrocephaly, prominent tall forehead, hypertelorism, long hypoplastic philtrum, bilateral preauricular..."

The source explicitly describes a long philtrum.

Preauricular pit HP:0004467

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"The patient is a 14‐year‐old female evaluated through the Mayo Clinic Department of Clinical Genomics for developmental delay, autism, epilepsy, and distinctive craniofacial features including macrocephaly, prominent tall forehead, hypertelorism, long hypoplastic philtrum, bilateral preauricular..."

The narrative explicitly documents bilateral pits; the broad ear-anomaly comparison row does not override that specific observation.

Broad nasal tip HP:0000455

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"The patient is a 14‐year‐old female evaluated through the Mayo Clinic Department of Clinical Genomics for developmental delay, autism, epilepsy, and distinctive craniofacial features including macrocephaly, prominent tall forehead, hypertelorism, long hypoplastic philtrum, bilateral preauricular..."

The quote establishes a broad nasal tip; no assumption about nostril orientation is needed.

Immune 1

Acne HP:0001061

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"Additional features include sensitive skin prone to acne and gastro‐intestinal problems such as constipation and gastroesophageal reflux."

The skin observation supports acne without a specific lesion subtype.

Limbs 1

Overlapping toe HP:0001845

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Overlapping toes + + Hepatic dysfunction + Bowel malrotation + + Volvulus +"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Overlapping toes were recorded in II-1 and II-4 without specifying which digits.

Musculoskeletal 6

Scoliosis HP:0002650

Show evidence (2 references)

PMID:26246518 SUPPORT Human Clinical

"Herein, we describe a consanguineous family of four sibs with a novel disorder, which we designate as seizures-scoliosis-macrocephaly syndrome, characterised by seizures, intellectual disability, hypotonia, scoliosis, macrocephaly, hypertelorism and renal dysfunction."

Records scoliosis among the defining features of the index family.

PMID:30997052 REFUTE Human Clinical

"However, skeletal issues such as scoliosis and decreased bone density and muscular issues such as hypotonia, observed with this disorder, were not observed in our patient."

A biallelic EXT2 patient without scoliosis, which is why the feature is not treated as obligate.

Hypotonia HP:0001252

Show evidence (2 references)

PMID:26246518 SUPPORT Human Clinical

"Herein, we describe a consanguineous family of four sibs with a novel disorder, which we designate as seizures-scoliosis-macrocephaly syndrome, characterised by seizures, intellectual disability, hypotonia, scoliosis, macrocephaly, hypertelorism and renal dysfunction."

Records hypotonia among the defining features.

PMID:30997052 REFUTE Human Clinical

"However, skeletal issues such as scoliosis and decreased bone density and muscular issues such as hypotonia, observed with this disorder, were not observed in our patient."

The Gupta proband lacked hypotonia despite biallelic EXT2 variants; tone abnormalities are variable.

Osteopenia HP:0000938

Show evidence (1 reference)

PMID:30075207 SUPPORT Human Clinical

"We report a consanguineous family where 2 boys presented with developmental delay, hypotonia, microcephaly, seizures, gastro-intestinal abnormalities, osteopenia, and neurological regression."

Records osteopenia in a reported family.

Multiple exostoses HP:0002762

Show evidence (2 references)

PMID:30288735 SUPPORT Human Clinical

"In addition, our patients developed multiple exostoses, which were not observed in the previously described families."

Records exostoses in biallelic patients and, in the same sentence, that they were absent in the earlier families.

PMID:30997052 REFUTE Human Clinical

"Heterozygous pathogenic variants within EXT2 are causative of an autosomal dominant disorder known as multiple Exostoses type 2 in which patients develop multiple benign (ie, non‐malignant) bone tumors called osteochondromas, not present in our patient."

The absence of osteochondromas in the Gupta proband qualifies the feature as variable; the general dominant-disease clause is not evidence for its frequency in AREXT2.

Kyphosis HP:0002808

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"In addition, he has significant scoliosis and kyphosis for which he wears a brace and his gait is stiff with out-toeing on a broad base."

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. II-1 had kyphosis as well as scoliosis and wore a brace. The broader scoliosis entry is retained for other patients.

Cervical segmentation defect HP:0004632

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Lateral cervical spine Failure of segmentation of C2-3 and possibly C1-2"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Failure of cervical segmentation at C2–3, and possibly C1–2, was recorded radiographically in founding patient II-1. The binding preserves a segmentation defect without assuming a fully characterized fusion morphology.

Nervous System 18

Seizure HP:0001250

Show evidence (1 reference)

PMID:26246518 SUPPORT Human Clinical

"Herein, we describe a consanguineous family of four sibs with a novel disorder, which we designate as seizures-scoliosis-macrocephaly syndrome, characterised by seizures, intellectual disability, hypotonia, scoliosis, macrocephaly, hypertelorism and renal dysfunction."

Records seizures among the defining features.

Intellectual disability HP:0001249

Show evidence (1 reference)

PMID:26246518 SUPPORT Human Clinical

"Herein, we describe a consanguineous family of four sibs with a novel disorder, which we designate as seizures-scoliosis-macrocephaly syndrome, characterised by seizures, intellectual disability, hypotonia, scoliosis, macrocephaly, hypertelorism and renal dysfunction."

Records intellectual disability among the defining features.

Developmental regression HP:0002376

Show evidence (2 references)

PMID:30075207 SUPPORT Human Clinical

"We report a consanguineous family where 2 boys presented with developmental delay, hypotonia, microcephaly, seizures, gastro-intestinal abnormalities, osteopenia, and neurological regression."

Records neurological regression in a reported family.

PMID:30997052 SUPPORT Human Clinical

"Developmental regression of verbal and social skills along with cognitive decline was reported at 27 months."

This dates regression in the Gupta proband, whose seizures began at 10 years; the source does not establish seizures as the cause of this earlier decline.

Autism HP:0000717

Show evidence (2 references)

PMID:30997052 SUPPORT Human Clinical

"We report a patient with developmental delay, autism, epilepsy, macrocephaly, facial dysmorphism, gastrointestinal, and behavioral issues due to EXT2 compound heterozygous likely pathogenic variants."

Records autism among the presenting features of a biallelic EXT2 patient.

PMID:30997052 SUPPORT Human Clinical

"Her fraternal twin sister has Asperger syndrome (diagnosed at 3 years of age), mild motor delays, and a history of cognitive and speech delays, which had improved over time."

The narrative describes an autism-spectrum diagnosis in the milder twin, although Table 2 marks her Autism row negative. Preserve the stated diagnosis and this narrative/table terminology discrepancy.

Global developmental delay HP:0001263

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"Her fraternal twin sister has Asperger syndrome (diagnosed at 3 years of age), mild motor delays, and a history of cognitive and speech delays, which had improved over time."

The milder twin still had delay across motor, cognitive and speech domains.

Delayed speech and language development HP:0000750

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"At the age of 2 years, language delay was also evident."

A specific language-development observation in the Gupta proband.

Aggressive behavior HP:0000718

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"She had aggressive behavior toward self and others, rocking stereotypies and sleep difficulty, which improved over time."

The aggression component is explicitly reported, with improvement over time.

Motor stereotypy HP:0000733

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"She had aggressive behavior toward self and others, rocking stereotypies and sleep difficulty, which improved over time."

Rocking is the specifically reported repetitive motor behavior.

Sleep disturbance HP:0002360

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"She had aggressive behavior toward self and others, rocking stereotypies and sleep difficulty, which improved over time."

The sleep-difficulty component supports a broad sleep disturbance.

Focal-onset seizure HP:0007359

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"EEG was abnormal and revealed occipital midline spike and waves consistent with focal seizures."

The authors interpret the occipital-midline discharges as consistent with focal seizures; the EEG finding is also recorded separately as a readout.

Status epilepticus HP:0002133

Sequelae: Seizure-Associated Brain Injury

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Case II-4 had a very similar phenotype to her brothers' however, she had recurrent episodes of prolonged status epilepticus."

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Recurrent prolonged status occurred in II-4; II-5 also developed status before death at 17 years. This does not establish that all deaths or regression are seizure mediated.

Hemiplegia HP:0002301

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"During one episode at the age of five, she had a four-hour long seizure and sustained significant brain injury. She was rendered hemiplegic on the right side, and has been wheelchair bound since that event."

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Right hemiplegia followed a four-hour seizure and brain injury at age five in II-4.

Inability to walk HP:0002540

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"all four affected sibs were capable of independent ambulation although case II-4 lost her ability to walk after an episode of prolonged status epilepticus."

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. All four originally walked independently; II-4 lost ambulation after prolonged status epilepticus. This is acquired loss in that patient, not congenital nonambulation in the founding family.

Bilateral tonic-clonic seizure with generalized onset HP:0025190

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"At age three years, he developed seizures that were generalized tonic clonic in nature, lasting two to three minutes."

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. II-1 had clinically described generalized tonic-clonic seizures beginning at three years.

Sleep apnea HP:0010535

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Sleep apnea + Tremor Coarse Seizures, onset (years) +, 2.5 +, 4-5 +, 2-3 +, 5"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Sleep apnea was recorded in II-5 without central/obstructive classification.

Tremor HP:0001337

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Tremor Coarse Seizures, onset (years) +, 2.5 +, 4-5 +, 2-3 +, 5"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. A coarse tremor was recorded in II-5; no rest, action or intention subtype is specified.

EEG with focal epileptiform discharges HP:0011185

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"EEG was abnormal and revealed occipital midline spike and waves consistent with focal seizures."

This is an electrophysiological observation, represented as a readout rather than an additional causal lesion.

Broad-based gait HP:0002136

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"his gait is stiff with out-toeing on a broad base."

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. A stiff, broad-based out-toeing gait was described in founding patient II-1. This does not by itself diagnose cerebellar ataxia.

Prenatal and Birth 1

Polyhydramnios HP:0001561

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"The pregnancy with case II-5 was complicated by polyhydramnios."

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Polyhydramnios was documented in the pregnancy with II-5, without a proven fetal mechanism.

Constitutional 2

Encopresis HP:0040183

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Encopresis + Morning nausea + + + + Regression + + Dysphagia + Tube-fed Low bone density + + +"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Encopresis was recorded in II-1 without a demonstrated continence or stool-retention mechanism.

Extremities cold to touch HP:6000500

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Circulation Cold extremities Cold extremities Strabismus +, left eye +, exotropia"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Cold extremities were recorded in founding patients II-3 and II-4. This observation does not establish Raynaud phenomenon or a specific vascular disorder.

🧬

Genetic Associations

1

EXT2 (Causal biallelic variant)

Gene: EXT2 hgnc:3513 gene page

Show evidence (6 references)

PMID:30997052 SUPPORT Human Clinical

"Two compound heterozygous VUSs (one paternally inherited—c.1118T>A p.(Val373Asp) and a maternally inherited—c.2015C>T p.(Thr672Met)) were identified within the EXT2 gene."

This is the initial sequencing classification in the Gupta report; its final Discussion reclassifies the pair as likely pathogenic rather than leaving the initial VUS wording as the final conclusion.

PMID:30997052 SUPPORT Human Clinical

"EXT2 is implicated in the autosomal dominant disorder multiple Exostoses type 2 (MIM: 133701). Biallelic EXT2 mutations, however, have also been reported in four siblings born to consanguineous parents, manifesting scoliosis, seizures, and macrocephaly (MIM: 616682) without exostosis, following..."

States the two-disease, two-mechanism structure of this gene explicitly, with both OMIM numbers.

PMID:30997052 SUPPORT Human Clinical

"Notably, the patient's fraternal twin sister who is mildly affected as compared to the proband, with some learning delays and speech concerns, was also found to have the two compound heterozygous EXT2 variants while the patient's unaffected brother was found to carry only the heterozygous..."

Documents the within-genotype variability and confirms that the heterozygous sibling was unaffected.

+ 3 more references

💊

Medical Actions

1

Symptom-directed supportive management

Action: supportive care Ontology label: Supportive Care NCIT:C15747

Platform: Other

Reported supportive interventions include spinal bracing in founding patient II-1, tube feeding in II-4 and bilateral strabismus surgery at age five in the Gupta proband. These case descriptions document care but do not establish comparative efficacy or correction of EXT2 biology. HS/enzyme replacement remains a proposed research direction, discussed separately.

Target Phenotypes: Scoliosis HP:0002650 Feeding difficulties HP:0011968 Strabismus HP:0000486

Show evidence (3 references)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"he has significant scoliosis and kyphosis for which he wears a brace"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Spinal bracing is a documented supportive intervention in II-1.

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT Human Clinical

"Dysphagia + Tube-fed Low bone density + + + Sensitive skin + + + +"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The clinical table documents tube feeding in II-4.

PMID:30997052 SUPPORT Human Clinical

"She underwent surgery for strabismus bilaterally at the age of 5 years."

This is an observed intervention in the Gupta proband, not a prospective AREXT2 treatment trial.

🔬

Biochemical Markers

1

Heparan sulfate (Abnormal)

Context: Heparan sulfate was measured during mucopolysaccharidosis screening in the Gupta proband. Serum was below the reported pediatric first percentile and the dried-blood-spot value equaled that percentile. The paper calls all three specimens low, but its urine value exceeds the table’s 99th percentile; urine direction therefore remains internally inconsistent.

Pathograph Readouts

Readout Of Impaired Heparan Sulfate Biosynthesis

Serum and dried-blood-spot HS measurements are limited peripheral readouts consistent with altered biosynthesis in one patient. Urine direction and tissue-wide generalization are unresolved.

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"Biochemical screening for mucopolysaccharidoses was performed in view of the coarse facial features and revealed low levels of heparan sulfate in dried blood spot (12 nmol/L), serum (4.46 ng/mL), and urine (0.5 mg/mmol creatinine) specimens (Reference ranges given in Table 1)."

These are the authors’ reported values and low-level interpretation. Serum and dried-blood-spot comparisons support reduced/low-end values, but the urine interpretation conflicts with the source table, as recorded in the dedicated discussion.

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"Biochemical screening for mucopolysaccharidoses was performed in view of the coarse facial features and revealed low levels of heparan sulfate in dried blood spot (12 nmol/L), serum (4.46 ng/mL), and urine (0.5 mg/mmol creatinine) specimens (Reference ranges given in Table 1)."

These are the authors’ reported values and low-level interpretation. Serum and dried-blood-spot comparisons support reduced/low-end values, but the urine interpretation conflicts with the source table, as recorded in the dedicated discussion.

🔬

Diagnosis

2

Exome sequencing with segregation analysis

Exome sequencing and familial segregation established the reported biallelic EXT2 genotypes; autozygosity mapping was also used in the founding consanguineous family. Phase and allele-specific interpretation distinguish recessive AREXT2 from dominant hereditary multiple exostoses. The unaffected parents and heterozygous brother in the Gupta family demonstrate why a single familial EXT2 variant is not automatically a dominant exostosis genotype.

whole-exome sequencing NCIT:C101295

Results: Biallelic EXT2 variants interpreted with phenotype, segregation and variant-specific evidence.

Show evidence (2 references)

PMID:26246518 SUPPORT Human Clinical

"Our application of autozygosity mapping and whole-exome sequencing allowed us to identify mutations in the patients."

Documents the diagnostic route used in the defining family.

PMID:30997052 SUPPORT Human Clinical

"Notably, the patient's fraternal twin sister who is mildly affected as compared to the proband, with some learning delays and speech concerns, was also found to have the two compound heterozygous EXT2 variants while the patient's unaffected brother was found to carry only the heterozygous..."

The same EXT2 pair segregated to both affected twins, whereas the brother carrying only the paternal variant was clinically unaffected.

Glycosaminoglycan measurement

Heparan sulfate measurement in dried blood spot, serum and urine was performed during mucopolysaccharidosis screening. The reported serum and dried-blood-spot results are low or at the low end of the source reference distribution, but the urine narrative and table conflict. These observations do not establish a validated diagnostic threshold, sensitivity or specificity for AREXT2.

laboratory procedure NCIT:C25294

Results: Reduced serum and low-end dried-blood-spot heparan sulfate in one patient; urinary direction unresolved because the narrative and table disagree.

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"Biochemical screening for mucopolysaccharidoses was performed in view of the coarse facial features and revealed low levels of heparan sulfate in dried blood spot (12 nmol/L), serum (4.46 ng/mL), and urine (0.5 mg/mmol creatinine) specimens (Reference ranges given in Table 1)."

The measurement and indication are directly documented; the paper’s low-urine interpretation is not adopted because Table 1 gives a lower 99th-percentile boundary than the reported urine value.

📊

Prevalence

1

Worldwide

Cases In Literature Ultra Rare

The reviewed reports provide small family series rather than a population prevalence estimate. The founding study described four affected siblings in 2015, followed by further families and an explicitly uncertain candidate case.

Show evidence (2 references)

PMID:26246518 SUPPORT Human Clinical

"Herein, we describe a consanguineous family of four sibs with a novel disorder, which we designate as seizures-scoliosis-macrocephaly syndrome, characterised by seizures, intellectual disability, hypotonia, scoliosis, macrocephaly, hypertelorism and renal dysfunction."

This counts the four siblings in the founding family; it does not supply a population prevalence or ascertainment denominator.

PMID:30288735 SUPPORT Human Clinical

"Here, we report the third family affected by AREXT2 syndrome, harboring compound missense variants in EXT2, p.Asp227Asn, and p.Tyr608Cys."

Establishes that only a small number of families had been reported by 2019.

🔀

Differential Diagnoses

3

Conditions with similar clinical presentations that must be differentiated from Seizures-scoliosis-macrocephaly syndrome:

Hereditary multiple exostoses type 2 Not Yet Curated MONDO:0007586

Overlapping Features Autosomal dominant EXT2-related hereditary multiple exostoses is an allelic disorder characterized by osteochondromas. Neurodevelopmental impairment is not its defining pattern. The presence of exostoses in the Gentile AREXT2 family means the skeletal finding alone does not distinguish the disorders; variant-specific mechanism, phase and the broader clinical phenotype are required.

Distinguishing Features

Dominant pathogenic EXT2 mechanism rather than the recessive family genotypes
Osteochondromas are central to the clinical presentation
A seizure-developmental syndrome prompts assessment for AREXT2 or an additional diagnosis

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"Heterozygous pathogenic variants within EXT2 are causative of an autosomal dominant disorder known as multiple Exostoses type 2 in which patients develop multiple benign (ie, non‐malignant) bone tumors called osteochondromas, not present in our patient."

States the dominant disease, its allele dose, and its phenotype, and contrasts it with the recessive patient in the same sentence.

Autosomal recessive intellectual disability type 46 Not Yet Curated MONDO:0014499

Overlapping Features Biallelic NDST1 variants cause a distinct recessive intellectual-disability disorder affecting HS modification. Both Gupta twins carried a monoallelic NDST1 VUS alongside the EXT2 pair; a second NDST1 alteration was not identified and a modifier effect was not established.

Distinguishing Features

Biallelic NDST1 rather than EXT2 variants
Sulfation and modification defect rather than chain elongation defect

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"Biallelic pathogenic variants within NDST1 are implicated in autosomal recessive intellectual disability type 46 (MIM: 616116)."

Names the NDST1 disorder and its biallelic requirement.

Mucopolysaccharidosis MONDO:0019249

Overlapping Features Coarse facial features prompted mucopolysaccharidosis screening in the Gupta proband. AREXT2 involves an HS-biosynthesis hypothesis rather than a demonstrated lysosomal degradation defect. The serum result was reduced, but the urinary result conflicts with the paper’s reference table and cannot serve as a validated exclusion test.

Distinguishing Features

Lysosomal degradation defect rather than the proposed EXT2 biosynthetic defect
Biochemical and molecular testing must be interpreted by the specific disorder; the inconsistent Gupta urine result is not an exclusion test

Show evidence (1 reference)

PMID:30997052 SUPPORT Human Clinical

"Biochemical screening for mucopolysaccharidoses was performed in view of the coarse facial features and revealed low levels of heparan sulfate in dried blood spot (12 nmol/L), serum (4.46 ng/mL), and urine (0.5 mg/mmol creatinine) specimens (Reference ranges given in Table 1)."

This documents the reason for testing and the authors’ reported values; the urine interpretation is internally inconsistent and is not adopted as a diagnostic discriminator.

🧫

Experimental Models

2

Founding-family patient fibroblast culture PRIMARY_CELL_CULTURE

Skin fibroblasts from affected family members and healthy controls were cultured and assessed by immunoblotting and RT-PCR. This is the patient-derived arm of the founding study.

Publication

PMID:26246518

Pathograph links

Reduced EXT2 Protein Availability measures Immunoblotting measures reduced EXT2 abundance in cultured patient fibroblasts.

Limitations: The experiment does not directly determine residual catalytic activity or neural physiology.

Readouts

Reduced EXT2 protein abundance

Reduced abundance in patient fibroblasts and reconstructed variants.

Direction: DECREASED

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT In Vitro

"We observed diminished EXT2 protein expression relative to a healthy EXT2-WT control (P<0.001)"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Cultured patient fibroblasts showed reduced EXT2 protein. This is an in-vitro patient-derived assay, not a tissue-wide concentration measurement.

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT In Vitro

"We observed diminished EXT2 protein expression relative to a healthy EXT2-WT control (P<0.001)"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Cultured patient fibroblasts showed reduced EXT2 protein. This is an in-vitro patient-derived assay, not a tissue-wide concentration measurement.

Reduced NDST1 Protein Stability measures Patient fibroblast protein and transcript comparisons identify NDST1 discordance.

Limitations: Absent protein with preserved transcript suggests a post-translational mechanism but does not directly measure degradation or trafficking.

Readouts

Absent NDST1 protein signal

NDST1 protein was absent in the patient-cell immunoblot.

Direction: ABOLISHED

Show evidence (1 reference)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT In Vitro

"Our findings indicate that cellular NDST1 protein levels are abolished in patient whole cell lysates"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. NDST1 immunoblot signal was absent in cultured patient-cell lysates; the corresponding transcript was not reduced. The assay measures protein abundance rather than direct EXT2 catalytic kinetics.

Show evidence (2 references)

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content SUPPORT In Vitro

"Our findings indicate that cellular NDST1 protein levels are abolished in patient whole cell lysates"

Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. NDST1 immunoblot signal was absent in cultured patient-cell lysates; the corresponding transcript was not reduced. The assay measures protein abundance rather than direct EXT2 catalytic kinetics.

+ 1 more reference

COS-7 and HEK293 EXT2 variant reconstruction CELL_LINE

Wild-type, p.Met87Arg, p.Arg95Cys and double-substitution constructs were compared in two cell lines. This is the reconstruction arm of the same founding study, not another clinical cohort.

Publication

PMID:26246518

Pathograph links

Reduced EXT2 Protein Availability perturbs Changing the encoded residues lowers EXT2 protein abundance, with the largest decrease for the double-substitution construct.

Limitations: Overexpression systems do not reproduce patient tissue dosage or directly measure HS-chain enzymatic activity.

Readouts

Construct-dependent EXT2 protein abundance

Protein levels were reduced by each construct and most by the double-substitution construct.

Direction: DECREASED

Show evidence (1 reference)

PMID:26246518 SUPPORT In Vitro

"We also performed an in vitro assay to determine which mutation has a larger effect on protein expression and observed reduced EXT2 expression in constructs expressing either one of the mutations but a greater reduction when both residues were mutated."

Constructs carrying either substitution lowered protein abundance; the double-substitution construct lowered it further. These are substitutions on the same complex allele, and the assay does not directly quantify residual glycosyltransferase activity.

Show evidence (1 reference)

PMID:26246518 SUPPORT In Vitro

"We also performed an in vitro assay to determine which mutation has a larger effect on protein expression and observed reduced EXT2 expression in constructs expressing either one of the mutations but a greater reduction when both residues were mutated."

Constructs carrying either substitution lowered protein abundance; the double-substitution construct lowered it further. These are substitutions on the same complex allele, and the assay does not directly quantify residual glycosyltransferase activity.

🐁

Animal Models

2

Ext2-null mouse

The homozygous-null arm arrests before gastrulation; the heterozygous arm survives with cartilage differentiation abnormalities and variably develops exostoses. The study was designed for HME, but its dosage/cartilage findings can inform a qualified shared EXT2 mechanism.

Species

Mouse

Genotype

Homozygous Ext2-null and heterozygous littermate arms

Publication

PMID:16236767

Pathograph links

Reduced EXT2 Protein Availability fails to recapitulate Complete null loss differs from the residual-expression complex allele in the founding patients.

Limitations: Embryonic arrest prevents assessment of postnatal neural manifestations. This is a genotype and developmental-stage mismatch, not proof that no useful model exists.

Show evidence (1 reference)

PMID:16236767 SUPPORT Model Organism

"Homozygous mutant embryos developed normally until embryonic day 6.0, when they became growth arrested and failed to gastrulate, pointing to the early essential role for heparan sulfate in developing embryos."

This documents mouse null-allele developmental arrest. It neither tests human biallelic null viability nor excludes partial mechanistic use of other Ext models.

Abnormal Chondrocyte Differentiation partially recapitulates The heterozygous arm reproduces abnormal cartilage differentiation relevant to the proposed skeletal route.

Limitations: Single null-allele mice are not the same genotype as biallelic missense AREXT2 patients; the human cartilage intermediate has not been measured.

Readouts

Disorganized chondrocytes and premature hypertrophy

Histological abnormalities in heterozygous mice.

Direction: ALTERED

Show evidence (1 reference)

PMID:16236767 SUPPORT INDIRECT Model Organism

"Significantly, all of the mice showed multiple abnormalities in cartilage differentiation, including disorganization of chondrocytes in long bones and premature hypertrophy in costochondral cartilage."

This refers to heterozygous Ext2-null mice. It supports a partial-loss cartilage mechanism while differing from the human biallelic missense genotypes.

Show evidence (1 reference)

PMID:16236767 SUPPORT INDIRECT Model Organism

"Significantly, all of the mice showed multiple abnormalities in cartilage differentiation, including disorganization of chondrocytes in long bones and premature hypertrophy in costochondral cartilage."

This refers to heterozygous Ext2-null mice. It supports a partial-loss cartilage mechanism while differing from the human biallelic missense genotypes.

Zebrafish ext2 dackel mutant

The model tests HS-dependent paracrine signaling during embryonic development. Maternal transcript permits early development; later HS reduction changes Fgf/Wnt responses. It is not an allele-matched human syndrome model.

Species

Zebrafish

Genotype

ext2 daktw25e mutant with genetic and morpholino perturbations

Publication

PMID:21892940

Pathograph links

Disrupted HS-Dependent FGF and Wnt Signaling partially recapitulates Direct fish experiments establish Fgf/Wnt sensitivity to ext2 deficiency.

Limitations: The developmental stage, allele and species differ from human AREXT2; selected Hh assays were normal and should not be generalized to all HS-dependent signaling.

Readouts

Reduced Fgf target-gene expression

etv5b and pea3 expression was reduced or more susceptible to Fgf inhibition in mutants.

Direction: DECREASED

Show evidence (1 reference)

PMID:21892940 SUPPORT Model Organism

"We found that Fgf targeted gene expression is reduced in ext2 mutants and that the remaining expression is readily inhibited by SU5402, an FGF receptor inhibitor."

Expression and inhibitor response are assay readouts of the Fgf signaling change.

Enhanced response to partial Wnt inhibition

Partial Wnt11/Wnt5b morpholino effects were greater in ext2 mutants.

Direction: ALTERED

Show evidence (1 reference)

PMID:21892940 SUPPORT INDIRECT Model Organism

"Also, Wnt signaling is affected in the ext2 mutants, as shown by a stronger phenotype in ext2 mutants injected with morpholinos that partially block translation of Wnt11 or Wnt5b, compared to injected wild type embryos."

Morpholino sensitization supports a Wnt signaling role in ext2 fish, not a measured Wnt deficit in AREXT2 patients.

Show evidence (2 references)

PMID:21892940 SUPPORT INDIRECT Model Organism

"In the ext2 mutants, Fgf signaling is shown to be affected during nervous system development and reduction of Fgf ligands in the mutants affects tail development."

The ext2 zebrafish model demonstrates altered developmental Fgf signaling; the tail experiment is not a human skeletal or neural phenotype.

+ 1 more reference

{ }

Source YAML

click to show

name: Seizures-scoliosis-macrocephaly syndrome
creation_date: "2026-08-29T00:00:00Z"
category: Mendelian
synonyms:
- SSMS
- SSM syndrome
- seizures, scoliosis, and macrocephaly syndrome
- AREXT2
- autosomal recessive EXT2-related syndrome
description: >-
  Seizures-scoliosis-macrocephaly syndrome, also called autosomal recessive EXT2-related syndrome (AREXT2), is a neurodevelopmental disorder associated with biallelic EXT2 variants. The original four siblings carried both p.Met87Arg and p.Arg95Cys in homozygous state on a complex allele. Subsequent families expanded the phenotype to microcephaly, variable scoliosis and multiple exostoses. Neither macrocephaly nor absence of exostoses is obligatory.


  Reduced EXT2 abundance and altered heparan-sulfate biosynthesis provide the supported molecular framework. Functional evidence is strongest for the original complex missense allele; it does not establish the residual activity of every reported variant. A later skeletal-dysplasia case had nonsense and splice-site variants in trans, but its AREXT2 attribution remained explicitly uncertain. Ext2-null mouse embryonic lethality is model evidence and does not prove that every human biallelic null genotype is lethal.


  Autosomal dominant hereditary multiple exostoses is an allelic disorder. Variant-specific mechanism, phase, segregation and clinical findings matter: the unaffected heterozygous relatives in AREXT2 families must not automatically be assigned a dominant exostosis genotype.
disease_term:
  preferred_term: seizures-scoliosis-macrocephaly syndrome
  term:
    id: MONDO:0014731
    label: seizures-scoliosis-macrocephaly syndrome
parents:
- Congenital disorder of glycosylation
- Hereditary disease
references:
- reference: PMID:26246518
  title: "Old gene, new phenotype: mutations in heparan sulfate synthesis enzyme, EXT2 leads to seizure and developmental disorder, no exostoses."
- reference: PMID:30075207
  title: A novel EXT2 mutation in a consanguineous family with severe developmental delay, microcephaly, seizures, feeding difficulties, and osteopenia extends the phenotypic spectrum of autosomal recessive EXT2-related syndrome (AREXT2).
- reference: PMID:30288735
  title: "Novel exostosin-2 missense variants in a family with autosomal recessive exostosin-2-related syndrome: further evidences on the phenotype."
- reference: PMID:30997052
  title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
- reference: PMID:16236767
  title: Mice deficient in Ext2 lack heparan sulfate and develop exostoses.
- reference: PMID:18337501
  title: Heparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and heparan sulfate sulfation.
- reference: PMID:21892940
  title: Zebrafish Ext2 is necessary for Fgf and Wnt signaling, but not for Hh signaling.
- reference: PMID:34092239
  title: Diagnostic yield of rare skeletal dysplasia conditions in the radiogenomics era.
- reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
  title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
- reference: DOI:10.1016/j.ejmg.2018.07.025
  title: "A novel EXT2 mutation in a consanguineous family with severe developmental delay, microcephaly, seizures, feeding difficulties, and osteopenia extends the phenotypic spectrum of autosomal recessive EXT2-related syndrome (AREXT2)"
- reference: PMID:16472589
  title: Intermittent spatial separation of diaphragm and lower esophageal sphincter favors acidic and weakly acidic reflux.
- reference: PMID:38803636
  title: 'Identification and treatment of intestinal malrotation with midgut volvulus in childhood: a multicenter retrospective study.'
classifications:
  icimd_category:
  - classification_value: o_linked_protein_glycosylation
    notes: >-
      ICIMD disorders of O-linked protein glycosylation include glycosaminoglycan synthesis. EXT2 participates in HS biosynthesis on the O-linked proteoglycan linker. The classification follows the biosynthetic mechanism, not a claim that every measured fluid has low HS or that urinary HS excludes a mucopolysaccharidosis.
    evidence:
    - reference: PMID:30288735
      reference_title: "Novel exostosin-2 missense variants in a family with autosomal recessive exostosin-2-related syndrome: further evidences on the phenotype."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        AREXT2 syndrome can be considered as a multiorgan Congenital Disorder of Glycosylation caused by a significant, but non-lethal, decrease in EXT2 expression, thereby affecting the synthesis of the heparan sulfate proteoglycans, which is relevant in many physiological processes.
      explanation: >-
        The authors classify the disorder as a congenital disorder of glycosylation and propose a nonlethal partial-loss mechanism; this is disease interpretation rather than a directly measured clinical phenotype.
inheritance:
- name: Autosomal recessive inheritance
  inheritance_term:
    preferred_term: Autosomal recessive inheritance
    term:
      id: HP:0000007
      label: Autosomal recessive inheritance
  description: >-
    Reported AREXT2 families show biallelic inheritance, including homozygous complex alleles and compound heterozygous variants. Unaffected heterozygous relatives support recessive segregation for those alleles. A heterozygous EXT2 variant must be interpreted for its specific pathogenic mechanism; it is not automatically a dominant hereditary multiple exostoses diagnosis.
  evidence:
  - reference: PMID:26246518
    reference_title: "Old gene, new phenotype: mutations in heparan sulfate synthesis enzyme, EXT2 leads to seizure and developmental disorder, no exostoses."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In short, we have unravelled the genetic basis of a new recessive disorder, seizures-scoliosis-macrocephaly syndrome.
    explanation: >-
      The paper's own conclusion that the disorder is recessive.
  - reference: PMID:26246518
    reference_title: "Old gene, new phenotype: mutations in heparan sulfate synthesis enzyme, EXT2 leads to seizure and developmental disorder, no exostoses."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      To confirm the autosomal-recessive mode of inheritance, all available family members were genotyped.
    explanation: >-
      Documents the segregation analysis behind that conclusion.
  - reference: PMID:30075207
    reference_title: A novel EXT2 mutation in a consanguineous family with severe developmental delay, microcephaly, seizures, feeding difficulties, and osteopenia extends the phenotypic spectrum of autosomal recessive EXT2-related syndrome (AREXT2).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Segregation analysis by Sanger sequencing confirmed homozygous by descent autosomal recessive transmission of this mutation.
    explanation: >-
      Independent confirmation of recessive transmission in a second family.
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: ULTRA_RARE
  notes: >-
    The reviewed reports provide small family series rather than a population prevalence estimate. The founding study described four affected siblings in 2015, followed by further families and an explicitly uncertain candidate case.
  evidence:
  - reference: PMID:26246518
    reference_title: "Old gene, new phenotype: mutations in heparan sulfate synthesis enzyme, EXT2 leads to seizure and developmental disorder, no exostoses."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Herein, we describe a consanguineous family of four sibs with a novel disorder, which we designate as seizures-scoliosis-macrocephaly syndrome, characterised by seizures, intellectual disability, hypotonia, scoliosis, macrocephaly, hypertelorism and renal dysfunction.
    explanation: >-
      This counts the four siblings in the founding family; it does not supply a population prevalence or ascertainment denominator.
  - reference: PMID:30288735
    reference_title: "Novel exostosin-2 missense variants in a family with autosomal recessive exostosin-2-related syndrome: further evidences on the phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Here, we report the third family affected by AREXT2 syndrome, harboring compound missense variants in EXT2, p.Asp227Asn, and p.Tyr608Cys.
    explanation: >-
      Establishes that only a small number of families had been reported by
      2019.
pathophysiology:
- name: Reduced EXT2 Protein Availability
  biological_scale: MOLECULAR
  description: >-
    The founding homozygous complex p.Met87Arg/p.Arg95Cys allele reduces EXT2 abundance in cultured patient fibroblasts and reconstructed COS-7/HEK293 cells. Each substitution contributes, with the larger effect from p.Arg95Cys and the greatest decrease when both are present. These protein-expression experiments do not establish an activity fraction for every AREXT2 allele.
  evidence:
  - reference: PMID:26246518
    reference_title: 'Old gene, new phenotype: mutations in heparan sulfate synthesis enzyme, EXT2 leads to seizure and developmental disorder, no exostoses.'
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      We also performed an in vitro assay to determine which mutation has a larger effect on protein expression and observed reduced EXT2 expression in constructs expressing either one of the mutations but a greater reduction when both residues were mutated.
    explanation: >-
      Constructs carrying either substitution lowered protein abundance; the double-substitution construct lowered it further. These are substitutions on the same complex allele, and the assay does not directly quantify residual glycosyltransferase activity.
  - &id009
    reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      We observed diminished EXT2 protein expression relative to a healthy EXT2-WT control (P<0.001)
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Cultured patient fibroblasts showed reduced EXT2 protein. This is an in-vitro patient-derived assay, not a tissue-wide concentration measurement.
  genes:
  - preferred_term: EXT2
    term:
      id: hgnc:3513
      label: EXT2
  downstream:
  - target: Impaired Heparan Sulfate Biosynthesis
    description: >-
      Reduced EXT2 availability compromises the EXT1/EXT2 biosynthetic complex. The founding study proposes impaired HS synthesis; complete absence of polymerization or uniformly short chains in human tissues was not measured.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - &id003
      reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        both variants contribute to decreased EXT2 expression potentially destabilizing the protein, disrupting heparan sulfate biosynthesis, and probably other developmental cascades requiring EXT2 for propagation, such as FGF and Wnt signalling
      explanation: >-
        Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The founding-study discussion proposes this causal sequence; FGF/Wnt activity was not measured in the patients.
      directness: INDIRECT
  - target: Reduced NDST1 Protein Stability
    description: >-
      Loss of available EXT2 is proposed to reduce stabilization or processing of its interacting protein NDST1. The founding cells show protein/transcript discordance, supported by independent coexpression work; the exact degradation route remains unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - &id001
      reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        Our findings indicate that cellular NDST1 protein levels are abolished in patient whole cell lysates
      explanation: >-
        Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. NDST1 immunoblot signal was absent in cultured patient-cell lysates; the corresponding transcript was not reduced. The assay measures protein abundance rather than direct EXT2 catalytic kinetics.
    - &id002
      reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        suggesting the absence of NDST1 protein expression is a product of an error in post-translational modification
      explanation: >-
        Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The authors infer post-translational instability or processing from protein/transcript discordance; protein turnover and the exact compartment were not directly measured.
      directness: INDIRECT
  - target: Seizure
    description: >-
      The founding genetic and functional study attributes the seizure-developmental syndrome to the complex EXT2 allele. This broad etiologic relation is retained with unresolved epileptogenic intermediates; the separate neural-patterning hypothesis is not treated as a demonstrated seizure circuit.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:26246518
      reference_title: 'Old gene, new phenotype: mutations in heparan sulfate synthesis enzyme, EXT2 leads to seizure and developmental disorder, no exostoses.'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        In short, we have unravelled the genetic basis of a new recessive disorder, seizures-scoliosis-macrocephaly syndrome.
      explanation: >-
        The study’s segregation and variant-expression experiments underpin its explicit etiologic conclusion about the defining seizure-developmental syndrome. This supports genetic attribution, not proof of a particular HS-dependent epileptogenic pathway.
      directness: INDIRECT
    - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Features seen in all affected individuals include: moderate intellectual disability, seizure disorder with onset between two and five years of age, hypotonia, scoliosis, macrocephaly, coarse facies, bilateral cryptorchidism in males, long hypoplastic philtrum, and hypertelorism.
      explanation: >-
        Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The clinical spectrum establishes seizure disorder in all four individuals carrying the causal complex allele; it does not measure circuit function.
      directness: INDIRECT
- name: Reduced NDST1 Protein Stability
  biological_scale: MOLECULAR
  description: >-
    Absence of NDST1 protein despite preserved transcript in the founding patient fibroblasts suggests post-translational loss. Independent EXT2/NDST1 coexpression experiments show altered NDST1 abundance, glycosylation and HS sulfation, but do not identify the exact degradation or trafficking step in AREXT2.
  evidence:
  - *id001
  - *id002
  mechanism_confidence: PROVISIONAL
  downstream:
  - target: Impaired Heparan Sulfate Biosynthesis
    description: >-
      NDST1 loss is proposed to impair the sulfation component of HS biosynthesis, alongside reduced EXT2 polymerization capacity. The patient study did not directly assay sulfation; independent enzyme-expression perturbations establish that NDST1 abundance can change HS structure.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:18337501
      reference_title: Heparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and heparan sulfate sulfation.
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        Whereas overexpression of EXT2 in HEK 293 cells enhanced NDST1 expression, increased NDST1 N-glycosylation, and resulted in elevated HS sulfation, overexpression of EXT1 had opposite effects.
      explanation: >-
        The intervention measured coordinated protein/glycosylation/sulfation changes. Its direction supports biochemical coupling, while the patient consequence remains an indirect inference rather than a measured reversal experiment.
      directness: INDIRECT
    - *id002
- name: Impaired Heparan Sulfate Biosynthesis
  biological_scale: MOLECULAR
  description: >-
    EXT1/EXT2 form the HS chain-polymerization machinery, with NDST1 contributing N-sulfation. AREXT2 is interpreted as impaired HS biosynthesis with residual function. Patient blood measurements provide limited biochemical support, but do not quantify tissue-wide polymer abundance, chain length or sulfation, and the urine interpretation conflicts with its reference table.
  evidence:
  - reference: PMID:18337501
    reference_title: Heparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and heparan sulfate sulfation.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      During polymerization of the HS chain, carried out by a complex of the exostosin proteins EXT1 and EXT2, the first modification enzyme, glucosaminyl N-deacetylase/N-sulfotransferase (NDST), introduces N-sulfate groups into the growing polymer.
    explanation: >-
      Background biochemistry distinguishes chain polymerization from NDST-dependent modification.
  - *id003
  mechanism_confidence: PROVISIONAL
  cellular_components:
  - preferred_term: Golgi apparatus
    term:
      id: GO:0005794
      label: Golgi apparatus
  biological_processes:
  - preferred_term: heparan sulfate proteoglycan biosynthetic process
    modifier: DECREASED
    term:
      id: GO:0015012
      label: heparan sulfate proteoglycan biosynthetic process
  downstream:
  - target: Disrupted HS-Dependent FGF and Wnt Signaling
    description: >-
      Reduced HS can alter growth-factor presentation and signaling. The human hypothesis is supported by ext2 zebrafish Fgf/Wnt perturbations; receptor-complex stability and ligand transport are alternatives, not established patient intermediates.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - *id003
    - &id004
      reference: PMID:21892940
      reference_title: Zebrafish Ext2 is necessary for Fgf and Wnt signaling, but not for Hh signaling.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        In the ext2 mutants, Fgf signaling is shown to be affected during nervous system development and reduction of Fgf ligands in the mutants affects tail development.
      explanation: >-
        The ext2 zebrafish model demonstrates altered developmental Fgf signaling; the tail experiment is not a human skeletal or neural phenotype.
      directness: INDIRECT
    - &id005
      reference: PMID:21892940
      reference_title: Zebrafish Ext2 is necessary for Fgf and Wnt signaling, but not for Hh signaling.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Also, Wnt signaling is affected in the ext2 mutants, as shown by a stronger phenotype in ext2 mutants injected with morpholinos that partially block translation of Wnt11 or Wnt5b, compared to injected wild type embryos.
      explanation: >-
        Morpholino sensitization supports a Wnt signaling role in ext2 fish, not a measured Wnt deficit in AREXT2 patients.
      directness: INDIRECT
  - target: Abnormal Chondrocyte Differentiation
    description: >-
      Partial Ext2 loss disrupts cartilage differentiation in mice. This is retained as a qualified shared mechanism for the exostosis-positive AREXT2 family, not proof that it causes scoliosis or osteopenia in every genotype.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - &id007
      reference: PMID:16236767
      reference_title: Mice deficient in Ext2 lack heparan sulfate and develop exostoses.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Significantly, all of the mice showed multiple abnormalities in cartilage differentiation, including disorganization of chondrocytes in long bones and premature hypertrophy in costochondral cartilage.
      explanation: >-
        This refers to heterozygous Ext2-null mice. It supports a partial-loss cartilage mechanism while differing from the human biallelic missense genotypes.
      directness: INDIRECT
    - &id008
      reference: PMID:30288735
      reference_title: 'Novel exostosin-2 missense variants in a family with autosomal recessive exostosin-2-related syndrome: further evidences on the phenotype.'
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Our finding expands the clinical and molecular spectrum of the AREXT2 syndrome and suggests a possible genotype/phenotype correlation in the development of the exostoses.
      explanation: >-
        Gentile proposes genotype dependence in the recessive family; it does not establish the same cellular threshold as the mouse or a dominant HME cohort.
      directness: INDIRECT
- name: Disrupted HS-Dependent FGF and Wnt Signaling
  biological_scale: CELLULAR
  description: >-
    Fgf and Wnt signaling are affected in ext2 zebrafish embryos. Reduced Fgf target-gene expression precedes later midbrain-hindbrain patterning changes; Wnt11/Wnt5b partial inhibition gives greater abnormalities in mutants. Hh target expression and selected differentiation assays were preserved. The founding human study proposes involvement of these pathways without direct patient signaling assays.
  evidence:
  - *id004
  - *id005
  - *id003
  mechanism_confidence: PROVISIONAL
  downstream:
  - target: Altered Neural Patterning and Connectivity
    description: >-
      Reduced developmental signaling is proposed to disturb neural patterning. In fish, reduced Fgf signaling precedes abnormal midbrain-hindbrain signaling; the authors cautiously interpret this as a possible cause, not a complete reconstruction of human brain development.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:21892940
      reference_title: Zebrafish Ext2 is necessary for Fgf and Wnt signaling, but not for Hh signaling.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        suggests that a reduction of Fgf signaling is a possible cause of the reduction in MHB signaling.
      explanation: >-
        Temporal ordering of fish expression readouts supports a possible Fgf-to-patterning route; it is not definitive human causal validation.
      directness: INDIRECT
    - &id006
      reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        while residual levels of heparan sulfate facilitate some cellular functions, they are not sufficient for proper neural development including brain morphology and midline axon guidance
      explanation: >-
        Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The authors use Ext-model evidence to propose impaired neural development in human partial-loss disease. This is a translational hypothesis, not patient brain histology.
      directness: INDIRECT
- name: Altered Neural Patterning and Connectivity
  biological_scale: TISSUE
  description: >-
    Insufficient or mistimed HS-dependent signaling may impair brain patterning, axon guidance and circuit development. This source-proposed pathway explains developmental impairment and macrocephaly provisionally; no patient brain assay establishes the detailed circuit lesion or why other families have microcephaly.
  evidence:
  - *id006
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      these studies help explain why SSM patients are alive but have macrocephaly and are severely delayed in their developmental course.
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The authors explicitly connect the model-based neural-development explanation to macrocephaly and severe developmental delay in the founding family.
    directness: INDIRECT
  mechanism_confidence: PROVISIONAL
  downstream:
  - target: Global developmental delay
    description: >-
      The authors explicitly connect deficient HS-dependent neural development to severe developmental delay; motor and cognitive domains are affected in the clinical reports.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        these studies help explain why SSM patients are alive but have macrocephaly and are severely delayed in their developmental course.
      explanation: >-
        Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The authors explicitly connect the model-based neural-development explanation to macrocephaly and severe developmental delay in the founding family.
      directness: INDIRECT
  - target: Intellectual disability
    description: >-
      The proposed disturbance of neural development provides a qualified explanation for the founding family’s cognitive impairment. It is not a measured IQ-to-pathway association.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        these studies help explain why SSM patients are alive but have macrocephaly and are severely delayed in their developmental course.
      explanation: >-
        Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The authors explicitly connect the model-based neural-development explanation to macrocephaly and severe developmental delay in the founding family.
      directness: INDIRECT
  - target: Delayed speech and language development
    description: >-
      Impaired neural development is a qualified explanation for the language component of the developmental phenotype; the source documents minimal expressive speech in the founding family but does not isolate a language-specific circuit.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        while residual levels of heparan sulfate facilitate some cellular functions, they are not sufficient for proper neural development including brain morphology and midline axon guidance
      explanation: >-
        Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The authors use Ext-model evidence to propose impaired neural development in human partial-loss disease. This is a translational hypothesis, not patient brain histology.
      directness: INDIRECT
  - target: Macrocephaly
    description: >-
      The founding-study discussion explicitly links altered HS-dependent brain-size/structure development to macrocephaly. This does not explain the opposite head-size direction in the El-Bazzal family.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        these studies help explain why SSM patients are alive but have macrocephaly and are severely delayed in their developmental course.
      explanation: >-
        Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The authors explicitly connect the model-based neural-development explanation to macrocephaly and severe developmental delay in the founding family.
      directness: INDIRECT
- name: Abnormal Chondrocyte Differentiation
  biological_scale: TISSUE
  description: >-
    Heterozygous Ext2-null mice show disorganized chondrocytes and premature hypertrophy. This supplies a plausible partial-loss cartilage mechanism for the exostosis-positive AREXT2 family, while allele, dosage and tissue thresholds differ and have not been tested in its patients.
  evidence:
  - *id007
  - *id008
  mechanism_confidence: PROVISIONAL
  downstream:
  - target: Multiple exostoses
    description: >-
      Abnormal cartilage differentiation is linked to ectopic bone growth in the Ext2 mouse model. The Gentile family establishes the human manifestation and proposes genotype dependence; the modeled causal route remains provisional for recessive AREXT2.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:16236767
      reference_title: Mice deficient in Ext2 lack heparan sulfate and develop exostoses.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        The finding that haploinsufficiency triggers abnormal cartilage differentiation gives insight into the complex molecular mechanisms underlying the development of exostoses.
      explanation: >-
        The model authors causally connect Ext2 dosage, abnormal cartilage differentiation and exostoses. Translation to AREXT2 remains provisional and genotype-dependent.
      directness: INDIRECT
    - *id008
- name: Seizure-Associated Brain Injury
  biological_scale: TISSUE
  description: >-
    In founding patient II-4, a four-hour seizure at age five caused significant brain injury, followed by right hemiplegia and loss of walking. This acquired route is separate from baseline developmental impairment and from the Gupta proband’s regression before epilepsy.
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      During one episode at the age of five, she had a four-hour long seizure and sustained significant brain injury. She was rendered hemiplegic on the right side, and has been wheelchair bound since that event.
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. II-4 sustained brain injury during a four-hour seizure, followed by right hemiplegia and wheelchair dependence; this clinical attribution supports a secondary injury route.
  downstream:
  - target: Hemiplegia
    description: >-
      The documented seizure-associated brain injury was followed by right hemiplegia in II-4.
    causal_link_type: DIRECT
    evidence:
    - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        During one episode at the age of five, she had a four-hour long seizure and sustained significant brain injury. She was rendered hemiplegic on the right side, and has been wheelchair bound since that event.
      explanation: >-
        Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. II-4 sustained brain injury during a four-hour seizure, followed by right hemiplegia and wheelchair dependence; this clinical attribution supports a secondary injury route.
  - target: Inability to walk
    description: >-
      II-4 lost independent walking after the injury and remained wheelchair dependent; the report gives no more detailed motor-pathway localization.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        During one episode at the age of five, she had a four-hour long seizure and sustained significant brain injury. She was rendered hemiplegic on the right side, and has been wheelchair bound since that event.
      explanation: >-
        Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. II-4 sustained brain injury during a four-hour seizure, followed by right hemiplegia and wheelchair dependence; this clinical attribution supports a secondary injury route.
  - target: Developmental regression
    description: >-
      Loss of a previously acquired walking skill after status-associated brain injury accounts for a motor-regression component in II-4. It does not explain all neurological regression across families.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        all four affected sibs were capable of independent ambulation although case II-4 lost her ability to walk after an episode of prolonged status epilepticus.
      explanation: >-
        Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. This is a documented loss of an acquired motor skill after prolonged status, distinct from Gupta’s earlier verbal/social regression.
phenotypes:
- name: Seizure
  category: Neurologic
  diagnostic: true
  description: >-
    Epilepsy includes generalized and focal seizures, prolonged seizures and status epilepticus. The founding family had onset between two and five years; the El-Bazzal brothers had onset at 6 and 16 months in the full report, whereas the Gupta proband began at ten years. These are family-specific observations, not a uniform onset range.
  phenotype_term:
    preferred_term: Seizure
    term:
      id: HP:0001250
      label: Seizure
  evidence:
  - reference: PMID:26246518
    reference_title: "Old gene, new phenotype: mutations in heparan sulfate synthesis enzyme, EXT2 leads to seizure and developmental disorder, no exostoses."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Herein, we describe a consanguineous family of four sibs with a novel disorder, which we designate as seizures-scoliosis-macrocephaly syndrome, characterised by seizures, intellectual disability, hypotonia, scoliosis, macrocephaly, hypertelorism and renal dysfunction.
    explanation: >-
      Records seizures among the defining features.
- name: Intellectual disability
  category: Neurologic
  diagnostic: true
  description: >-
    Intellectual disability with developmental delay, present in every reported
    family and in some the presenting problem.
  phenotype_term:
    preferred_term: Intellectual disability
    term:
      id: HP:0001249
      label: Intellectual disability
  evidence:
  - reference: PMID:26246518
    reference_title: "Old gene, new phenotype: mutations in heparan sulfate synthesis enzyme, EXT2 leads to seizure and developmental disorder, no exostoses."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Herein, we describe a consanguineous family of four sibs with a novel disorder, which we designate as seizures-scoliosis-macrocephaly syndrome, characterised by seizures, intellectual disability, hypotonia, scoliosis, macrocephaly, hypertelorism and renal dysfunction.
    explanation: >-
      Records intellectual disability among the defining features.
- name: Scoliosis
  category: Skeletal
  diagnostic: true
  description: >-
    The founding-study narrative describes scoliosis or kyphoscoliosis in all four siblings, while its clinical table marks three and leaves one cell blank. Gupta Table 2 reproduces this as three positives and one negative. No four-patient frequency is assigned across these inconsistent summaries. Scoliosis was also reported in the Gentile family and absent in the El-Bazzal brothers and Gupta proband.
  phenotype_term:
    preferred_term: Scoliosis
    term:
      id: HP:0002650
      label: Scoliosis
  evidence:
  - reference: PMID:26246518
    reference_title: "Old gene, new phenotype: mutations in heparan sulfate synthesis enzyme, EXT2 leads to seizure and developmental disorder, no exostoses."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Herein, we describe a consanguineous family of four sibs with a novel disorder, which we designate as seizures-scoliosis-macrocephaly syndrome, characterised by seizures, intellectual disability, hypotonia, scoliosis, macrocephaly, hypertelorism and renal dysfunction.
    explanation: >-
      Records scoliosis among the defining features of the index family.
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      However, skeletal issues such as scoliosis and decreased bone density and muscular issues such as hypotonia, observed with this disorder, were not observed in our patient.
    explanation: >-
      A biallelic EXT2 patient without scoliosis, which is why the feature is not
      treated as obligate.
- name: Macrocephaly
  category: Craniofacial
  diagnostic: true
  description: >-
    Macrocephaly was reported in the founding family and the Gupta proband, whereas the El-Bazzal family had microcephaly. Head size is heterogeneous even among reported biallelic genotypes.
  phenotype_term:
    preferred_term: Macrocephaly
    term:
      id: HP:0000256
      label: Macrocephaly
  evidence:
  - reference: PMID:26246518
    reference_title: "Old gene, new phenotype: mutations in heparan sulfate synthesis enzyme, EXT2 leads to seizure and developmental disorder, no exostoses."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Herein, we describe a consanguineous family of four sibs with a novel disorder, which we designate as seizures-scoliosis-macrocephaly syndrome, characterised by seizures, intellectual disability, hypotonia, scoliosis, macrocephaly, hypertelorism and renal dysfunction.
    explanation: >-
      Records macrocephaly in the family that named the syndrome.
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      Macrocephaly + + + +
      Cryptorchidism + +  +
      Precocious puberty    +
      Scoliosis + + +
      Hiatus hernia +
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. All four are labeled macrocephalic in the founding clinical table, although one listed circumference is at the 90th percentile. The table and narrative diagnoses are preserved without redefining the quantitative HPO threshold.
- name: Microcephaly
  category: Craniofacial
  description: >-
    Microcephaly rather than macrocephaly in a second consanguineous family. The
    two head-size findings are recorded as separate phenotypes rather than
    averaged, because the direction is opposite and the syndrome name asserts
    only one of them.
  phenotype_term:
    preferred_term: Microcephaly
    term:
      id: HP:0000252
      label: Microcephaly
  evidence:
  - reference: PMID:30075207
    reference_title: A novel EXT2 mutation in a consanguineous family with severe developmental delay, microcephaly, seizures, feeding difficulties, and osteopenia extends the phenotypic spectrum of autosomal recessive EXT2-related syndrome (AREXT2).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report a consanguineous family where 2 boys presented with developmental delay, hypotonia, microcephaly, seizures, gastro-intestinal abnormalities, osteopenia, and neurological regression.
    explanation: >-
      Documents microcephaly in a family with the same recessive disorder.
- name: Hypotonia
  category: Neurologic
  description: >-
    Hypotonia was reported in the founding and El-Bazzal families and in one Gentile patient. It was explicitly absent in the Gupta proband.
  phenotype_term:
    preferred_term: Hypotonia
    term:
      id: HP:0001252
      label: Hypotonia
  evidence:
  - reference: PMID:26246518
    reference_title: "Old gene, new phenotype: mutations in heparan sulfate synthesis enzyme, EXT2 leads to seizure and developmental disorder, no exostoses."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Herein, we describe a consanguineous family of four sibs with a novel disorder, which we designate as seizures-scoliosis-macrocephaly syndrome, characterised by seizures, intellectual disability, hypotonia, scoliosis, macrocephaly, hypertelorism and renal dysfunction.
    explanation: >-
      Records hypotonia among the defining features.
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      However, skeletal issues such as scoliosis and decreased bone density and muscular issues such as hypotonia, observed with this disorder, were not observed in our patient.
    explanation: >-
      The Gupta proband lacked hypotonia despite biallelic EXT2 variants; tone abnormalities are variable.
- name: Hypertelorism
  category: Craniofacial
  description: >-
    Hypertelorism, part of the dysmorphic facial pattern together with coarse
    features and a long hypoplastic philtrum.
  phenotype_term:
    preferred_term: Hypertelorism
    term:
      id: HP:0000316
      label: Hypertelorism
  evidence:
  - reference: PMID:26246518
    reference_title: "Old gene, new phenotype: mutations in heparan sulfate synthesis enzyme, EXT2 leads to seizure and developmental disorder, no exostoses."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Herein, we describe a consanguineous family of four sibs with a novel disorder, which we designate as seizures-scoliosis-macrocephaly syndrome, characterised by seizures, intellectual disability, hypotonia, scoliosis, macrocephaly, hypertelorism and renal dysfunction.
    explanation: >-
      Records hypertelorism among the defining features.
- name: Coarse facial features
  category: Craniofacial
  description: >-
    Coarse facial features were reported in several families. They prompted mucopolysaccharidosis screening in the Gupta proband; no referral frequency has been measured.
  phenotype_term:
    preferred_term: Coarse facial features
    term:
      id: HP:0000280
      label: Coarse facial features
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Biochemical screening for mucopolysaccharidoses was performed in view of the coarse facial features and revealed low levels of heparan sulfate in dried blood spot (12 nmol/L), serum (4.46 ng/mL), and urine (0.5 mg/mmol creatinine) specimens (Reference ranges given in Table 1).
    explanation: >-
      Records the coarse facies and the screening it prompted in the same
      sentence.
- name: Abnormal renal physiology
  category: Renal
  description: >-
    Renal abnormalities occurred in the founding family, including hematuria and proteinuria. II-3 developed hemolytic uremic syndrome at 18 months and required peritoneal dialysis, providing a competing or proximate explanation for his renal failure. The Gupta comparison table also records unspecified renal involvement in one Gentile patient.
  phenotype_term:
    preferred_term: Abnormal renal physiology
    term:
      id: HP:0012211
      label: Abnormal renal physiology
  evidence:
  - reference: PMID:26246518
    reference_title: "Old gene, new phenotype: mutations in heparan sulfate synthesis enzyme, EXT2 leads to seizure and developmental disorder, no exostoses."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Herein, we describe a consanguineous family of four sibs with a novel disorder, which we designate as seizures-scoliosis-macrocephaly syndrome, characterised by seizures, intellectual disability, hypotonia, scoliosis, macrocephaly, hypertelorism and renal dysfunction.
    explanation: >-
      Records renal dysfunction among the defining features.
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      he developed hemolytic uremic syndrome and required peritoneal dialysis.
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. This names a renal comorbidity and treatment in II-3; it does not establish EXT2 deficiency as the cause of hemolytic uremic syndrome.
- name: Developmental regression
  category: Neurologic
  description: >-
    Neurological regression occurred in the El-Bazzal family. The Gupta proband lost verbal and social skills with cognitive decline at 27 months, well before seizure onset at 10 years; epilepsy cannot explain that early regression by chronology alone.
  phenotype_term:
    preferred_term: Developmental regression
    term:
      id: HP:0002376
      label: Developmental regression
  evidence:
  - reference: PMID:30075207
    reference_title: A novel EXT2 mutation in a consanguineous family with severe developmental delay, microcephaly, seizures, feeding difficulties, and osteopenia extends the phenotypic spectrum of autosomal recessive EXT2-related syndrome (AREXT2).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report a consanguineous family where 2 boys presented with developmental delay, hypotonia, microcephaly, seizures, gastro-intestinal abnormalities, osteopenia, and neurological regression.
    explanation: >-
      Records neurological regression in a reported family.
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Developmental regression of verbal and social skills along with cognitive decline was reported at 27 months.
    explanation: >-
      This dates regression in the Gupta proband, whose seizures began at 10 years; the source does not establish seizures as the cause of this earlier decline.
- name: Osteopenia
  category: Skeletal
  description: >-
    Reduced bone density was documented in the El-Bazzal brothers and summarized for members of the founding family. It was explicitly absent in the Gupta proband; the skeletal phenotype varies between families.
  phenotype_term:
    preferred_term: Osteopenia
    term:
      id: HP:0000938
      label: Osteopenia
  evidence:
  - reference: PMID:30075207
    reference_title: A novel EXT2 mutation in a consanguineous family with severe developmental delay, microcephaly, seizures, feeding difficulties, and osteopenia extends the phenotypic spectrum of autosomal recessive EXT2-related syndrome (AREXT2).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report a consanguineous family where 2 boys presented with developmental delay, hypotonia, microcephaly, seizures, gastro-intestinal abnormalities, osteopenia, and neurological regression.
    explanation: >-
      Records osteopenia in a reported family.
- name: Ventricular septal defect
  category: Cardiovascular
  description: >-
    Reported in two of four siblings of the founding family. This family-level observation is not an estimate of frequency across AREXT2 genotypes.
  phenotype_term:
    preferred_term: Ventricular septal defect
    term:
      id: HP:0001629
      label: Ventricular septal defect
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      There is clinical heterogeneity in this disorder, with two of four patients with biallelic EXT2 alterations noted to have a ventricular septal defect.1
    explanation: >-
      Gupta summarizes two affected individuals among the four founding siblings; this is a selected family denominator, not syndrome-wide prevalence.
- name: Autism
  category: Behavioral
  description: >-
    Autism was reported in the Gupta proband and summarized for the Gentile patients. The Gupta twin sister had a reported Asperger syndrome diagnosis with milder motor, cognitive and speech difficulties. Both twins carried the same EXT2 pair and the same monoallelic NDST1 VUS; their different severity cannot be attributed to that shared VUS alone.
  phenotype_term:
    preferred_term: Autism
    term:
      id: HP:0000717
      label: Autism
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report a patient with developmental delay, autism, epilepsy, macrocephaly, facial dysmorphism, gastrointestinal, and behavioral issues due to EXT2 compound heterozygous likely pathogenic variants.
    explanation: >-
      Records autism among the presenting features of a biallelic EXT2 patient.
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Her fraternal twin sister has Asperger syndrome (diagnosed at 3 years of age), mild motor delays, and a history of cognitive and speech delays, which had improved over time.
    explanation: >-
      The narrative describes an autism-spectrum diagnosis in the milder twin, although Table 2 marks her Autism row negative. Preserve the stated diagnosis and this narrative/table terminology discrepancy.
- name: Gastroesophageal reflux
  category: Gastrointestinal
  description: >-
    Gastro-oesophageal reflux, part of the gastrointestinal involvement reported
    in more than one family.
  phenotype_term:
    preferred_term: Gastroesophageal reflux
    term:
      id: HP:0002020
      label: Gastroesophageal reflux
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Additional features include sensitive skin prone to acne and gastro‐intestinal problems such as constipation and gastroesophageal reflux.
    explanation: >-
      Names both gastrointestinal problems in the patient described in detail.
  sequelae:
  - target: Esophageal ulceration
    description: >-
      The founding report attributes esophageal ulceration to the associated severe reflux in II-1; this is a case-specific mucosal complication.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Significant gastroesophageal reflux and associated ulceration of the esophagus were documented.
      explanation: >-
        Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The report explicitly associates the reflux and ulceration in II-1.
- name: Constipation
  category: Gastrointestinal
  description: >-
    Constipation, reported alongside the reflux.
  phenotype_term:
    preferred_term: Constipation
    term:
      id: HP:0002019
      label: Constipation
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Additional features include sensitive skin prone to acne and gastro‐intestinal problems such as constipation and gastroesophageal reflux.
    explanation: >-
      Names constipation among the gastrointestinal features.
- name: Feeding difficulties
  category: Gastrointestinal
  description: >-
    Feeding impairment was documented in the founding family, whose clinical table records dysphagia and tube feeding. The El-Bazzal primary report also describes feeding difficulties; the evidence below uses the accessible founding-study table rather than substituting a gastrointestinal umbrella quote for feeding itself.
  phenotype_term:
    preferred_term: Feeding difficulties
    term:
      id: HP:0011968
      label: Feeding difficulties
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      Dysphagia +  Tube-fed
      Low bone density +  + +
      Sensitive skin + + + +
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The clinical table records dysphagia in II-1 and tube feeding in II-4. Empty cells are unavailable information, not negatives.
- name: Multiple exostoses
  category: Skeletal
  description: >-
    Both patients in the Gentile family developed multiple exostoses. These were absent in the founding family and in the Gupta proband. Presence or absence does not independently distinguish AREXT2 from dominant hereditary multiple exostoses; genotype and the broader phenotype must be considered.
  phenotype_term:
    preferred_term: Multiple exostoses
    term:
      id: HP:0002762
      label: Multiple exostoses
  evidence:
  - reference: PMID:30288735
    reference_title: "Novel exostosin-2 missense variants in a family with autosomal recessive exostosin-2-related syndrome: further evidences on the phenotype."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In addition, our patients developed multiple exostoses, which were not observed in the previously described families.
    explanation: >-
      Records exostoses in biallelic patients and, in the same sentence, that
      they were absent in the earlier families.
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Heterozygous pathogenic variants within EXT2 are causative of an autosomal dominant disorder known as multiple Exostoses type 2 in which patients develop multiple benign (ie, non‐malignant) bone tumors called osteochondromas, not present in our patient.
    explanation: >-
      The absence of osteochondromas in the Gupta proband qualifies the feature as variable; the general dominant-disease clause is not evidence for its frequency in AREXT2.
- name: Global developmental delay
  category: Neurologic
  description: >-
    Motor, language and cognitive development were affected across reported families, with marked differences in severity.
  phenotype_term:
    preferred_term: Global developmental delay
    term:
      id: HP:0001263
      label: Global developmental delay
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Her fraternal twin sister has Asperger syndrome (diagnosed at 3 years of age), mild motor delays, and a history of cognitive and speech delays, which had improved over time.
    explanation: >-
      The milder twin still had delay across motor, cognitive and speech domains.
- name: Delayed speech and language development
  category: Neurologic
  description: >-
    Language delay was evident by age two in the Gupta proband, before later verbal regression.
  phenotype_term:
    preferred_term: Delayed speech and language development
    term:
      id: HP:0000750
      label: Delayed speech and language development
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      At the age of 2 years, language delay was also evident.
    explanation: >-
      A specific language-development observation in the Gupta proband.
- name: Strabismus
  category: Ophthalmologic
  description: >-
    Bilateral strabismus required surgery at age five in the Gupta proband. The type of ocular deviation is not specified for this patient.
  phenotype_term:
    preferred_term: Strabismus
    term:
      id: HP:0000486
      label: Strabismus
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      She underwent surgery for strabismus bilaterally at the age of 5 years.
    explanation: >-
      The reported diagnosis supports strabismus without selecting an unspecified narrower deviation.
- name: Flat forehead
  category: Craniofacial
  description: >-
    Both El-Bazzal brothers had a flat forehead, as recorded in Gupta’s comparison table.
  phenotype_term:
    preferred_term: Flat forehead
    term:
      id: HP:0004425
      label: Flat forehead
  evidence:
  - reference: PMID:30997052
    reference_title: "Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      | Forehead |  |  |  |  | Flat | Flat | High | High | Prominent tall |  |
    explanation: >-
      Gupta Table 2 summarizes the two El-Bazzal brothers in columns 5 and 6, both marked Flat; their ages at examination are 8 and 6 years. This is secondary reporting of those same patients, not two new observations or a syndrome-wide frequency. The four preceding empty cells do not establish absence in the founding family.
- name: High forehead
  category: Craniofacial
  description: >-
    A tall forehead was documented in the Gupta proband.
  phenotype_term:
    preferred_term: High forehead
    term:
      id: HP:0000348
      label: High forehead
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The patient is a 14‐year‐old female evaluated through the Mayo Clinic Department of Clinical Genomics for developmental delay, autism, epilepsy, and distinctive craniofacial features including macrocephaly, prominent tall forehead, hypertelorism, long hypoplastic philtrum, bilateral preauricular pits, upturned and round broad nasal tip.
    explanation: >-
      The height component of the reported prominent tall forehead supports this finding.
- name: Prominent forehead
  category: Craniofacial
  description: >-
    The Gupta proband had a prominent as well as tall forehead.
  phenotype_term:
    preferred_term: Prominent forehead
    term:
      id: HP:0011220
      label: Prominent forehead
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The patient is a 14‐year‐old female evaluated through the Mayo Clinic Department of Clinical Genomics for developmental delay, autism, epilepsy, and distinctive craniofacial features including macrocephaly, prominent tall forehead, hypertelorism, long hypoplastic philtrum, bilateral preauricular pits, upturned and round broad nasal tip.
    explanation: >-
      Prominence and height are both explicitly described; this records prominence.
- name: Long philtrum
  category: Craniofacial
  description: >-
    A long hypoplastic philtrum was documented in the Gupta proband. The binding records the explicit length abnormality without assuming a specific degree of philtral smoothness.
  phenotype_term:
    preferred_term: Long philtrum
    term:
      id: HP:0000343
      label: Long philtrum
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The patient is a 14‐year‐old female evaluated through the Mayo Clinic Department of Clinical Genomics for developmental delay, autism, epilepsy, and distinctive craniofacial features including macrocephaly, prominent tall forehead, hypertelorism, long hypoplastic philtrum, bilateral preauricular pits, upturned and round broad nasal tip.
    explanation: >-
      The source explicitly describes a long philtrum.
- name: Preauricular pit
  category: Craniofacial
  description: >-
    Bilateral preauricular pits were documented in the Gupta proband.
  phenotype_term:
    preferred_term: Preauricular pit
    term:
      id: HP:0004467
      label: Preauricular pit
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The patient is a 14‐year‐old female evaluated through the Mayo Clinic Department of Clinical Genomics for developmental delay, autism, epilepsy, and distinctive craniofacial features including macrocephaly, prominent tall forehead, hypertelorism, long hypoplastic philtrum, bilateral preauricular pits, upturned and round broad nasal tip.
    explanation: >-
      The narrative explicitly documents bilateral pits; the broad ear-anomaly comparison row does not override that specific observation.
- name: Broad nasal tip
  category: Craniofacial
  description: >-
    The nasal tip was broad, round and upturned in the Gupta proband.
  phenotype_term:
    preferred_term: Broad nasal tip
    term:
      id: HP:0000455
      label: Broad nasal tip
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The patient is a 14‐year‐old female evaluated through the Mayo Clinic Department of Clinical Genomics for developmental delay, autism, epilepsy, and distinctive craniofacial features including macrocephaly, prominent tall forehead, hypertelorism, long hypoplastic philtrum, bilateral preauricular pits, upturned and round broad nasal tip.
    explanation: >-
      The quote establishes a broad nasal tip; no assumption about nostril orientation is needed.
- name: Aggressive behavior
  category: Behavioral
  description: >-
    Aggression toward self and others in the Gupta proband improved over time. Actual self-inflicted injury was not specified, so a separate self-injury diagnosis is not inferred.
  phenotype_term:
    preferred_term: Aggressive behavior
    term:
      id: HP:0000718
      label: Aggressive behavior
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      She had aggressive behavior toward self and others, rocking stereotypies and sleep difficulty, which improved over time.
    explanation: >-
      The aggression component is explicitly reported, with improvement over time.
- name: Motor stereotypy
  category: Behavioral
  description: >-
    Rocking stereotypies were reported in the Gupta proband and improved over time.
  phenotype_term:
    preferred_term: Motor stereotypy
    term:
      id: HP:0000733
      label: Motor stereotypy
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      She had aggressive behavior toward self and others, rocking stereotypies and sleep difficulty, which improved over time.
    explanation: >-
      Rocking is the specifically reported repetitive motor behavior.
- name: Sleep disturbance
  category: Behavioral
  description: >-
    Sleep difficulty in the Gupta proband improved over time; the report does not specify insomnia subtype or sleep-disordered breathing.
  phenotype_term:
    preferred_term: Sleep disturbance
    term:
      id: HP:0002360
      label: Sleep disturbance
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      She had aggressive behavior toward self and others, rocking stereotypies and sleep difficulty, which improved over time.
    explanation: >-
      The sleep-difficulty component supports a broad sleep disturbance.
- name: Acne
  category: Dermatologic
  description: >-
    The Gupta proband had sensitive skin described as prone to acne; severity and subtype were not given.
  phenotype_term:
    preferred_term: Acne
    term:
      id: HP:0001061
      label: Acne
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Additional features include sensitive skin prone to acne and gastro‐intestinal problems such as constipation and gastroesophageal reflux.
    explanation: >-
      The skin observation supports acne without a specific lesion subtype.
- name: Focal-onset seizure
  category: Neurologic
  description: >-
    Focal seizures were interpreted from the Gupta proband’s clinical EEG findings. Other families also had generalized seizure types, so the broad seizure entry is retained.
  phenotype_term:
    preferred_term: Focal-onset seizure
    term:
      id: HP:0007359
      label: Focal-onset seizure
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      EEG was abnormal and revealed occipital midline spike and waves consistent with focal seizures.
    explanation: >-
      The authors interpret the occipital-midline discharges as consistent with focal seizures; the EEG finding is also recorded separately as a readout.
- name: Bilateral cryptorchidism
  category: Genitourinary
  description: >-
    The three affected males in the founding family had bilateral cryptorchidism; this is not a syndrome-wide frequency.
  phenotype_term:
    preferred_term: Bilateral cryptorchidism
    term:
      id: HP:0008689
      label: Bilateral cryptorchidism
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Features seen in all affected individuals include: moderate intellectual disability, seizure disorder with onset between two and five years of age, hypotonia, scoliosis, macrocephaly, coarse facies, bilateral cryptorchidism in males, long hypoplastic philtrum, and hypertelorism.
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The three affected males in the founding family had bilateral cryptorchidism; this is not a syndrome-wide frequency.
- name: Status epilepticus
  category: Neurologic
  description: >-
    Recurrent prolonged status occurred in II-4; II-5 also developed status before death at 17 years. This does not establish that all deaths or regression are seizure mediated.
  phenotype_term:
    preferred_term: Status epilepticus
    term:
      id: HP:0002133
      label: Status epilepticus
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Case II-4 had a very similar phenotype to her brothers' however, she had recurrent episodes of prolonged status epilepticus.
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Recurrent prolonged status occurred in II-4; II-5 also developed status before death at 17 years. This does not establish that all deaths or regression are seizure mediated.
  sequelae:
  - target: Seizure-Associated Brain Injury
    description: >-
      A four-hour episode at age five caused significant brain injury in II-4; injury is a possible consequence of prolonged status, not an inevitable outcome of every seizure.
    causal_link_type: DIRECT
    evidence:
    - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        During one episode at the age of five, she had a four-hour long seizure and sustained significant brain injury. She was rendered hemiplegic on the right side, and has been wheelchair bound since that event.
      explanation: >-
        Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. II-4 sustained brain injury during a four-hour seizure, followed by right hemiplegia and wheelchair dependence; this clinical attribution supports a secondary injury route.
- name: Hemiplegia
  category: Neurologic
  description: >-
    Right hemiplegia followed a four-hour seizure and brain injury at age five in II-4.
  phenotype_term:
    preferred_term: Hemiplegia
    term:
      id: HP:0002301
      label: Hemiplegia
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      During one episode at the age of five, she had a four-hour long seizure and sustained significant brain injury. She was rendered hemiplegic on the right side, and has been wheelchair bound since that event.
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Right hemiplegia followed a four-hour seizure and brain injury at age five in II-4.
- name: Inability to walk
  category: Neurologic
  description: >-
    All four originally walked independently; II-4 lost ambulation after prolonged status epilepticus. This is acquired loss in that patient, not congenital nonambulation in the founding family.
  phenotype_term:
    preferred_term: Inability to walk
    term:
      id: HP:0002540
      label: Inability to walk
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      all four affected sibs were capable of independent ambulation although case II-4 lost her ability to walk after an episode of prolonged status epilepticus.
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. All four originally walked independently; II-4 lost ambulation after prolonged status epilepticus. This is acquired loss in that patient, not congenital nonambulation in the founding family.
- name: Bilateral tonic-clonic seizure with generalized onset
  category: Neurologic
  description: >-
    II-1 had clinically described generalized tonic-clonic seizures beginning at three years.
  phenotype_term:
    preferred_term: Bilateral tonic-clonic seizure with generalized onset
    term:
      id: HP:0025190
      label: Bilateral tonic-clonic seizure with generalized onset
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      At age three years, he developed seizures that were generalized tonic clonic in nature, lasting two to three minutes.
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. II-1 had clinically described generalized tonic-clonic seizures beginning at three years.
- name: Kyphosis
  category: Skeletal
  description: >-
    II-1 had kyphosis as well as scoliosis and wore a brace. The broader scoliosis entry is retained for other patients.
  phenotype_term:
    preferred_term: Kyphosis
    term:
      id: HP:0002808
      label: Kyphosis
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In addition, he has significant scoliosis and kyphosis for which he wears a brace and his gait is stiff with out-toeing on a broad base.
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. II-1 had kyphosis as well as scoliosis and wore a brace. The broader scoliosis entry is retained for other patients.
- name: Gastrointestinal dysmotility
  category: Gastrointestinal
  description: >-
    II-3 had dysfunctional gastrointestinal motility with easy vomiting and documented reflux.
  phenotype_term:
    preferred_term: Gastrointestinal dysmotility
    term:
      id: HP:0002579
      label: Gastrointestinal dysmotility
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      He too suffers from dysfunctional gastrointestinal motility
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. II-3 had dysfunctional gastrointestinal motility with easy vomiting and documented reflux.
  sequelae:
  - target: Vomiting
    description: >-
      The founding report describes dysfunctional gastrointestinal motility in II-3 with easy vomiting. This clinical explanation is retained without assigning a neuronal or smooth-muscle EXT2 mechanism.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        He too suffers from dysfunctional gastrointestinal motility
      explanation: >-
        Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. This identifies the motility disorder in the same case whose next clause describes easy vomiting.
    - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        tends to vomit easily and has documented gastroesophageal reflux.
      explanation: >-
        Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The following clause specifies the clinical manifestation in II-3; the molecular cause of his dysmotility is not established.
- name: Vomiting
  category: Gastrointestinal
  description: >-
    Easy vomiting was described in II-3 in the context of gastrointestinal dysmotility.
  phenotype_term:
    preferred_term: Vomiting
    term:
      id: HP:0002013
      label: Vomiting
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      tends to vomit easily and has documented gastroesophageal reflux.
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Easy vomiting was described in II-3 in the context of gastrointestinal dysmotility.
- name: Diarrhea
  category: Gastrointestinal
  description: >-
    II-1 had later diarrhea following early constipation. These are different timepoints.
  phenotype_term:
    preferred_term: Diarrhea
    term:
      id: HP:0002014
      label: Diarrhea
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      While chronic constipation was a feature in early life, diarrhea has been a feature lately.
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. II-1 had later diarrhea following early constipation. These are different timepoints.
- name: Volvulus
  category: Gastrointestinal
  description: >-
    Neonatal intestinal volvulus in II-5 required surgery; the report does not establish whether EXT2 directly caused the anatomical predisposition.
  phenotype_term:
    preferred_term: Volvulus
    term:
      id: HP:0002580
      label: Volvulus
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      At four days of age, he was diagnosed with intestinal volvulus, which required surgical intervention.
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Neonatal intestinal volvulus in II-5 required surgery; the report does not establish whether EXT2 directly caused the anatomical predisposition.
- name: Polyhydramnios
  category: Prenatal
  description: >-
    Polyhydramnios was documented in the pregnancy with II-5, without a proven fetal mechanism.
  phenotype_term:
    preferred_term: Polyhydramnios
    term:
      id: HP:0001561
      label: Polyhydramnios
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The pregnancy with case II-5 was complicated by polyhydramnios.
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Polyhydramnios was documented in the pregnancy with II-5, without a proven fetal mechanism.
- name: Dysphagia
  category: Gastrointestinal
  description: >-
    The founding clinical table explicitly records dysphagia; tube feeding in a different sibling is retained without assuming its precise swallowing mechanism.
  phenotype_term:
    preferred_term: Dysphagia
    term:
      id: HP:0002015
      label: Dysphagia
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      Dysphagia +  Tube-fed
      Low bone density +  + +
      Sensitive skin + + + +
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The founding clinical table explicitly records dysphagia; tube feeding in a different sibling is retained without assuming its precise swallowing mechanism.
- name: Hematuria
  category: Genitourinary
  description: >-
    Hematuria was recorded in II-1 and II-3; the latter also had renal failure and hemolytic uremic syndrome.
  phenotype_term:
    preferred_term: Hematuria
    term:
      id: HP:0000790
      label: Hematuria
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      Hematuria + +, Kidney failure
      Proteinuria + +
      Wide-based gait +  Loss of ambulation
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Hematuria was recorded in II-1 and II-3; the latter also had renal failure and hemolytic uremic syndrome.
- name: Proteinuria
  category: Genitourinary
  description: >-
    Proteinuria was recorded in II-1 and II-3; no protein selectivity or quantified excretion is provided.
  phenotype_term:
    preferred_term: Proteinuria
    term:
      id: HP:0000093
      label: Proteinuria
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      Proteinuria + +
      Wide-based gait +  Loss of ambulation
      Overlapping toes +  +
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Proteinuria was recorded in II-1 and II-3; no protein selectivity or quantified excretion is provided.
- name: Intestinal malrotation
  category: Gastrointestinal
  description: >-
    The founding clinical table records bowel malrotation in II-3 and II-5. The bowel rotational defect is distinct from the volvulus complication.
  phenotype_term:
    preferred_term: Intestinal malrotation
    term:
      id: HP:0002566
      label: Intestinal malrotation
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      Bowel malrotation  +  +
      Volvulus    +
      Encopresis +
      Morning nausea + + + +
      Regression +   +
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The founding clinical table records bowel malrotation in II-3 and II-5. The bowel rotational defect is distinct from the volvulus complication.
  sequelae:
  - target: Volvulus
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Abnormal fixation in malrotation can leave a short mesenteric attachment that permits twisting. This established anatomical route provides a qualified explanation for neonatal volvulus in II-5, who also had malrotation; his operative mesenteric anatomy was not detailed, and the EXT2-to-malrotation route remains unresolved.
    evidence:
    - reference: PMID:38803636
      reference_title: 'Identification and treatment of intestinal malrotation with midgut volvulus in childhood: a multicenter retrospective study.'
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        Abnormal midgut fixation leads to a short mesenteric attachment, which makes the midgut prone to twisting (volvulus) around the SMA and SMV
      explanation: >-
        This anatomical mechanism is summarized in a primary multicenter pediatric surgical series. It supports a general malrotation-to-volvulus route, not an AREXT2 frequency or a measured mesenteric width in II-5.
      directness: INDIRECT
    - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: |-
        Bowel malrotation  +  +
        Volvulus    +
        Encopresis +
        Morning nausea + + + +
        Regression +   +
      explanation: >-
        Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The founding clinical table records bowel malrotation in II-3 and II-5. The bowel rotational defect is distinct from the volvulus complication.
    - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        At four days of age, he was diagnosed with intestinal volvulus, which required surgical intervention.
      explanation: >-
        Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Neonatal intestinal volvulus in II-5 required surgery; the report does not establish whether EXT2 directly caused the anatomical predisposition.
- name: Sleep apnea
  category: Respiratory
  description: >-
    Sleep apnea was recorded in II-5 without central/obstructive classification.
  phenotype_term:
    preferred_term: Sleep apnea
    term:
      id: HP:0010535
      label: Sleep apnea
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      Sleep apnea    +
      Tremor    Coarse
      Seizures, onset (years) +, 2.5 +, 4-5 +, 2-3 +, 5
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Sleep apnea was recorded in II-5 without central/obstructive classification.
- name: Tremor
  category: Neurologic
  description: >-
    A coarse tremor was recorded in II-5; no rest, action or intention subtype is specified.
  phenotype_term:
    preferred_term: Tremor
    term:
      id: HP:0001337
      label: Tremor
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      Tremor    Coarse
      Seizures, onset (years) +, 2.5 +, 4-5 +, 2-3 +, 5
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. A coarse tremor was recorded in II-5; no rest, action or intention subtype is specified.
- name: Cerebral hemorrhage
  category: Neurologic
  description: >-
    Brain hemorrhage was recorded in II-3 and II-4; the table does not establish timing or a vascular mechanism, including its relation to status-associated injury.
  phenotype_term:
    preferred_term: Cerebral hemorrhage
    term:
      id: HP:0001342
      label: Cerebral hemorrhage
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      Brain hemorrhage  + +
      Circulation  Cold extremities Cold extremities
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Brain hemorrhage was recorded in II-3 and II-4; the table does not establish timing or a vascular mechanism, including its relation to status-associated injury.
- name: Overlapping toe
  category: Skeletal
  description: >-
    Overlapping toes were recorded in II-1 and II-4 without specifying which digits.
  phenotype_term:
    preferred_term: Overlapping toe
    term:
      id: HP:0001845
      label: Overlapping toe
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      Overlapping toes +  +
      Hepatic dysfunction    +
      Bowel malrotation  +  +
      Volvulus    +
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Overlapping toes were recorded in II-1 and II-4 without specifying which digits.
- name: Precocious puberty
  category: Endocrine
  description: >-
    Precocious puberty was recorded in II-5; hormonal evaluation and central/peripheral classification were not provided.
  phenotype_term:
    preferred_term: Precocious puberty
    term:
      id: HP:0000826
      label: Precocious puberty
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      Precocious puberty    +
      Scoliosis + + +
      Hiatus hernia +
      Bowel dysfunction +  + +
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Precocious puberty was recorded in II-5; hormonal evaluation and central/peripheral classification were not provided.
- name: Hiatus hernia
  category: Gastrointestinal
  description: >-
    Hiatus hernia was recorded in II-1. Coexisting reflux does not by itself prove the hernia caused all reflux in this syndrome.
  phenotype_term:
    preferred_term: Hiatus hernia
    term:
      id: HP:0002036
      label: Hiatus hernia
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      Hiatus hernia +
      Bowel dysfunction +  + +
      Hypertension +
      Hematuria + +, Kidney failure
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Hiatus hernia was recorded in II-1. Coexisting reflux does not by itself prove the hernia caused all reflux in this syndrome.
  sequelae:
  - target: Gastroesophageal reflux
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
    description: >-
      Separation of the lower esophageal sphincter from the diaphragm can weaken the antireflux barrier. This supplies a plausible contribution from the documented hiatus hernia to II-1’s severe reflux. His hernia subtype, size and pressure dynamics were not measured, so the relation is qualified and does not explain reflux in siblings without documented hernia.
    evidence:
    - reference: PMID:16472589
      reference_title: Intermittent spatial separation of diaphragm and lower esophageal sphincter favors acidic and weakly acidic reflux.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        More reflux occurred when the LES and diaphragm were separated versus the reduced hernia state (23.1 +/- 5.1 vs 12.2 +/- 2.4 episodes per hour, respectively; P < .05).
      explanation: >-
        Within-subject high-resolution manometry and pH-impedance monitoring in 16 patients with small hiatal hernias associated the separated state with more reflux. AREXT2 patients were not studied; the numerical rates are not transferred to II-1.
      directness: INDIRECT
    - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: |-
        Hiatus hernia +
        Bowel dysfunction +  + +
        Hypertension +
        Hematuria + +, Kidney failure
      explanation: >-
        Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Hiatus hernia was recorded in II-1. Coexisting reflux does not by itself prove the hernia caused all reflux in this syndrome.
    - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Significant gastroesophageal reflux and associated ulceration of the esophagus were documented.
      explanation: >-
        Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The founding narrative establishes severe reflux in the same II-1 who has hiatus hernia in Table 3.4.1; the clinical paper does not directly test the barrier mechanism.
      directness: INDIRECT
- name: Hypertension
  category: Cardiovascular
  description: >-
    Hypertension in II-1 appears in the patient clinical findings section, distinct from the separate maternal gestational hypertension row.
  phenotype_term:
    preferred_term: Hypertension
    term:
      id: HP:0000822
      label: Hypertension
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      Hypertension +
      Hematuria + +, Kidney failure
      Proteinuria + +
      Wide-based gait +  Loss of ambulation
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Hypertension in II-1 appears in the patient clinical findings section, distinct from the separate maternal gestational hypertension row.
- name: Encopresis
  category: Gastrointestinal
  description: >-
    Encopresis was recorded in II-1 without a demonstrated continence or stool-retention mechanism.
  phenotype_term:
    preferred_term: Encopresis
    term:
      id: HP:0040183
      label: Encopresis
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      Encopresis +
      Morning nausea + + + +
      Regression +   +
      Dysphagia +  Tube-fed
      Low bone density +  + +
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Encopresis was recorded in II-1 without a demonstrated continence or stool-retention mechanism.
- name: Nausea
  category: Gastrointestinal
  description: >-
    Morning nausea was recorded for all four founding siblings, not assessed as a population frequency.
  phenotype_term:
    preferred_term: Nausea
    term:
      id: HP:0002018
      label: Nausea
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      Morning nausea + + + +
      Regression +   +
      Dysphagia +  Tube-fed
      Low bone density +  + +
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Morning nausea was recorded for all four founding siblings, not assessed as a population frequency.
- name: Abnormal liver physiology
  category: Hepatic
  description: >-
    The table records hepatic dysfunction in II-5 but does not specify biochemical or histological type. A broad physiological term avoids inventing a liver lesion.
  phenotype_term:
    preferred_term: Abnormal liver physiology
    term:
      id: HP:0031865
      label: Abnormal liver physiology
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      Hepatic dysfunction    +
      Bowel malrotation  +  +
      Volvulus    +
      Encopresis +
      Morning nausea + + + +
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The table records hepatic dysfunction in II-5 but does not specify biochemical or histological type. A broad physiological term avoids inventing a liver lesion.
- name: Exotropia
  category: Ophthalmologic
  description: >-
    Exotropia is specifically recorded in II-5; the broad strabismus entry remains appropriate for the other cases without a specified deviation.
  phenotype_term:
    preferred_term: Exotropia
    term:
      id: HP:0000577
      label: Exotropia
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      Circulation  Cold extremities Cold extremities
      Strabismus   +, left eye +, exotropia
      Hypotonia + + + +
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Exotropia is specifically recorded in II-5; the broad strabismus entry remains appropriate for the other cases without a specified deviation.
- name: EEG with focal epileptiform discharges
  category: Neurologic
  description: >-
    Occipital-midline spike-and-wave discharges in the Gupta proband were interpreted as consistent with focal seizures.
  phenotype_term:
    preferred_term: EEG with focal epileptiform discharges
    term:
      id: HP:0011185
      label: EEG with focal epileptiform discharges
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      EEG was abnormal and revealed occipital midline spike and waves consistent with focal seizures.
    explanation: >-
      This is an electrophysiological observation, represented as a readout rather than an additional causal lesion.
  reports_on:
  - target: Focal-onset seizure
    relationship: READOUT_OF
    description: >-
      The focal EEG discharges support the authors’ focal-seizure interpretation; they do not explain why EXT2 variants produce epilepsy.
    evidence:
    - reference: PMID:30997052
      reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        EEG was abnormal and revealed occipital midline spike and waves consistent with focal seizures.
      explanation: >-
        The authors directly connect this EEG result with focal seizures.
- name: Broad-based gait
  category: Neurologic
  description: >-
    A stiff, broad-based out-toeing gait was described in founding patient II-1. This does not by itself diagnose cerebellar ataxia.
  phenotype_term:
    preferred_term: Broad-based gait
    term:
      id: HP:0002136
      label: Broad-based gait
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      his gait is stiff with out-toeing on a broad base.
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. A stiff, broad-based out-toeing gait was described in founding patient II-1. This does not by itself diagnose cerebellar ataxia.
- name: Esophageal ulceration
  category: Gastrointestinal
  description: >-
    Esophageal ulceration accompanied significant reflux in founding patient II-1.
  phenotype_term:
    preferred_term: Esophageal ulceration
    term:
      id: HP:0004791
      label: Esophageal ulceration
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Significant gastroesophageal reflux and associated ulceration of the esophagus were documented.
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Esophageal ulceration accompanied significant reflux in founding patient II-1.
- name: Extremities cold to touch
  category: Cardiovascular
  description: >-
    Cold extremities were recorded in founding patients II-3 and II-4. This observation does not establish Raynaud phenomenon or a specific vascular disorder.
  phenotype_term:
    preferred_term: Extremities cold to touch
    term:
      id: HP:6000500
      label: Extremities cold to touch
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Circulation Cold extremities Cold extremities Strabismus +, left eye +, exotropia
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Cold extremities were recorded in founding patients II-3 and II-4. This observation does not establish Raynaud phenomenon or a specific vascular disorder.
- name: Cervical segmentation defect
  category: Skeletal
  description: >-
    Failure of cervical segmentation at C2–3, and possibly C1–2, was recorded radiographically in founding patient II-1. The binding preserves a segmentation defect without assuming a fully characterized fusion morphology.
  phenotype_term:
    preferred_term: Cervical segmentation defect
    term:
      id: HP:0004632
      label: Cervical segmentation defect
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Lateral cervical spine Failure of segmentation of C2-3 and possibly C1-2
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Failure of cervical segmentation at C2–3, and possibly C1–2, was recorded radiographically in founding patient II-1. The binding preserves a segmentation defect without assuming a fully characterized fusion morphology.
biochemical:
- name: Heparan sulfate
  context: >-
    Heparan sulfate was measured during mucopolysaccharidosis screening in the Gupta proband. Serum was below the reported pediatric first percentile and the dried-blood-spot value equaled that percentile. The paper calls all three specimens low, but its urine value exceeds the table’s 99th percentile; urine direction therefore remains internally inconsistent.
  biomarker_term:
    preferred_term: heparan sulfate
    term:
      id: CHEBI:28815
      label: heparan sulfate
  presence: Abnormal
  notes: >-
    Reported values: dried blood spot 12 nmol/L, serum 4.46 ng/mL, urine 0.5 mg/mmol creatinine. Table 1 gives first percentiles of 12.0, 7.06 and 0.014 respectively, and a urine 99th percentile of 0.292 mg/mmol creatinine. The refreshed source cache now includes this table. Do not silently change the urine value, units or direction, and do not infer uniform tissue-wide depletion from these measurements.
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Biochemical screening for mucopolysaccharidoses was performed in view of the coarse facial features and revealed low levels of heparan sulfate in dried blood spot (12 nmol/L), serum (4.46 ng/mL), and urine (0.5 mg/mmol creatinine) specimens (Reference ranges given in Table 1).
    explanation: >-
      These are the authors’ reported values and low-level interpretation. Serum and dried-blood-spot comparisons support reduced/low-end values, but the urine interpretation conflicts with the source table, as recorded in the dedicated discussion.
  readouts:
  - target: Impaired Heparan Sulfate Biosynthesis
    relationship: READOUT_OF
    description: >-
      Serum and dried-blood-spot HS measurements are limited peripheral readouts consistent with altered biosynthesis in one patient. Urine direction and tissue-wide generalization are unresolved.
    evidence:
    - reference: PMID:30997052
      reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Biochemical screening for mucopolysaccharidoses was performed in view of the coarse facial features and revealed low levels of heparan sulfate in dried blood spot (12 nmol/L), serum (4.46 ng/mL), and urine (0.5 mg/mmol creatinine) specimens (Reference ranges given in Table 1).
      explanation: >-
        These are the authors’ reported values and low-level interpretation. Serum and dried-blood-spot comparisons support reduced/low-end values, but the urine interpretation conflicts with the source table, as recorded in the dedicated discussion.
genetic:
- name: EXT2
  association: Causal biallelic variant
  gene_term:
    preferred_term: EXT2
    term:
      id: hgnc:3513
      label: EXT2
  notes: >-
    The established families reviewed here carried biallelic missense genotypes: a homozygous complex p.Met87Arg/p.Arg95Cys allele, homozygous p.Ser4Leu, compound p.Asp227Asn/p.Tyr608Cys, and compound p.Val373Asp/p.Thr672Met. The first pair comprises two substitutions in cis on each homolog, not two separate alleles in trans. Assays of that complex allele do not establish the functional effect of every later allele.


    The Gupta report initially returned the EXT2 pair as VUSs in a gene of uncertain significance, then concluded they were likely pathogenic under ACMG/AMP criteria using segregation, biochemical and emerging gene-phenotype evidence. Both affected twins also had the same monoallelic NDST1 p.Arg454Cys VUS. The proposed modifier effect was unproven; neuronal potassium-channel antibodies only in the proband were another possible contributor to discordance.


    A 2021 skeletal-dysplasia cohort reported nonsense p.Trp79Ter and splice-site c.1404+2T>C EXT2 variants in trans in a possible AREXT2 case. The authors explicitly retained diagnostic uncertainty and requested functional work. This does not establish a new definitive null/null subtype or justify excluding all non-missense candidates.
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Two compound heterozygous VUSs (one paternally inherited—c.1118T>A p.(Val373Asp) and a maternally inherited—c.2015C>T p.(Thr672Met)) were identified within the EXT2 gene.
    explanation: >-
      This is the initial sequencing classification in the Gupta report; its final Discussion reclassifies the pair as likely pathogenic rather than leaving the initial VUS wording as the final conclusion.
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      EXT2 is implicated in the autosomal dominant disorder multiple Exostoses type 2 (MIM: 133701). Biallelic EXT2 mutations, however, have also been reported in four siblings born to consanguineous parents, manifesting scoliosis, seizures, and macrocephaly (MIM: 616682) without exostosis, following an autosomal recessive pattern of inheritance.1
    explanation: >-
      States the two-disease, two-mechanism structure of this gene explicitly,
      with both OMIM numbers.
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Notably, the patient's fraternal twin sister who is mildly affected as compared to the proband, with some learning delays and speech concerns, was also found to have the two compound heterozygous EXT2 variants while the patient's unaffected brother was found to carry only the heterozygous paternally inherited EXT2 variant (Figure 1).
    explanation: >-
      Documents the within-genotype variability and confirms that the
      heterozygous sibling was unaffected.
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      However, no second mutation was identified in this patient within this gene, and the deletion/duplication analysis for this gene yielded normal/negative results.
    explanation: >-
      No second NDST1 alteration was identified; this limits evidence for a biallelic NDST1 diagnosis but does not prove absence of every other contributor.
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In summary, the genetic variants found in EXT2 are likely pathogenic according to ACMG/AMP guidelines,16 based on the collective evidence of familial cosegregation, biochemical analysis, and emerging gene‐phenotype reports in the literature.
    explanation: >-
      The final assessment supersedes the initial VUS/GUS report within this paper; it is the authors’ published classification.
  - reference: PMID:34092239
    reference_title: Diagnostic yield of rare skeletal dysplasia conditions in the radiogenomics era.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      It is unclear whether patient 13 has AREXT2 thus, functional work is required.
    explanation: >-
      The authors explicitly leave this candidate diagnosis unresolved and request functional work; this is diagnostic interpretation rather than a measured phenotype.
environmental: []
treatments:
- name: Symptom-directed supportive management
  description: >-
    Reported supportive interventions include spinal bracing in founding patient II-1, tube feeding in II-4 and bilateral strabismus surgery at age five in the Gupta proband. These case descriptions document care but do not establish comparative efficacy or correction of EXT2 biology. HS/enzyme replacement remains a proposed research direction, discussed separately.
  therapeutic_modality: OTHER
  treatment_term:
    preferred_term: supportive care
    term:
      id: NCIT:C15747
      label: Supportive Care
  target_phenotypes:
  - preferred_term: Scoliosis
    term:
      id: HP:0002650
      label: Scoliosis
  - preferred_term: Feeding difficulties
    term:
      id: HP:0011968
      label: Feeding difficulties
  - preferred_term: Strabismus
    term:
      id: HP:0000486
      label: Strabismus
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      he has significant scoliosis and kyphosis for which he wears a brace
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Spinal bracing is a documented supportive intervention in II-1.
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      Dysphagia +  Tube-fed
      Low bone density +  + +
      Sensitive skin + + + +
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The clinical table documents tube feeding in II-4.
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      She underwent surgery for strabismus bilaterally at the age of 5 years.
    explanation: >-
      This is an observed intervention in the Gupta proband, not a prospective AREXT2 treatment trial.
diagnosis:
- name: Exome sequencing with segregation analysis
  description: >-
    Exome sequencing and familial segregation established the reported biallelic EXT2 genotypes; autozygosity mapping was also used in the founding consanguineous family. Phase and allele-specific interpretation distinguish recessive AREXT2 from dominant hereditary multiple exostoses. The unaffected parents and heterozygous brother in the Gupta family demonstrate why a single familial EXT2 variant is not automatically a dominant exostosis genotype.
  results: Biallelic EXT2 variants interpreted with phenotype, segregation and variant-specific evidence.
  diagnosis_term:
    preferred_term: whole-exome sequencing
    term:
      id: NCIT:C101295
      label: Whole Exome Sequencing
  evidence:
  - reference: PMID:26246518
    reference_title: "Old gene, new phenotype: mutations in heparan sulfate synthesis enzyme, EXT2 leads to seizure and developmental disorder, no exostoses."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Our application of autozygosity mapping and whole-exome sequencing allowed us to identify mutations in the patients.
    explanation: >-
      Documents the diagnostic route used in the defining family.
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Notably, the patient's fraternal twin sister who is mildly affected as compared to the proband, with some learning delays and speech concerns, was also found to have the two compound heterozygous EXT2 variants while the patient's unaffected brother was found to carry only the heterozygous paternally inherited EXT2 variant (Figure 1).
    explanation: >-
      The same EXT2 pair segregated to both affected twins, whereas the brother carrying only the paternal variant was clinically unaffected.
- name: Glycosaminoglycan measurement
  description: >-
    Heparan sulfate measurement in dried blood spot, serum and urine was performed during mucopolysaccharidosis screening. The reported serum and dried-blood-spot results are low or at the low end of the source reference distribution, but the urine narrative and table conflict. These observations do not establish a validated diagnostic threshold, sensitivity or specificity for AREXT2.
  results: >-
    Reduced serum and low-end dried-blood-spot heparan sulfate in one patient; urinary direction unresolved because the narrative and table disagree.
  diagnosis_term:
    preferred_term: laboratory procedure
    term:
      id: NCIT:C25294
      label: Laboratory Procedure
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Biochemical screening for mucopolysaccharidoses was performed in view of the coarse facial features and revealed low levels of heparan sulfate in dried blood spot (12 nmol/L), serum (4.46 ng/mL), and urine (0.5 mg/mmol creatinine) specimens (Reference ranges given in Table 1).
    explanation: >-
      The measurement and indication are directly documented; the paper’s low-urine interpretation is not adopted because Table 1 gives a lower 99th-percentile boundary than the reported urine value.
differential_diagnoses:
- name: Hereditary multiple exostoses type 2
  description: >-
    Autosomal dominant EXT2-related hereditary multiple exostoses is an allelic disorder characterized by osteochondromas. Neurodevelopmental impairment is not its defining pattern. The presence of exostoses in the Gentile AREXT2 family means the skeletal finding alone does not distinguish the disorders; variant-specific mechanism, phase and the broader clinical phenotype are required.
  disease_term:
    preferred_term: exostoses, multiple, type 2
    term:
      id: MONDO:0007586
      label: exostoses, multiple, type 2
  distinguishing_features:
  - Dominant pathogenic EXT2 mechanism rather than the recessive family genotypes
  - Osteochondromas are central to the clinical presentation
  - A seizure-developmental syndrome prompts assessment for AREXT2 or an additional diagnosis
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Heterozygous pathogenic variants within EXT2 are causative of an autosomal dominant disorder known as multiple Exostoses type 2 in which patients develop multiple benign (ie, non‐malignant) bone tumors called osteochondromas, not present in our patient.
    explanation: >-
      States the dominant disease, its allele dose, and its phenotype, and
      contrasts it with the recessive patient in the same sentence.
- name: Autosomal recessive intellectual disability type 46
  description: >-
    Biallelic NDST1 variants cause a distinct recessive intellectual-disability disorder affecting HS modification. Both Gupta twins carried a monoallelic NDST1 VUS alongside the EXT2 pair; a second NDST1 alteration was not identified and a modifier effect was not established.
  disease_term:
    preferred_term: intellectual disability, autosomal recessive 46
    term:
      id: MONDO:0014499
      label: intellectual disability, autosomal recessive 46
  distinguishing_features:
  - Biallelic NDST1 rather than EXT2 variants
  - Sulfation and modification defect rather than chain elongation defect
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Biallelic pathogenic variants within NDST1 are implicated in autosomal recessive intellectual disability type 46 (MIM: 616116).
    explanation: >-
      Names the NDST1 disorder and its biallelic requirement.
- name: Mucopolysaccharidosis
  description: >-
    Coarse facial features prompted mucopolysaccharidosis screening in the Gupta proband. AREXT2 involves an HS-biosynthesis hypothesis rather than a demonstrated lysosomal degradation defect. The serum result was reduced, but the urinary result conflicts with the paper’s reference table and cannot serve as a validated exclusion test.
  disease_term:
    preferred_term: mucopolysaccharidosis
    term:
      id: MONDO:0019249
      label: mucopolysaccharidosis
  distinguishing_features:
  - Lysosomal degradation defect rather than the proposed EXT2 biosynthetic defect
  - Biochemical and molecular testing must be interpreted by the specific disorder; the inconsistent Gupta urine result is not an exclusion test
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Biochemical screening for mucopolysaccharidoses was performed in view of the coarse facial features and revealed low levels of heparan sulfate in dried blood spot (12 nmol/L), serum (4.46 ng/mL), and urine (0.5 mg/mmol creatinine) specimens (Reference ranges given in Table 1).
    explanation: >-
      This documents the reason for testing and the authors’ reported values; the urine interpretation is internally inconsistent and is not adopted as a diagnostic discriminator.
animal_models:
- name: Ext2-null mouse
  species: Mouse
  genotype: Homozygous Ext2-null and heterozygous littermate arms
  publication: PMID:16236767
  description: >-
    The homozygous-null arm arrests before gastrulation; the heterozygous arm survives with cartilage differentiation abnormalities and variably develops exostoses. The study was designed for HME, but its dosage/cartilage findings can inform a qualified shared EXT2 mechanism.
  modeled_mechanisms:
  - target: Reduced EXT2 Protein Availability
    relationship: FAILS_TO_RECAPITULATE
    description: >-
      Complete null loss differs from the residual-expression complex allele in the founding patients.
    limitations: >-
      Embryonic arrest prevents assessment of postnatal neural manifestations. This is a genotype and developmental-stage mismatch, not proof that no useful model exists.
    evidence:
    - reference: PMID:16236767
      reference_title: Mice deficient in Ext2 lack heparan sulfate and develop exostoses.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Homozygous mutant embryos developed normally until embryonic day 6.0, when they became growth arrested and failed to gastrulate, pointing to the early essential role for heparan sulfate in developing embryos.
      explanation: >-
        This documents mouse null-allele developmental arrest. It neither tests human biallelic null viability nor excludes partial mechanistic use of other Ext models.
  - target: Abnormal Chondrocyte Differentiation
    relationship: PARTIALLY_RECAPITULATES
    description: >-
      The heterozygous arm reproduces abnormal cartilage differentiation relevant to the proposed skeletal route.
    limitations: >-
      Single null-allele mice are not the same genotype as biallelic missense AREXT2 patients; the human cartilage intermediate has not been measured.
    evidence:
    - *id007
    readouts:
    - name: Disorganized chondrocytes and premature hypertrophy
      target: Abnormal Chondrocyte Differentiation
      direction: ALTERED
      description: >-
        Histological abnormalities in heterozygous mice.
      evidence:
      - reference: PMID:16236767
        reference_title: Mice deficient in Ext2 lack heparan sulfate and develop exostoses.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          Significantly, all of the mice showed multiple abnormalities in cartilage differentiation, including disorganization of chondrocytes in long bones and premature hypertrophy in costochondral cartilage.
        explanation: >-
          This refers to heterozygous Ext2-null mice. It supports a partial-loss cartilage mechanism while differing from the human biallelic missense genotypes.
        directness: INDIRECT
- name: Zebrafish ext2 dackel mutant
  species: Zebrafish
  genotype: ext2 daktw25e mutant with genetic and morpholino perturbations
  publication: PMID:21892940
  description: >-
    The model tests HS-dependent paracrine signaling during embryonic development. Maternal transcript permits early development; later HS reduction changes Fgf/Wnt responses. It is not an allele-matched human syndrome model.
  modeled_mechanisms:
  - target: Disrupted HS-Dependent FGF and Wnt Signaling
    relationship: PARTIALLY_RECAPITULATES
    description: >-
      Direct fish experiments establish Fgf/Wnt sensitivity to ext2 deficiency.
    limitations: >-
      The developmental stage, allele and species differ from human AREXT2; selected Hh assays were normal and should not be generalized to all HS-dependent signaling.
    evidence:
    - *id004
    - *id005
    readouts:
    - name: Reduced Fgf target-gene expression
      target: Disrupted HS-Dependent FGF and Wnt Signaling
      direction: DECREASED
      description: >-
        etv5b and pea3 expression was reduced or more susceptible to Fgf inhibition in mutants.
      evidence:
      - reference: PMID:21892940
        reference_title: Zebrafish Ext2 is necessary for Fgf and Wnt signaling, but not for Hh signaling.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          We found that Fgf targeted gene expression is reduced in ext2 mutants and that the remaining expression is readily inhibited by SU5402, an FGF receptor inhibitor.
        explanation: >-
          Expression and inhibitor response are assay readouts of the Fgf signaling change.
    - name: Enhanced response to partial Wnt inhibition
      target: Disrupted HS-Dependent FGF and Wnt Signaling
      direction: ALTERED
      description: >-
        Partial Wnt11/Wnt5b morpholino effects were greater in ext2 mutants.
      evidence:
      - reference: PMID:21892940
        reference_title: Zebrafish Ext2 is necessary for Fgf and Wnt signaling, but not for Hh signaling.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          Also, Wnt signaling is affected in the ext2 mutants, as shown by a stronger phenotype in ext2 mutants injected with morpholinos that partially block translation of Wnt11 or Wnt5b, compared to injected wild type embryos.
        explanation: >-
          Morpholino sensitization supports a Wnt signaling role in ext2 fish, not a measured Wnt deficit in AREXT2 patients.
        directness: INDIRECT
discussions:
- discussion_id: interpretation_arext2_hs_reference_conflict
  kind: INTERPRETATION
  status: OPEN
  prompt: >-
    How should the reported urinary HS result be interpreted when its value exceeds the paper’s own 99th-percentile reference boundary?
  attaches_to:
  - biochemical#Heparan sulfate
  - diagnosis#Glycosaminoglycan measurement
  - pathophysiology#Impaired Heparan Sulfate Biosynthesis
  rationale: >-
    Gupta reports dried-blood-spot HS 12 nmol/L, serum 4.46 ng/mL and urine 0.5 mg/mmol creatinine, calling all low. Table 1 instead gives first-percentile values 12.0, 7.06 and 0.014, and a urinary 99th percentile of 0.292. Serum is below its first percentile and dried blood spot equals it, but the stated urine value is above the 99th. The full source table was fetched and inspected; this is an internal value/interpretation conflict, not evidence that a cache is missing text. No number, unit or direction is silently repaired. These peripheral measures do not establish uniform tissue HS depletion.
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Biochemical screening for mucopolysaccharidoses was performed in view of the coarse facial features and revealed low levels of heparan sulfate in dried blood spot (12 nmol/L), serum (4.46 ng/mL), and urine (0.5 mg/mmol creatinine) specimens (Reference ranges given in Table 1).
    explanation: >-
      The narrative supplies the observed values and its low-level interpretation.
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      | 99%ile | 96.1 | 53.89 | 0.292 |
    explanation: >-
      The last column of Table 1 is urine HS in mg/mmol creatinine; 0.292 is its stated 99th-percentile boundary.
- discussion_id: mismatch_arext2_neural_models
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  prompt: >-
    Which aspects of the proposed HS-dependent neural-development pathway operate in human AREXT2, and which are allele- or species-specific?
  attaches_to:
  - pathophysiology#Disrupted HS-Dependent FGF and Wnt Signaling
  - pathophysiology#Altered Neural Patterning and Connectivity
  - phenotypes#Macrocephaly
  - phenotypes#Global developmental delay
  - phenotypes#Intellectual disability
  - phenotypes#Delayed speech and language development
  rationale: >-
    The founding authors explicitly use Ext-model neural-patterning and axon-guidance findings to explain developmental delay and macrocephaly, so qualified causal paths are represented. Zebrafish experiments establish Fgf/Wnt dependence, with selected Hh outcomes preserved; they do not directly assay human circuits, head growth or language. Mouse null embryonic arrest differs from viable patient complex alleles and does not establish human null lethality. Patient fibroblasts and variant reconstruction are informative proximal models, not evidence that no cellular model exists. The unresolved issue is translational fidelity and feature-specific mediation, not absence of a published hypothesis.
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      these studies help explain why SSM patients are alive but have macrocephaly and are severely delayed in their developmental course.
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The authors explicitly connect the model-based neural-development explanation to macrocephaly and severe developmental delay in the founding family.
    directness: INDIRECT
  - reference: PMID:21892940
    reference_title: Zebrafish Ext2 is necessary for Fgf and Wnt signaling, but not for Hh signaling.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      In contrast, Hh dependent signaling is apparently unaffected in the ext2 mutants; Hh targeted gene expression is not reduced, the Hh inhibitor cyclopamine is not more affective in the mutants and Hh dependent cell differentiation in the retina and in the myotome are normal in ext2 mutants.
    explanation: >-
      Selected fish Hh assays were preserved; this constrains a universal morphogen-signaling claim without proving every Hh-dependent function normal.
  - reference: PMID:16236767
    reference_title: Mice deficient in Ext2 lack heparan sulfate and develop exostoses.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Homozygous mutant embryos developed normally until embryonic day 6.0, when they became growth arrested and failed to gastrulate, pointing to the early essential role for heparan sulfate in developing embryos.
    explanation: >-
      This documents mouse null-allele developmental arrest. It neither tests human biallelic null viability nor excludes partial mechanistic use of other Ext models.
- discussion_id: gap_arext2_seizure_types_and_tone
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    Which neural or neuromuscular processes explain seizure type, status susceptibility, hypotonia, tremor and gait abnormalities beyond the established EXT2 etiology?
  attaches_to:
  - phenotypes#Seizure
  - phenotypes#Focal-onset seizure
  - phenotypes#Bilateral tonic-clonic seizure with generalized onset
  - phenotypes#Status epilepticus
  - phenotypes#Hypotonia
  - phenotypes#Tremor
  - phenotypes#Broad-based gait
  rationale: >-
    The genetic cause of the defining seizure-developmental syndrome is retained, but the sources do not establish the circuit mechanisms selecting focal versus generalized seizures or progression to status. Status-associated brain injury explains a specific acquired motor deficit, not baseline hypotonia or the broad-based gait in a different sibling. Hypotonia is absent in the Gupta proband; central versus peripheral contributions were not resolved in the reviewed families. A coarse tremor lacks physiological classification, and a broad-based gait alone does not establish cerebellar degeneration. These are unresolved mediators/localizations rather than a requirement for complete pathway reconstruction.
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      However, skeletal issues such as scoliosis and decreased bone density and muscular issues such as hypotonia, observed with this disorder, were not observed in our patient.
    explanation: >-
      The Gupta proband lacked hypotonia despite biallelic EXT2 variants; tone abnormalities are variable.
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      his gait is stiff with out-toeing on a broad base.
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The description establishes the gait finding without a cerebellar diagnosis.
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      EEG was abnormal and revealed occipital midline spike and waves consistent with focal seizures.
    explanation: >-
      The authors interpret the occipital-midline discharges as consistent with focal seizures; the EEG finding is also recorded separately as a readout.
- discussion_id: gap_arext2_regression_behavior
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    What explains early regression and behavioral variability when the same EXT2/NDST1 genotype occurs in twins with different severity?
  attaches_to:
  - phenotypes#Developmental regression
  - phenotypes#Autism
  - phenotypes#Aggressive behavior
  - phenotypes#Motor stereotypy
  - phenotypes#Sleep disturbance
  rationale: >-
    Gupta’s verbal/social regression at 27 months preceded seizures at ten years, so the seizure-injury route cannot explain that episode. The proband had voltage-gated potassium-channel antibodies and a reported transient immunotherapy response, but the study does not establish an autoimmune cause of the entire phenotype. Both twins carried the same EXT2 pair and monoallelic NDST1 VUS, making its proposed modifier effect unproven. Autism, aggression, rocking and nonspecific sleep difficulty are documented, but no experiment attributes each to a particular HS-dependent circuit. The twin’s narrative Asperger diagnosis and negative Autism table cell are preserved as a terminology inconsistency.
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Developmental regression of verbal and social skills along with cognitive decline was reported at 27 months.
    explanation: >-
      This dates regression in the Gupta proband, whose seizures began at 10 years; the source does not establish seizures as the cause of this earlier decline.
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Her fraternal twin sister has Asperger syndrome (diagnosed at 3 years of age), mild motor delays, and a history of cognitive and speech delays, which had improved over time.
    explanation: >-
      The narrative describes an autism-spectrum diagnosis in the milder twin, although Table 2 marks her Autism row negative. Preserve the stated diagnosis and this narrative/table terminology discrepancy.
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      She had aggressive behavior toward self and others, rocking stereotypies and sleep difficulty, which improved over time.
    explanation: >-
      This reports behavior and its course without proving its molecular attribution.
- discussion_id: gap_arext2_head_and_facial_pattern
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    Why do EXT2 families differ in head-size direction, and which developmental processes cause their individual craniofacial findings?
  attaches_to:
  - phenotypes#Microcephaly
  - phenotypes#Hypertelorism
  - phenotypes#Coarse facial features
  - phenotypes#High forehead
  - phenotypes#Prominent forehead
  - phenotypes#Long philtrum
  - phenotypes#Preauricular pit
  - phenotypes#Broad nasal tip
  - phenotypes#Flat forehead
  rationale: >-
    The founding authors offer a model-based neural explanation for macrocephaly, which is represented. It does not establish the mechanism of postnatal microcephaly in the El-Bazzal brothers or prove an allele-specific residual-HS threshold. Facial traits are distinct observations, not interchangeable consequences of head size. General HS-dependent morphogenesis is plausible, but the reviewed human reports do not map orbital spacing, forehead dimensions, philtral length, preauricular pits or nasal shape to a defined neural-crest or skeletal process. Coarse facies do not demonstrate lysosomal storage.
  evidence:
  - reference: PMID:30075207
    reference_title: A novel EXT2 mutation in a consanguineous family with severe developmental delay, microcephaly, seizures, feeding difficulties, and osteopenia extends the phenotypic spectrum of autosomal recessive EXT2-related syndrome (AREXT2).
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report a consanguineous family where 2 boys presented with developmental delay, hypotonia, microcephaly, seizures, gastro-intestinal abnormalities, osteopenia, and neurological regression.
    explanation: >-
      Documents microcephaly in a family with the same recessive disorder.
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The patient is a 14‐year‐old female evaluated through the Mayo Clinic Department of Clinical Genomics for developmental delay, autism, epilepsy, and distinctive craniofacial features including macrocephaly, prominent tall forehead, hypertelorism, long hypoplastic philtrum, bilateral preauricular pits, upturned and round broad nasal tip.
    explanation: >-
      The quote establishes a broad nasal tip; no assumption about nostril orientation is needed.
- discussion_id: gap_arext2_skeletal_variability
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  prompt: >-
    Does abnormal cartilage differentiation explain the variable human spinal curves and bone density, or only the modeled exostosis route?
  attaches_to:
  - pathophysiology#Abnormal Chondrocyte Differentiation
  - phenotypes#Scoliosis
  - phenotypes#Kyphosis
  - phenotypes#Osteopenia
  - phenotypes#Overlapping toe
  - phenotypes#Multiple exostoses
  - phenotypes#Cervical segmentation defect
  rationale: >-
    The Ext2 mouse study provides a qualified cartilage-differentiation route to exostoses, and Gentile explicitly proposes genotype dependence in the human exostosis-positive family. That evidence does not establish that the same cartilage lesion causes scoliosis, kyphosis, reduced bone density or overlapping toes. Human growth-plate morphology, the effects of mobility and nutrition, and anatomic thresholds were not separated. Scoliosis narrative/table disagreement and absent skeletal findings in Gupta prevent a uniform-frequency claim. A supported model mechanism is retained; translation to each other skeletal feature remains unresolved. The cervical segmentation defect is a developmental anatomical observation, not proof of the later cartilage-differentiation mechanism.
  evidence:
  - reference: PMID:16236767
    reference_title: Mice deficient in Ext2 lack heparan sulfate and develop exostoses.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Significantly, all of the mice showed multiple abnormalities in cartilage differentiation, including disorganization of chondrocytes in long bones and premature hypertrophy in costochondral cartilage.
    explanation: >-
      This refers to heterozygous Ext2-null mice. It supports a partial-loss cartilage mechanism while differing from the human biallelic missense genotypes.
    directness: INDIRECT
  - reference: PMID:30288735
    reference_title: 'Novel exostosin-2 missense variants in a family with autosomal recessive exostosin-2-related syndrome: further evidences on the phenotype.'
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Our finding expands the clinical and molecular spectrum of the AREXT2 syndrome and suggests a possible genotype/phenotype correlation in the development of the exostoses.
    explanation: >-
      Gentile proposes genotype dependence in the recessive family; it does not establish the same cellular threshold as the mouse or a dominant HME cohort.
    directness: INDIRECT
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: REFUTE
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      However, skeletal issues such as scoliosis and decreased bone density and muscular issues such as hypotonia, observed with this disorder, were not observed in our patient.
    explanation: >-
      A biallelic EXT2 patient without scoliosis, which is why the feature is not
      treated as obligate.
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Lateral cervical spine Failure of segmentation of C2-3 and possibly C1-2
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Failure of cervical segmentation at C2–3, and possibly C1–2, was recorded radiographically in founding patient II-1. The binding preserves a segmentation defect without assuming a fully characterized fusion morphology.
- discussion_id: gap_arext2_gastrointestinal_origins
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    Which upstream processes cause malrotation, hiatus hernia and motility/feeding abnormalities, beyond their supported local complications?
  attaches_to:
  - phenotypes#Gastrointestinal dysmotility
  - phenotypes#Gastroesophageal reflux
  - phenotypes#Constipation
  - phenotypes#Feeding difficulties
  - phenotypes#Dysphagia
  - phenotypes#Diarrhea
  - phenotypes#Volvulus
  - phenotypes#Intestinal malrotation
  - phenotypes#Hiatus hernia
  - phenotypes#Encopresis
  - phenotypes#Nausea
  - phenotypes#Polyhydramnios
  rationale: >-
    Case-level motility-to-vomiting and reflux-to-ulceration relations are represented. General anatomical evidence additionally supports qualified malrotation-to-volvulus in II-5 and hiatus-hernia-to-reflux in II-1. The general studies do not establish those patients’ mesenteric dimensions, hernia subtype or pressure measurements, and none explains why EXT2 variants would cause their structural abnormalities. The reports do not establish whether the upstream dysmotility is enteric-neural, smooth-muscle or secondary to other disability. Constipation followed by diarrhea in II-1 is longitudinal variation, not an inevitable progression. Dysphagia and tube feeding do not identify oral versus pharyngeal versus esophageal dysfunction. Encopresis and nausea lack physiological attribution. Polyhydramnios in II-5’s pregnancy is not proven to result from impaired fetal swallowing. The remaining uncertainty concerns upstream attribution and patient-specific mediation, not whether malrotation or hiatus
    hernia can have those local complications.
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      He too suffers from dysfunctional gastrointestinal motility
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. II-3 had dysfunctional gastrointestinal motility with easy vomiting and documented reflux.
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      While chronic constipation was a feature in early life, diarrhea has been a feature lately.
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. II-1 had later diarrhea following early constipation. These are different timepoints.
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      At four days of age, he was diagnosed with intestinal volvulus, which required surgical intervention.
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Neonatal intestinal volvulus in II-5 required surgery; the report does not establish whether EXT2 directly caused the anatomical predisposition.
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      Dysphagia +  Tube-fed
      Low bone density +  + +
      Sensitive skin + + + +
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The clinical table records dysphagia in II-1 and tube feeding in II-4. Empty cells are unavailable information, not negatives.
  - reference: PMID:38803636
    reference_title: 'Identification and treatment of intestinal malrotation with midgut volvulus in childhood: a multicenter retrospective study.'
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Abnormal midgut fixation leads to a short mesenteric attachment, which makes the midgut prone to twisting (volvulus) around the SMA and SMV
    explanation: >-
      This anatomical mechanism is summarized in a primary multicenter pediatric surgical series. It supports a general malrotation-to-volvulus route, not an AREXT2 frequency or a measured mesenteric width in II-5.
    directness: INDIRECT
  - reference: PMID:16472589
    reference_title: Intermittent spatial separation of diaphragm and lower esophageal sphincter favors acidic and weakly acidic reflux.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      More reflux occurred when the LES and diaphragm were separated versus the reduced hernia state (23.1 +/- 5.1 vs 12.2 +/- 2.4 episodes per hour, respectively; P < .05).
    explanation: >-
      Within-subject high-resolution manometry and pH-impedance monitoring in 16 patients with small hiatal hernias associated the separated state with more reflux. AREXT2 patients were not studied; the numerical rates are not transferred to II-1.
    directness: INDIRECT
- discussion_id: gap_arext2_renal_vascular_visceral
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    Which renal and other visceral observations are intrinsic to EXT2 dysfunction, and which reflect comorbidity or secondary injury?
  attaches_to:
  - phenotypes#Abnormal renal physiology
  - phenotypes#Hematuria
  - phenotypes#Proteinuria
  - phenotypes#Hypertension
  - phenotypes#Cerebral hemorrhage
  - phenotypes#Ventricular septal defect
  - phenotypes#Abnormal liver physiology
  - phenotypes#Bilateral cryptorchidism
  - phenotypes#Precocious puberty
  - phenotypes#Extremities cold to touch
  rationale: >-
    Renal findings require special attribution: II-3 had hemolytic uremic syndrome and dialysis, so renal failure is not direct proof of an EXT2 glomerular lesion. Hematuria and proteinuria in another sibling remain unexplained; the reports do not establish altered renal HS as their cause. Brain hemorrhage lacks timing and vascular mechanism, and must not be equated automatically with II-4’s status-associated injury. Hypertension, unspecified hepatic dysfunction, ventricular septal defects, bilateral cryptorchidism and precocious puberty are clinically documented but lack feature-specific physiological or developmental attribution in the reviewed sources. Maternal gestational hypertension is excluded from the child phenotype. Cold extremities do not establish vasospasm, neuropathy or impaired circulation as the causal route.
  evidence:
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      he developed hemolytic uremic syndrome and required peritoneal dialysis.
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. This names a renal comorbidity and treatment in II-3; it does not establish EXT2 deficiency as the cause of hemolytic uremic syndrome.
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      Brain hemorrhage  + +
      Circulation  Cold extremities Cold extremities
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Brain hemorrhage was recorded in II-3 and II-4; the table does not establish timing or a vascular mechanism, including its relation to status-associated injury.
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      There is clinical heterogeneity in this disorder, with two of four patients with biallelic EXT2 alterations noted to have a ventricular septal defect.1
    explanation: >-
      Gupta summarizes two affected individuals among the four founding siblings; this is a selected family denominator, not syndrome-wide prevalence.
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Features seen in all affected individuals include: moderate intellectual disability, seizure disorder with onset between two and five years of age, hypotonia, scoliosis, macrocephaly, coarse facies, bilateral cryptorchidism in males, long hypoplastic philtrum, and hypertelorism.
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The three affected males in the founding family had bilateral cryptorchidism; this is not a syndrome-wide frequency.
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Circulation Cold extremities Cold extremities Strabismus +, left eye +, exotropia
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Cold extremities were recorded in founding patients II-3 and II-4. This observation does not establish Raynaud phenomenon or a specific vascular disorder.
- discussion_id: gap_arext2_ocular_skin_apnea
  kind: KNOWLEDGE_GAP
  status: OPEN
  prompt: >-
    What explains ocular alignment, acne and sleep apnea without assigning unmeasured nerve, skin or respiratory mechanisms?
  attaches_to:
  - phenotypes#Strabismus
  - phenotypes#Exotropia
  - phenotypes#Acne
  - phenotypes#Sleep apnea
  rationale: >-
    The reports document ocular deviations and corrective surgery, but do not distinguish ocular motor nerve, muscle or central-control causes. Zebrafish eye-field or optic-tract findings are not proof of the same lesion in human strabismus. Acne-prone sensitive skin has no demonstrated HS-dependent cutaneous mechanism. Sleep apnea in the founding table is not classified as central or obstructive; it cannot be placed downstream of a particular brainstem or airway lesion.
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      She underwent surgery for strabismus bilaterally at the age of 5 years.
    explanation: >-
      The reported diagnosis supports strabismus without selecting an unspecified narrower deviation.
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Additional features include sensitive skin prone to acne and gastro‐intestinal problems such as constipation and gastroesophageal reflux.
    explanation: >-
      The skin observation supports acne without a specific lesion subtype.
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: |-
      Sleep apnea    +
      Tremor    Coarse
      Seizures, onset (years) +, 2.5 +, 4-5 +, 2-3 +, 5
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Sleep apnea was recorded in II-5 without central/obstructive classification.
- discussion_id: interpretation_arext2_candidate_nonmissense
  kind: INTERPRETATION
  status: OPEN
  prompt: >-
    How should the nonsense/splice candidate be interpreted without assuming either a confirmed AREXT2 diagnosis or universal human null lethality?
  attaches_to:
  - genetic#EXT2
  rationale: >-
    The 2021 radiogenomics series describes one possible AREXT2 patient with maternal p.Trp79Ter and paternal c.1404+2T>C variants, but explicitly requests functional work and leaves syndrome attribution unclear. Its short stature, congenital heart disease, hearing loss, hemimegalencephaly and bilateral iris coloboma therefore remain scoped candidate findings rather than automatically entering the confirmed AREXT2 phenotype set. The whole 15-patient skeletal-dysplasia cohort is not an AREXT2 denominator. PMID:35045016 is a later title-only accessible record; without its case text, patient identity and follow-up conclusions are not assumed.
  evidence:
  - reference: PMID:34092239
    reference_title: Diagnostic yield of rare skeletal dysplasia conditions in the radiogenomics era.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      It is unclear whether patient 13 has AREXT2 thus, functional work is required.
    explanation: >-
      The authors explicitly leave this candidate diagnosis unresolved and request functional work; this is diagnostic interpretation rather than a measured phenotype.
  - reference: PMID:34092239
    reference_title: Diagnostic yield of rare skeletal dysplasia conditions in the radiogenomics era.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Patient 13 presented with SD (short stature, macrocephaly, and scoliosis) with non-skeletal syndromal features (congenital heart disease and hearing loss).
    explanation: >-
      These observations belong to the explicitly uncertain candidate case.
- discussion_id: hypothesis_arext2_replacement_therapy
  kind: EMERGING_HYPOTHESIS
  status: OPEN
  prompt: >-
    Could restoring HS biosynthesis improve clinically relevant outcomes without toxic or mistimed excess?
  attaches_to:
  - pathophysiology#Impaired Heparan Sulfate Biosynthesis
  rationale: >-
    Enzyme or HS administration was proposed in the clinical papers; no disease-modifying intervention experiment is presented in the reviewed cases. The founding author explicitly cautions about genotype, possible toxicity of excess HS and developmental timing. These proposals are not clinical trial results, measured datasets or established treatments.
  evidence:
  - reference: PMID:30997052
    reference_title: Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The findings described above could allow for a better characterization of distinct features of such clinically variable and nonspecific phenotypes and may also provide potential strategies for therapeutic intervention by enzyme replacement therapy or administration of heparan sulfate to the patients.
    explanation: >-
      This is a therapeutic proposal, not observed treatment efficacy.
  - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      it is not clear if excess heparan sulfate is toxic to cells.
    explanation: >-
      Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. The author identifies toxicity uncertainty in the same proposed replacement-therapy discussion.
clinical_trials: []
datasets: []
notes: >-
  The 2015 founding study and Farhan’s 2016 thesis chapter 3 describe the same four siblings and related experiments; the thesis is cited only for accessible full-text details and is not independent replication. Bare URL reference titles reproduce the fetcher metadata exactly. The full Gupta source was refreshed to include its tables. The complete El-Bazzal HAL PDF was visually reviewed, but its fetched text layer contains only the repository cover; that extraction limitation is not a biological knowledge gap. Gentile was assessed from its primary abstract and the Gupta comparison table; the later Sabir title-only record supplies no patient facts.


  The Falcon report was reviewed as navigation, with source checks correcting absence-of-exostoses claims, allele phase, family denominators, seizure/regression chronology and the urinary HS interpretation. An HME GeneReviews chapter was checked for its short AREXT2 allelic-disorder summary; its dominant-disease cohorts were not imported as AREXT2 evidence. Family counts and conflicting source timepoints are kept explicit rather than converted to population prevalence.


  Existing glycosylation classification is retained. The current Congenital_Disorders_of_Glycosylation grouping is explicitly restricted to protein N-glycosylation, and its sibling mechanism module centers on generalized client-protein hypoglycosylation. Neither is automatically instantiated by EXT2-dependent HS-chain synthesis, so no grouping/module conformance is added. Shared experimental mechanisms from Ext2 fish and mice are considered on biological relevance with explicit genotype/species limitations, rather than excluded solely because their original study concerned HME.


  Evidence grades distinguish human observations from cultured patient-cell assays, animal perturbations and author hypotheses. Assay readouts remain separate from clinical causal endpoints. The source-supported status-associated injury, motility/vomiting and reflux/ulceration relations are case scoped; they do not imply a complete gene-to-phenotype chain for every observation.


  Additional El-Bazzal body-only findings are preserved here because the fetched image-only manuscript cannot supply validated exact text: both brothers never walked or spoke, had axial hypotonia, large ears, dental decay and gingival hypertrophy; the younger had a single left transverse palmar crease, gastrostomy feeding and an infantile-spasm/West presentation. The article raises antiseizure treatment as a possible explanation for gingival hypertrophy. These visually reviewed observations are not replaced with unrelated or overly broad snippets; the extractability limitation does not establish a biological knowledge gap. Flat forehead is separately represented from the accessible Gupta comparison-table row summarizing these same brothers. Slightly elevated lactate and pyruvate are not labeled acidosis.


  The founding table records sensitive skin in all four siblings, without a sufficiently specific dermatological lesion to bind beyond the independently documented acne in Gupta. Reduced respiratory-chain assay activities in one founding patient did not establish a separate mitochondrial disease; negative genetic tests and the original diagnostic uncertainty are not converted into a mitochondrial causal pathway.


  General anatomical complication evidence is explicitly separate from syndrome membership: the pediatric malrotation surgical series and hiatal-hernia manometry study inform qualified local routes in the founding patients. Their cohorts and numerical rates are not imported as AREXT2 prevalence, and their measurements do not establish the anatomical intermediate in the individual AREXT2 case.
experimental_models:
- name: Founding-family patient fibroblast culture
  experimental_model_type: PRIMARY_CELL_CULTURE
  publication: PMID:26246518
  description: >-
    Skin fibroblasts from affected family members and healthy controls were cultured and assessed by immunoblotting and RT-PCR. This is the patient-derived arm of the founding study.
  modeled_mechanisms:
  - target: Reduced EXT2 Protein Availability
    relationship: MEASURES
    description: >-
      Immunoblotting measures reduced EXT2 abundance in cultured patient fibroblasts.
    limitations: >-
      The experiment does not directly determine residual catalytic activity or neural physiology.
    evidence:
    - *id009
    readouts:
    - name: Reduced EXT2 protein abundance
      target: Reduced EXT2 Protein Availability
      direction: DECREASED
      description: >-
        Reduced abundance in patient fibroblasts and reconstructed variants.
      evidence:
      - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
        reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: >-
          We observed diminished EXT2 protein expression relative to a healthy EXT2-WT control (P<0.001)
        explanation: >-
          Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. Cultured patient fibroblasts showed reduced EXT2 protein. This is an in-vitro patient-derived assay, not a tissue-wide concentration measurement.
  - target: Reduced NDST1 Protein Stability
    relationship: MEASURES
    description: >-
      Patient fibroblast protein and transcript comparisons identify NDST1 discordance.
    limitations: >-
      Absent protein with preserved transcript suggests a post-translational mechanism but does not directly measure degradation or trafficking.
    evidence:
    - *id001
    - *id002
    readouts:
    - name: Absent NDST1 protein signal
      target: Reduced NDST1 Protein Stability
      direction: ABOLISHED
      description: >-
        NDST1 protein was absent in the patient-cell immunoblot.
      evidence:
      - reference: url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
        reference_title: https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: >-
          Our findings indicate that cellular NDST1 protein levels are abolished in patient whole cell lysates
        explanation: >-
          Farhan thesis chapter 3 reproduces the founding PMID:26246518 study, not an additional cohort. NDST1 immunoblot signal was absent in cultured patient-cell lysates; the corresponding transcript was not reduced. The assay measures protein abundance rather than direct EXT2 catalytic kinetics.
- name: COS-7 and HEK293 EXT2 variant reconstruction
  experimental_model_type: CELL_LINE
  publication: PMID:26246518
  description: >-
    Wild-type, p.Met87Arg, p.Arg95Cys and double-substitution constructs were compared in two cell lines. This is the reconstruction arm of the same founding study, not another clinical cohort.
  modeled_mechanisms:
  - target: Reduced EXT2 Protein Availability
    relationship: PERTURBS
    description: >-
      Changing the encoded residues lowers EXT2 protein abundance, with the largest decrease for the double-substitution construct.
    limitations: >-
      Overexpression systems do not reproduce patient tissue dosage or directly measure HS-chain enzymatic activity.
    evidence:
    - reference: PMID:26246518
      reference_title: 'Old gene, new phenotype: mutations in heparan sulfate synthesis enzyme, EXT2 leads to seizure and developmental disorder, no exostoses.'
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        We also performed an in vitro assay to determine which mutation has a larger effect on protein expression and observed reduced EXT2 expression in constructs expressing either one of the mutations but a greater reduction when both residues were mutated.
      explanation: >-
        Constructs carrying either substitution lowered protein abundance; the double-substitution construct lowered it further. These are substitutions on the same complex allele, and the assay does not directly quantify residual glycosyltransferase activity.
    readouts:
    - name: Construct-dependent EXT2 protein abundance
      target: Reduced EXT2 Protein Availability
      direction: DECREASED
      description: >-
        Protein levels were reduced by each construct and most by the double-substitution construct.
      evidence:
      - reference: PMID:26246518
        reference_title: 'Old gene, new phenotype: mutations in heparan sulfate synthesis enzyme, EXT2 leads to seizure and developmental disorder, no exostoses.'
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: >-
          We also performed an in vitro assay to determine which mutation has a larger effect on protein expression and observed reduced EXT2 expression in constructs expressing either one of the mutations but a greater reduction when both residues were mutated.
        explanation: >-
          Constructs carrying either substitution lowered protein abundance; the double-substitution construct lowered it further. These are substitutions on the same complex allele, and the assay does not directly quantify residual glycosyltransferase activity.

📚

References & Deep Research

References

12

PMID:26246518

Old gene, new phenotype: mutations in heparan sulfate synthesis enzyme, EXT2 leads to seizure and developmental disorder, no exostoses.

No top-level findings curated for this source.

PMID:30075207

A novel EXT2 mutation in a consanguineous family with severe developmental delay, microcephaly, seizures, feeding difficulties, and osteopenia extends the phenotypic spectrum of autosomal recessive EXT2-related syndrome (AREXT2).

No top-level findings curated for this source.

PMID:30288735

Novel exostosin-2 missense variants in a family with autosomal recessive exostosin-2-related syndrome: further evidences on the phenotype.

No top-level findings curated for this source.

PMID:30997052

Developmental delay, coarse facial features, and epilepsy in a patient with EXT2 gene variants.

No top-level findings curated for this source.

PMID:16236767

Mice deficient in Ext2 lack heparan sulfate and develop exostoses.

No top-level findings curated for this source.

PMID:18337501

Heparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and heparan sulfate sulfation.

No top-level findings curated for this source.

PMID:21892940

Zebrafish Ext2 is necessary for Fgf and Wnt signaling, but not for Hh signaling.

No top-level findings curated for this source.

PMID:34092239

Diagnostic yield of rare skeletal dysplasia conditions in the radiogenomics era.

No top-level findings curated for this source.

url:https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content

https://uwo.scholaris.ca/server/api/core/bitstreams/9c05addc-1235-4172-b033-10d272ebcc44/content

No top-level findings curated for this source.

DOI:10.1016/j.ejmg.2018.07.025

A novel EXT2 mutation in a consanguineous family with severe developmental delay, microcephaly, seizures, feeding difficulties, and osteopenia extends the phenotypic spectrum of autosomal recessive EXT2-related syndrome (AREXT2)

No top-level findings curated for this source.

PMID:16472589

Intermittent spatial separation of diaphragm and lower esophageal sphincter favors acidic and weakly acidic reflux.

No top-level findings curated for this source.

PMID:38803636

Identification and treatment of intestinal malrotation with midgut volvulus in childhood: a multicenter retrospective study.

No top-level findings curated for this source.

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Falcon ▸

Disease Characteristics Research Template

Edison Scientific Literature 25 citations 2026-08-28T19:22:02.446501

Question: You are an expert researcher providing comprehensive, well-cited information.

Provide detailed information focusing on: 1. Key concepts and definitions with current understanding 2. Recent developments and latest research (prioritize 2023-2024 sources) 3. Current applications and real-world implementations 4. Expert opinions and analysis from authoritative sources 5. Relevant statistics and data from recent studies

Format as a comprehensive research report with proper citations. Include URLs and publication dates where available. Always prioritize recent, authoritative sources and provide specific citations for all major claims.

Disease Characteristics Research Template

Target Disease

Disease Name: seizures-scoliosis-macrocephaly syndrome (SSMS, biallelic EXT2 - the autosomal recessive phenotype, NOT dominant hereditary multiple exostoses)
MONDO ID: MONDO:0014731 (if available)
Category: Mendelian

Research Objectives

Please provide a comprehensive research report on seizures-scoliosis-macrocephaly syndrome (SSMS, biallelic EXT2 - the autosomal recessive phenotype, NOT dominant hereditary multiple exostoses) covering all of the disease characteristics listed below. This report will be used to populate a disease knowledge base entry. Be thorough and cite primary literature (PMID preferred) for all claims.

For each section, suggested databases/resources are listed. These are the first places you should search for information on each topic.

1. Disease Information

Search first: OMIM, Orphanet, ICD-10/ICD-11, MeSH, PubMed

What is the disease? Provide a concise overview.
What are the key identifiers? (OMIM, Orphanet, ICD-10/ICD-11, MeSH, Mondo)
What are the common synonyms and alternative names?
Is the information derived from individual patients (e.g., EHR) or aggregated disease-level resources?

2. Etiology

Disease Causal Factors: What are the primary causes? (genetic, environmental, infectious, mechanistic)
Risk Factors:

Search first: PubMed, Cochrane Library, UpToDate, clinical guidelines, ClinVar, ClinGen, GWAS Catalog, PheGenI, CTD, CDC, WHO, epidemiological databases
Genetic risk factors (causal variants, susceptibility loci, modifier genes)
Environmental risk factors (toxins, lifestyle, occupational exposures, age, sex, family history)
Protective Factors:

Search first: PubMed, Cochrane Library, clinical trial databases, GWAS Catalog, gnomAD, WHO, CDC, nutrition databases
Genetic protective factors (protective variants, modifier alleles)
Environmental protective factors (diet, lifestyle, exposures that reduce risk)
Gene-Environment Interactions: How do genetic and environmental factors interact to influence disease?

Search first: CTD, PubMed, PheGenI, GxE databases

3. Phenotypes

Search first: HPO (Human Phenotype Ontology), OMIM, Orphanet, PubMed, clinicaltrials.gov, MedDRA, SNOMED CT, DECIPHER, LOINC

For each phenotype, provide: - Phenotype type: symptoms, clinical signs, physical manifestations, behavioral changes, or laboratory abnormalities

For symptoms/signs: HPO, OMIM, Orphanet, PubMed For behavioral changes: HPO, DSM, RDoC (Research Domain Criteria), PubMed For laboratory abnormalities: LOINC, SNOMED CT, LabTests Online, PubMed - Phenotype characteristics: Search first: OMIM, Orphanet, HPO, PubMed - Age of symptom onset (neonatal, childhood, adult-onset, late-onset) - Symptom severity (mild, moderate, severe, variable) - Symptom progression (stable, progressive, episodic, fluctuating) - Frequency among affected individuals (percentage or qualitative) - Quality of life impact: Effects on daily functioning and well-being (per-phenotype when possible) Search first: EQ-5D database, SF-36, WHO QOL databases, PubMed - Suggest HPO (Human Phenotype Ontology) terms for each phenotype

4. Genetic/Molecular Information

Causal Genes: Gene mutations or chromosomal abnormalities responsible for disease (gene symbols, OMIM IDs)

Search first: OMIM, ClinVar, HGMD, Ensembl, NCBI Gene
Pathogenic Variants:
Affected genes (gene symbols, HGNC IDs) > Search first: OMIM, NCBI Gene, Ensembl, HGNC, UniProt, GeneCards
Variant classification (pathogenic, likely pathogenic, VUS per ACMG/AMP guidelines) > Search first: ClinVar, ClinGen, ACMG/AMP guidelines, VarSome
Variant type/class (missense, frameshift, nonsense, splice-site, structural)
Allele frequency in population databases > Search first: gnomAD, 1000 Genomes, ExAC, TOPMed, dbSNP
Somatic vs germline origin > Search first: COSMIC (somatic), ClinVar, ICGC, TCGA
Functional consequences (loss of function, gain of function, dominant negative)
Modifier Genes: Genes that modify disease severity or expression
Epigenetic Information: DNA methylation, histone modifications, chromatin changes affecting disease

Search first: ENCODE, Roadmap Epigenomics, MethBase, DiseaseMeth
Chromosomal Abnormalities: Large-scale genetic changes (aneuploidy, translocations, inversions)

Search first: DECIPHER, ClinVar, ECARUCA, UCSC Genome Browser

5. Environmental Information

Environmental Factors: Non-genetic contributing factors (toxins, radiation, pollution, occupational exposure)

Search first: CTD (Comparative Toxicogenomics Database), TOXNET, PubMed, EPA databases
Lifestyle Factors: Behavioral factors (smoking, diet, exercise, alcohol consumption)

Search first: CDC databases, WHO, PubMed, NHANES
Infectious Agents: If applicable, pathogens causing or triggering disease (bacteria, viruses, fungi, parasites)

Search first: NCBI Taxonomy, ViPR, BV-BRC, MicrobeDB, GIDEON

6. Mechanism / Pathophysiology

Molecular Pathways: Specific signaling cascades or biochemical pathways involved (Wnt, MAPK, mTOR, PI3K-AKT, etc.)

Search first: KEGG, Reactome, WikiPathways, PathBank, BioCyc
Cellular Processes: Cell-level mechanisms (apoptosis, autophagy, cell cycle dysregulation, inflammation, etc.)

Search first: Gene Ontology (GO), Reactome, KEGG, PubMed
Protein Dysfunction: How protein structure or function is altered (misfolding, aggregation, loss of function, gain of function)

Search first: UniProt, PDB (Protein Data Bank), InterPro, Pfam, AlphaFold
Metabolic Changes: Alterations in metabolic processes (energy metabolism, lipid metabolism, amino acid metabolism)

Search first: KEGG, BioCyc, HMDB (Human Metabolome Database), BRENDA
Immune System Involvement: Role of immune response (autoimmunity, immunodeficiency, chronic inflammation)

Search first: ImmPort, Immunome Database, IEDB, Gene Ontology
Tissue Damage Mechanisms: How tissues/ are injured (oxidative stress, ischemia, fibrosis, necrosis)

Search first: PubMed, Gene Ontology, Reactome
Biochemical Abnormalities: Specific molecular defects (enzyme deficiencies, receptor dysfunction, ion channel defects)

Search first: BRENDA, UniProt, KEGG, OMIM, PubMed
Epigenetic Changes: DNA methylation, histone modifications affecting gene expression in disease

Search first: ENCODE, Roadmap Epigenomics, MethBase, DiseaseMeth
Molecular Profiling (if available):
Transcriptomics/gene expression changes > Search first: GEO (Gene Expression Omnibus), ArrayExpress, GTEx, Human Cell Atlas, SRA
Proteomics findings > Search first: PRIDE, ProteomeXchange, Human Protein Atlas, STRING, BioGRID
Metabolomics signatures > Search first: MetaboLights, Metabolomics Workbench, HMDB, METLIN
Lipidomics alterations > Search first: LIPID MAPS, SwissLipids, LipidHome, Metabolomics Workbench
Genomic structural features > Search first: UCSC Genome Browser, Ensembl, NCBI, dbVar, DGV
Advanced Technologies (if applicable):
Single-cell analysis findings (cell-type specific mechanisms, cellular heterogeneity) > Search first: Human Cell Atlas, Single Cell Portal, GEO, CELLxGENE
Spatial transcriptomics findings > Search first: GEO, Spatial Research, Vizgen, 10x Genomics data
Multi-omics integration results > Search first: TCGA, ICGC, cBioPortal, LinkedOmics, PubMed
Functional genomics screens (CRISPR, RNAi) > Search first: DepMap, GenomeRNAi, PubMed, BioGRID ORCS

For each mechanism, describe: - The causal chain from initial trigger to clinical manifestation - Which mechanisms are upstream vs downstream - What cell types and biological processes are involved - Suggest GO terms for biological processes and CL terms for cell types

7. Anatomical Structures Affected

Organ Level:
Primary organs directly affected
Secondary organ involvement (complications, secondary effects)
Body systems involved (cardiovascular, nervous, digestive, respiratory, endocrine, etc.)

Search first: Uberon, FMA (Foundational Model of Anatomy), OMIM, HPO, ICD-11, MeSH, SNOMED CT
Tissue and Cell Level:
Specific tissue types affected (epithelial, connective, muscle, nervous)
Specific cell populations targeted (with Cell Ontology terms)

Search first: Uberon, Human Protein Atlas, Cell Ontology, Human Cell Atlas, CellMarker, PanglaoDB
Subcellular Level:
Cellular compartments involved (mitochondria, nucleus, ER, lysosomes) (with GO Cellular Component terms)

Search first: Gene Ontology (Cellular Component), UniProt, Human Protein Atlas
Localization:
Specific anatomical sites (with UBERON terms) > Search first: FMA, Uberon, NeuroNames (for brain), SNOMED CT
Lateralization (unilateral, bilateral, asymmetric) > Search first: HPO, clinical literature, imaging databases

8. Temporal Development

Onset:
Typical age of onset (congenital, pediatric, adult, geriatric)
Onset pattern (acute, subacute, chronic, insidious)

Search first: OMIM, Orphanet, HPO, PubMed
Progression:
Disease stages (early, intermediate, advanced, end-stage) > Search first: Cancer Staging Manual (AJCC), WHO classifications, PubMed
Progression rate (rapid, slow, variable)
Disease course pattern (episodic, relapsing-remitting, progressive, stable)
Disease duration (self-limited, chronic lifelong)

Search first: Disease registries, longitudinal cohort databases, natural history studies, PubMed, Orphanet, OMIM
Patterns:
Remission patterns (spontaneous, treatment-induced) > Search first: Clinical trial databases, disease registries, PubMed
Critical periods (time windows of vulnerability or opportunity for intervention) > Search first: PubMed, developmental biology databases, clinical guidelines

9. Inheritance and Population

Epidemiology:
Prevalence (cases per 100,000 at given time)
Incidence (new cases per 100,000 per year)

Search first: Orphanet, CDC, WHO, GBD (Global Burden of Disease), national registries, SEER, disease registries
For Genetic Etiology:
Inheritance pattern (AD, AR, X-linked, mitochondrial, multifactorial, polygenic) > Search first: OMIM, Orphanet, ClinVar, GTR (Genetic Testing Registry)
Penetrance (complete, incomplete, age-dependent) > Search first: ClinVar, OMIM, PubMed, ClinGen
Expressivity (variable, consistent) > Search first: OMIM, ClinVar, PubMed
Genetic anticipation (increasing severity in successive generations) > Search first: OMIM, PubMed (especially for repeat expansion disorders)
Germline mosaicism > Search first: ClinVar, OMIM, genetic counseling literature, PubMed
Founder effects (population-specific mutations) > Search first: gnomAD, population genetics databases, PubMed
Consanguinity role > Search first: OMIM, population studies, genetic counseling resources
Carrier frequency > Search first: gnomAD, carrier screening databases, GeneReviews, GTR
Population Demographics:
Affected populations (ethnic or demographic groups with higher prevalence) > Search first: gnomAD, 1000 Genomes, PAGE Study, PubMed, population registries
Geographic distribution (endemic areas, regional variation) > Search first: WHO, CDC, GBD, Orphanet, geographic epidemiology databases
Geographic distribution of specific variants
Sex ratio (male:female) > Search first: Disease registries, OMIM, PubMed, epidemiological databases
Age distribution of affected individuals > Search first: CDC, disease registries, SEER, Orphanet

10. Diagnostics

Clinical Tests:
Laboratory tests (blood, urine, tissue chemistry, specific enzyme assays) > Search first: LOINC, LabTests Online, PubMed
Biomarkers (proteins, metabolites, genetic markers, circulating biomarkers) > Search first: FDA Biomarker List, BEST (Biomarkers, EndpointS, and other Tools), PubMed
Imaging studies (X-ray, CT, MRI, PET, ultrasound) > Search first: RadLex, DICOM, Radiopaedia, imaging databases
Functional tests (pulmonary function, cardiac stress tests) > Search first: LOINC, clinical guidelines, PubMed
Electrophysiology (EEG, EMG, ECG, nerve conduction studies) > Search first: LOINC, clinical neurophysiology databases, PubMed
Biopsy findings (histopathology, immunohistochemistry) > Search first: SNOMED CT, College of American Pathologists resources, PubMed
Pathology findings (microscopic examination) > Search first: SNOMED CT, Digital Pathology databases, PubMed
Genetic Testing:

Search first: GTR (Genetic Testing Registry), GeneReviews, ClinGen
Overview of recommended genetic testing approach
Whole genome sequencing (WGS) utility > Search first: GTR, ClinVar, GEL (Genomics England), gnomAD
Whole exome sequencing (WES) utility > Search first: GTR, ClinVar, OMIM, GeneMatcher
Gene panels (which panels, which genes) > Search first: GTR, ClinVar, laboratory-specific databases
Single gene testing > Search first: GTR, ClinVar, OMIM, GeneReviews
Chromosomal microarray (CMA) > Search first: DECIPHER, ClinVar, dbVar, ECARUCA
Karyotyping > Search first: Chromosome Abnormality Database, ClinVar, cytogenetics resources
FISH > Search first: ClinVar, cytogenetics databases, PubMed
Mitochondrial DNA testing > Search first: MITOMAP, MSeqDR, ClinVar, GTR
Repeat expansion testing > Search first: GTR, ClinVar, repeat expansion databases, PubMed
Omics-Based Diagnostics (if applicable):
RNA sequencing / transcriptomics > Search first: GEO, ArrayExpress, GTEx, RNA-seq databases
Proteomics > Search first: PRIDE, ProteomeXchange, FDA Biomarker database
Metabolomics > Search first: MetaboLights, Metabolomics Workbench, HMDB
Epigenomics > Search first: GEO, ENCODE, Roadmap Epigenomics, MethBase
Liquid biopsy > Search first: COSMIC, ClinVar, liquid biopsy databases, PubMed
Clinical Criteria:
Standardized diagnostic criteria (DSM, ICD, society guidelines) > Search first: DSM-5, ICD-11, clinical society guidelines, UpToDate
Differential diagnosis (other conditions to rule out, with distinguishing features) > Search first: DynaMed, UpToDate, clinical decision support systems
Screening:
Screening methods for asymptomatic individuals (newborn screening, carrier screening, cascade screening) > Search first: ACMG recommendations, CDC newborn screening, GTR

11. Outcome/Prognosis

Survival and Mortality:
Survival rate (5-year, 10-year, overall) > Search first: SEER, cancer registries, disease-specific registries, PubMed
Life expectancy (with and without treatment if applicable) > Search first: Orphanet, disease registries, actuarial databases, PubMed
Mortality rate > Search first: CDC, WHO, GBD, national mortality databases
Disease-specific mortality (deaths directly attributable to disease) > Search first: Disease registries, CDC Wonder, GBD, PubMed
Morbidity and Function:
Morbidity (disease-related disability and health impacts) > Search first: GBD, WHO, disability databases, PubMed
Disability outcomes (long-term functional impairments) > Search first: ICF (International Classification of Functioning), disability registries
Quality of life measures (EQ-5D, SF-36, PROMIS, disease-specific tools) > Search first: EQ-5D database, SF-36, PROMIS, PubMed
Disease Course:
Complications (secondary problems: infections, organ failure, etc.) > Search first: ICD codes, disease registries, clinical databases, PubMed
Recovery potential (likelihood and extent of recovery, with vs without treatment) > Search first: Natural history studies, rehabilitation databases, PubMed
Prediction:
Prognostic factors (age, disease severity, biomarkers, treatment response) > Search first: Prognostic models databases, clinical calculators, PubMed
Prognostic biomarkers (molecular markers predicting disease course) > Search first: FDA Biomarker database, PubMed, cancer prognostic databases

12. Treatment

Pharmacotherapy:
Pharmacological treatments (drug names, drug classes, mechanisms of action) > Search first: DrugBank, RxNorm, ATC classification, DailyMed, FDA databases
Pharmacogenomics (how genetic variants affect drug metabolism, efficacy, toxicity) > Search first: PharmGKB, CPIC (Clinical Pharmacogenetics), FDA Table of PGx Biomarkers
Advanced Therapeutics:
Gene therapy (viral vectors, CRISPR, gene replacement, gene editing) > Search first: ClinicalTrials.gov, FDA gene therapy database, ASGCT resources
Cell therapy (stem cell transplant, CAR-T, cellular therapeutics) > Search first: ClinicalTrials.gov, FDA cell therapy database, FACT standards
RNA-based therapies (ASOs, siRNA, mRNA therapies) > Search first: ClinicalTrials.gov, FDA approvals, PubMed
Targeted therapies (treatments directed at specific molecular targets) > Search first: My Cancer Genome, OncoKB, ClinicalTrials.gov, FDA approvals
Immunotherapies (checkpoint inhibitors, monoclonal antibodies) > Search first: Cancer Immunotherapy Database, FDA approvals, ClinicalTrials.gov
Surgical and Interventional:
Surgical interventions (types of surgery, timing, outcomes) > Search first: CPT codes, surgical registries, clinical guidelines, PubMed
Supportive and Rehabilitative:
Supportive care (symptom management, pain control, nutrition) > Search first: Clinical guidelines, Cochrane Library, PubMed
Rehabilitation (physical therapy, occupational therapy, speech therapy) > Search first: Rehabilitation medicine databases, clinical guidelines, PubMed
Experimental:
Experimental treatments in clinical trials (with NCT identifiers if available) > Search first: ClinicalTrials.gov, EU Clinical Trials Register, WHO ICTRP
Treatment Outcomes:
Treatment response rates > Search first: Clinical trial databases, FDA reviews, systematic reviews, PubMed
Side effects and adverse events > Search first: FDA Adverse Event Reporting System (FAERS), MedWatch, PubMed
Treatment Strategy:
Treatment algorithms (clinical pathways, decision trees) > Search first: Clinical practice guidelines, NCCN Guidelines, UpToDate
Combination therapies > Search first: ClinicalTrials.gov, treatment guidelines, PubMed
Personalized medicine approaches (genotype-guided treatment) > Search first: My Cancer Genome, CIViC, PharmGKB, precision medicine databases

For each treatment, suggest NCIT (NCI Thesaurus) clinical-intervention terms where applicable.

13. Prevention

Prevention Levels:
Primary prevention (preventing disease occurrence: vaccination, risk factor modification) > Search first: CDC, WHO, USPSTF recommendations, Cochrane Library
Secondary prevention (early detection and treatment: screening programs, early intervention) > Search first: USPSTF, CDC screening guidelines, WHO
Tertiary prevention (preventing complications in those with disease) > Search first: Clinical guidelines, disease management protocols, PubMed
Immunization: Vaccine strategies (if applicable)

Search first: CDC vaccine schedules, WHO immunization, FDA vaccine database
Screening and Early Detection:
Screening programs (population-based: newborn screening, cancer screening) > Search first: CDC screening programs, USPSTF, cancer screening databases
Genetic screening (carrier screening, preimplantation genetic diagnosis, prenatal testing) > Search first: ACMG recommendations, ACOG guidelines, GTR
Risk stratification (identifying high-risk individuals for targeted prevention) > Search first: Risk prediction models, clinical calculators, PubMed
Behavioral Interventions: Lifestyle modifications to reduce risk

Search first: CDC, WHO, behavioral intervention databases, Cochrane Library
Counseling: Genetic counseling (risk assessment, family planning guidance)

Search first: NSGC resources, ACMG guidelines, GeneReviews
Public Health:
Public health interventions (sanitation, vector control, health education) > Search first: CDC, WHO, public health databases, PubMed
Environmental interventions (reducing environmental risk factors) > Search first: EPA databases, WHO environmental health, PubMed
Prophylaxis: Preventive medications or procedures

Search first: Clinical guidelines, FDA approvals, PubMed

14. Other Species / Natural Disease

Taxonomy: Species affected (with NCBI Taxon identifiers)

Search first: NCBI Taxonomy
Breed: Specific breeds affected (with VBO identifiers if applicable)

Search first: VBO (Vertebrate Breed Ontology)
Gene: Orthologous genes in other species (with NCBI Gene IDs)

Search first: NCBI Gene
Natural Disease:
Naturally occurring disease in other species (companion animals, wildlife) > Search first: OMIA (Online Mendelian Inheritance in Animals), VetCompass, PubMed
Veterinary relevance and importance in animal health > Search first: OMIA, veterinary databases, PubMed
Comparative Biology:
Comparative pathology (similarities and differences across species) > Search first: OMIA, comparative pathology databases, PubMed
Evolutionary conservation of disease mechanisms > Search first: HomoloGene, OrthoMCL, Alliance of Genome Resources
Transmission (if applicable):
Zoonotic potential > Search first: CDC zoonotic diseases, WHO zoonoses, GIDEON
Cross-species susceptibility > Search first: NCBI Taxonomy, veterinary databases, PubMed

15. Model Organisms

Model Types:
Model organism type (mammalian, invertebrate, cellular, in vitro) > Search first: Alliance of Genome Resources, model organism databases
Specific model systems (mouse, rat, zebrafish, Drosophila, C. elegans, yeast, cell lines, organoids, iPSCs) > Search first: MGI, RGD, ZFIN, FlyBase, WormBase, SGD, ATCC, Cellosaurus
Induced models (drug treatment, surgical intervention, environmental manipulation) > Search first: MGI, model organism databases, PubMed
Genetic Models:
Types available (knockout, knock-in, transgenic, conditional, humanized) > Search first: MGI, IMPC, KOMP, EuMMCR, IMSR
Model Characteristics:
Phenotype recapitulation (how well model reproduces human disease features) > Search first: Model organism databases, comparative studies, PubMed
Model limitations (aspects of human disease not captured) > Search first: Model organism databases, PubMed, review articles
Applications:
Research applications (what aspects of disease can be studied) > Search first: Model organism databases, PubMed
Resources:
Model databases > Search first: MGI, RGD, ZFIN, FlyBase, WormBase, IMSR, EMMA, MMRRC

Citation Requirements

Cite primary literature (PMID preferred) for all mechanistic and clinical claims
Prioritize recent reviews and landmark papers
Include direct quotes from abstracts where possible to support key statements
Distinguish evidence source types: human clinical, model organism, in vitro, computational

Output Format

Structure your response as a comprehensive narrative organized by the sections above. For each section, provide: - Factual content with specific details (numbers, percentages, gene names, variant nomenclature) - Ontology term suggestions (HPO, GO, CL, UBERON, CHEBI, NCIT, MONDO) where applicable - Evidence citations with PMIDs - Direct quotes from abstracts to support key claims - Clear indication when information is not available or not applicable for this disease

This report will be used to populate a disease knowledge base entry with: - Pathophysiology descriptions with causal chains - Gene/protein annotations (HGNC, GO terms) - Phenotype associations (HP terms) with frequencies - Cell type involvement (CL terms) - Anatomical locations (UBERON terms) - Chemical entities (CHEBI terms) - Treatment annotations (NCIT terms) - Evidence items with PMIDs and exact abstract quotes - Epidemiology, prognosis, diagnostic, and prevention information - Animal model descriptions with phenotype recapitulation details

Seizures–scoliosis–macrocephaly syndrome (SSMS)

Biallelic EXT2 / autosomal-recessive EXT2-related syndrome (AREXT2)

Executive summary

SSMS is an ultra-rare, autosomal-recessive developmental disorder caused by biallelic hypomorphic EXT2 variants. It is characterized primarily by developmental/intellectual disability, epilepsy, abnormal head size, hypotonia, spinal deformity and dysmorphic features, with variable gastrointestinal, cardiac, renal, behavioral and growth abnormalities. “Autosomal-recessive EXT2-related syndrome” (AREXT2) is the broader and increasingly appropriate label because later families do not invariably have all three eponymous findings: microcephaly rather than macrocephaly and absence of scoliosis have both been reported. The defining distinction is from autosomal-dominant hereditary multiple exostoses type 2: osteochondromas are not a defining feature of AREXT2 and were specifically absent in the original family. (jaeken2020congenitaldisordersof pages 4-5, mizumoto2021congenitaldisordersof pages 12-13, gupta2019developmentaldelaycoarse pages 1-2, gupta2019developmentaldelaycoarse pages 2-4)

The evidence base remains exceptionally small. The foundational report was Farhan et al., published August 2015 (J Med Genet 52:666–675; PMID 26246518; DOI/URL: https://doi.org/10.1136/jmedgenet-2015-103279). Subsequent informative reports include El-Bazzal et al. (2018; DOI: https://doi.org/10.1016/j.ejmg.2018.07.025), Gentile et al. (online 2018/issue 2019; DOI: https://doi.org/10.1111/cge.13458), Gupta et al. (accepted January 8, 2019; DOI: https://doi.org/10.1002/ccr3.2010), and Sabir et al. (2022; DOI: https://doi.org/10.1097/MCD.0000000000000406). No disease-specific clinical study published in 2023–2024 was identified in the searches performed for this report. The main relevant 2024 advance is structural work on the interacting HS-modification enzyme NDST1, not new SSMS natural-history or treatment evidence. (OpenTargets Search: seizures-scoliosis-macrocephaly syndrome-EXT2, gupta2019developmentaldelaycoarse pages 1-2, gupta2019developmentaldelaycoarse pages 5-6)

Key primary-source abstract quotation (Gupta et al., 2019): “We report a patient with developmental delay, autism, epilepsy, macrocephaly, facial dysmorphism, gastrointestinal, and behavioral issues due to EXT2 compound heterozygous likely pathogenic variants.” (gupta2019developmentaldelaycoarse pages 1-2)

The available human cohorts and their evidentiary limitations are summarized below.

Publication / cohort	Family / patients	EXT2 genotype	Key phenotype and onset	Major outcomes	Evidence caveats
Farhan et al., 2015; J Med Genet 52:666-675; PMID: 26246518; DOI: 10.1136/jmedgenet-2015-103279	1 Old Order Mennonite family; 4 affected siblings (3M, 1F), assessed ages reported in later summaries/thesis as ~10-19 years	Complex homozygous missense variants: p.Met87Arg and p.Arg95Cys; family segregated with recessive disease	Core SSMS phenotype: developmental delay/intellectual disability, hypotonia, seizures with onset ~2.5-5 years, macrocephaly, scoliosis/kyphosis, hypertelorism; additional renal/GI/cardiac findings in some; exostoses specifically absent (mizumoto2018defectsinbiosynthesis pages 13-14, mizumoto2021congenitaldisordersof pages 12-13, farhan2016genediscoveryin pages 110-114, farhan2016genediscoveryina pages 110-114)	Severe variable course: one patient died after status epilepticus at 17; one had prolonged seizure/status with hemiplegic stroke and wheelchair dependence; one had renal failure; patient fibroblasts showed reduced EXT2 protein/transcript and abolished NDST1 protein (farhan2016genediscoveryina pages 123-130, farhan2016genediscoveryin pages 110-114, farhan2016genediscoveryina pages 110-114)	Most granular clinical detail available from thesis/review excerpts rather than full 2015 paper text in retrieved context; some ages differ across excerpt types because thesis followed patients longer (farhan2016genediscoveryina pages 123-130, farhan2016genediscoveryina pages 131-135, farhan2016genediscoveryin pages 110-114, farhan2016genediscoveryina pages 110-114)
El-Bazzal et al., 2018; Eur J Med Genet, cited in Gupta 2019; DOI reported as 10.1016/j.ejmg.2018.07.025	1 family; 2 brothers	Homozygous p.Ser4Leu (c.11C>T)	Severe developmental delay, seizures, feeding difficulties, microcephaly rather than macrocephaly/normal head size in later AREXT2 spectrum summaries; facial flattening/coarse features summarized in comparison table; exostoses absent in AREXT2 framing (gupta2019developmentaldelaycoarse pages 4-5, gupta2019developmentaldelaycoarse pages 5-6)	Expanded phenotype toward more severe neurodevelopmental disease; both boys alive at reported ages 6 and 8 in comparison table (gupta2019developmentaldelaycoarse pages 4-5)	Direct article text was not retrieved; details come from Gupta 2019 comparison table/citation trail, so onset specifics and full systems review should be treated as second-hand summary (gupta2019developmentaldelaycoarse pages 4-5, gupta2019developmentaldelaycoarse pages 5-6)
Gentile et al., 2019; Clin Genet 95:165-171; DOI: 10.1111/cge.13458	1 family; 2 affected relatives/patients (F15, M21 in Gupta comparison table)	Compound heterozygous missense variants p.Asp227Asn and p.Tyr608Cys	Intellectual disability/developmental delay, seizures in one or both, macrocephaly reported as “high” head size in comparison table, facial dysmorphism; phenotype milder/variable compared with founder family; exostoses not reported as present in AREXT2 summaries (gupta2019developmentaldelaycoarse pages 4-5, gupta2019developmentaldelaycoarse pages 5-6)	Survived into adolescence/adulthood (15 and 21 years in comparison table), supporting variable severity and nonlethal course in some genotypes (gupta2019developmentaldelaycoarse pages 4-5)	Full paper not retrieved; patient-level details limited to secondary table excerpt and review mentions, so seizure onset/treatment/systemic findings cannot be stated with confidence here (gupta2019developmentaldelaycoarse pages 4-5, gupta2019developmentaldelaycoarse pages 5-6)
Gupta et al., 2019; Clin Case Rep 7:632-637; DOI: 10.1002/ccr3.2010	1 nonconsanguineous family; proband F14 plus mildly affected fraternal twin sister; unaffected brother carried only one paternal EXT2 variant	Compound heterozygous EXT2 p.Val373Asp (c.1118T>A) and p.Thr672Met (c.2015C>T); both sisters also carried heterozygous NDST1 p.Arg454Cys VUS	Proband: developmental delay during first 2 years, regression at 27 months, autism, macrocephaly, hypertelorism, long philtrum, strabismus, GI issues, behavioral issues, seizures at ~10 years; EEG abnormal with occipital/midline spike-wave; brain MRI normal; no scoliosis/hypotonia/decreased bone density documented. Twin: milder Asperger syndrome/motor-cognitive-speech delay (gupta2019developmentaldelaycoarse pages 1-2, gupta2019developmentaldelaycoarse pages 2-4, gupta2019developmentaldelaycoarse pages 5-6)	Demonstrates intrafamilial variability and possible modifier effect; low heparan sulfate measured in dried blood spot, serum, and urine in proband and unaffected parents; variants submitted to ClinVar; no exostoses reported (gupta2019developmentaldelaycoarse pages 1-2, gupta2019developmentaldelaycoarse pages 2-4, gupta2019developmentaldelaycoarse pages 5-6)	EXT2 variants were classified as likely pathogenic/clinical-interest in context of emerging AREXT2 literature, but authors noted NDST1 contribution remained uncertain; unaffected parents also had low heparan sulfate, limiting biomarker specificity (gupta2019developmentaldelaycoarse pages 2-4, gupta2019developmentaldelaycoarse pages 5-6)
Sabir et al., 2022; Clin Dysmorphol 31:84-90; DOI: 10.1097/MCD.0000000000000406	Reported as a further case / extending phenotype	Not extractable from retrieved context	Not extractable from retrieved context	Not extractable from retrieved context	Mentioned only as an unobtainable paper in search results; because no supporting details were retrieved, it is intentionally not summarized beyond bibliographic mention to avoid inventing facts (gupta2019developmentaldelaycoarse pages 4-5)

Table: This table summarizes the main published human cohorts for autosomal recessive EXT2-related syndrome/SSMS, emphasizing genotype, core phenotype, outcomes, and limits of the available evidence. It is useful for quickly separating well-supported patient data from second-hand summaries and unretrieved reports.

1. Disease information

Definition and identifiers

Preferred disease name: autosomal-recessive EXT2-related syndrome (AREXT2).
Historical/eponymous name: seizures–scoliosis–macrocephaly syndrome (SSMS or SSM syndrome).
MONDO: MONDO:0014731.
OMIM phenotype: 616682.
Causal gene: EXT2, OMIM 608210; Ensembl ENSG00000151348; approved name “exostosin glycosyltransferase 2.” Open Targets identifies EXT2 as the sole associated target for MONDO:0014731 and links the association to PMID 26246518 and subsequent literature. (OpenTargets Search: seizures-scoliosis-macrocephaly syndrome-EXT2)
Distinct dominant disorder: multiple exostoses type 2, OMIM 133701, caused by monoallelic pathogenic EXT2 variants. It must not be merged with SSMS/AREXT2. (gupta2019developmentaldelaycoarse pages 1-2, gupta2019developmentaldelaycoarse pages 2-4, farhan2016genediscoveryina pages 131-135)
Other nomenclature encountered: EXT2-CDG and recessive EXT2 deficiency. Because the molecular defect involves glycosaminoglycan rather than classical N-linked glycoprotein biosynthesis, “EXT2-related glycosaminoglycan-biosynthesis disorder” is mechanistically precise.
Orphanet, ICD-10, ICD-11 and MeSH: no retrieved evidence established a dedicated disorder-specific identifier. Coding therefore generally requires broader categories such as genetic neurodevelopmental disorder, epilepsy and scoliosis, rather than a unique SSMS code.

Source granularity

Knowledge is derived mainly from individual patients and multiplex families published as case reports/series, then aggregated by OMIM/MONDO and reviews—not from EHR-scale cohorts, registries or population surveillance. The original report involved four siblings; subsequent publications added only small families or single cases. Accordingly, apparent frequencies are descriptive proportions among published cases and are highly vulnerable to ascertainment and publication bias. (gupta2019developmentaldelaycoarse pages 1-2, gupta2019developmentaldelaycoarse pages 4-5, farhan2016genediscoveryin pages 110-114)

2. Etiology

Causal factor

The primary cause is germline biallelic EXT2 variation, usually missense alleles retaining partial function. In the original consanguineous Old Order Mennonite family, all affected siblings were homozygous for both NM_000401.3:c.260T>G, p.(Met87Arg) and c.283C>T, p.(Arg95Cys) on the same disease haplotype (“complex homozygosity”). Patient fibroblasts had significantly reduced EXT2 protein (P<0.001), modestly reduced transcript (P<0.05), and loss of detectable NDST1 protein despite preserved NDST1 transcript. Expression constructs showed that each variant reduced EXT2 abundance and that the combined changes had the greatest effect; p.Arg95Cys had the larger individual effect. This supports synergistic partial loss of protein stability/function rather than gain of function. (farhan2016genediscoveryina pages 123-130)

Other reported genotypes include homozygous c.11C>T, p.(Ser4Leu); compound-heterozygous c.679G>A, p.(Asp227Asn) plus c.1823A>G, p.(Tyr608Cys); and compound-heterozygous c.1118T>A, p.(Val373Asp) plus c.2015C>T, p.(Thr672Met). The last pair was considered likely pathogenic by the authors under ACMG/AMP reasoning, although originally returned as VUSs in a gene with an emerging disease relationship. (gupta2019developmentaldelaycoarse pages 2-4, gupta2019developmentaldelaycoarse pages 4-5, gupta2019developmentaldelaycoarse pages 5-6)

Genetic risk and modifiers

Major risk: inheriting two disease-associated EXT2 alleles in trans, or the same pathogenic/hypomorphic haplotype from both parents.
Consanguinity/founder structure: central in the original Mennonite family and compatible with homozygosity-by-descent. In local screening, p.Met87Arg had 3 heterozygotes among 78 persons (carrier frequency 3.85%), whereas no p.Arg95Cys carrier or double heterozygote was found. In 311 additional healthy Caucasian controls, neither allele was detected. Historical NHLBI ESP minor-allele frequencies were 0.054% and 0.015%, respectively; these are not contemporary ancestry-stratified carrier estimates. (farhan2016genediscoveryina pages 123-130)
Gupta-family allele frequencies: p.Val373Asp occurred in 3/246,244 gnomAD alleles (0.001%; no homozygotes) and p.Thr672Met in 20/276,874 (0.007%; no homozygotes). (gupta2019developmentaldelaycoarse pages 2-4)
Potential modifier: the Gupta proband and her more mildly affected twin also carried heterozygous NDST1 c.1360C>T, p.(Arg454Cys), frequency 44/275,364 alleles (0.02%; no homozygotes). The authors explicitly considered an NDST1 modifier effect but concluded that evidence was insufficient. Neuronal voltage-gated-potassium-channel antibodies present in the more severely affected twin were another possible contributor to discordance, but not an established SSMS mechanism. (gupta2019developmentaldelaycoarse pages 2-4, gupta2019developmentaldelaycoarse pages 5-6)
No validated protective EXT2 allele, modifier gene, polygenic score, anticipation, recurrent de novo mechanism or germline-mosaicism estimate has been reported.

Environmental, infectious and gene–environment factors

No toxin, diet, lifestyle, occupational exposure, radiation or infectious agent is known to cause SSMS. No protective lifestyle factor or reproducible gene–environment interaction has been identified. Fever, sleep loss or medication nonadherence may trigger seizures in any epilepsy, but there is no SSMS-specific evidence. Family history and consanguinity alter the probability of inheriting the genotype, not its molecular action.

3. Phenotypes

Core and variable manifestations

The original four siblings all had developmental delay/intellectual disability, seizures beginning at approximately 2.5–5 years, hypotonia, macrocephaly and scoliosis/kyphosis. They had minimal expressive speech with relatively preserved comprehension. Additional findings included coarse/dysmorphic facies, hypertelorism, long hypoplastic philtrum, cryptorchidism in males, ventricular septal defects, gastrointestinal dysmotility/reflux, and renal abnormalities. No exostoses were found. (farhan2016genediscoveryin pages 110-114, farhan2016genediscoveryina pages 110-114, farhan2016genediscoveryin pages 105-110)

Later cases broadened the spectrum to microcephaly, feeding difficulty, osteopenia, absent scoliosis, autism, behavioral dysregulation, sleep disturbance, normal brain MRI and later-onset focal epilepsy. The Gupta proband sat at 7–8 months, walked at 14 months, had language delay by age 2 and regression at 27 months; seizures began around age 10. EEG showed occipital-midline spike-and-wave discharges consistent with focal seizures, whereas MRI was normal. Her fraternal twin carrying the same EXT2 variants had much milder motor, speech and cognitive difficulties/Asperger syndrome. (gupta2019developmentaldelaycoarse pages 1-2, gupta2019developmentaldelaycoarse pages 2-4, gupta2019developmentaldelaycoarse pages 4-5)

Suggested phenotype annotations

Clinical domain	Character/course	Published frequency signal	Suggested HPO term
Global developmental delay	Infancy/early childhood; variable, sometimes regression	Very common across reported cases	HP:0001263 Global developmental delay
Intellectual disability	Mild to severe; lifelong	Very common	HP:0001249 Intellectual disability
Speech/language delay	Often marked; minimal expressive speech in founder cohort	Common	HP:0000750 Delayed speech and language development
Seizures/epilepsy	Usually childhood; generalized tonic–clonic, focal or status epilepticus	Very common; onset 2.5–5 years in all four founder cases, age 10 in Gupta proband	HP:0001250 Seizure; HP:0002069 Generalized tonic-clonic seizure; HP:0002133 Status epilepticus
Hypotonia	Congenital or early childhood; variable	All four founder cases; absent in Gupta proband	HP:0001252 Muscular hypotonia
Macrocephaly	Congenital/postnatal; nonprogressive status unclear	All four founder cases and Gupta proband; not universal	HP:0000256 Macrocephaly
Microcephaly	Alternative head-size phenotype	Reported in the severe El-Bazzal family	HP:0000252 Microcephaly
Scoliosis/kyphoscoliosis	Childhood, potentially progressive and function-limiting	All four founder cases; absent in Gupta proband	HP:0002650 Scoliosis; HP:0002751 Kyphoscoliosis
Facial dysmorphism	Coarse facies, hypertelorism, tall/prominent forehead, long philtrum, broad/bulbous nose	Common but variable	HP:0000316 Hypertelorism; HP:0000343 Long philtrum; HP:0000280 Coarse facial features
Autism/behavioral abnormalities	Autism, stereotypies, aggression/self-injury, sleep difficulty	Variable	HP:0000717 Autism; HP:0000718 Aggressive behavior; HP:0002360 Sleep disturbance
GI dysfunction	GERD, constipation/diarrhea, dysmotility; volvulus/malrotation in founder family	Variable	HP:0002020 Gastroesophageal reflux; HP:0002019 Constipation; HP:0002566 Intestinal malrotation
Renal disease	Hematuria/proteinuria; renal failure in one founder sibling	Uncommon but clinically important	HP:0000093 Proteinuria; HP:0000790 Hematuria; HP:0000083 Renal insufficiency
Cardiac defect	Ventricular septal defect in members of founder family	Variable	HP:0001629 Ventricular septal defect
Cryptorchidism	Bilateral in affected males in founder family	Reported in founder males	HP:0000028 Cryptorchidism
Strabismus	Surgically treated in Gupta proband	Variable	HP:0000486 Strabismus
Osteopenia	Described in later severe cases	Variable	HP:0000938 Osteopenia
Osteochondroma/exostoses	Absent, an important discriminator	Absent in original family and reported AREXT2 cases	HP:0002859 Multiple exostoses—use as an excluded/negative phenotype

These are suggested knowledge-base mappings, not a formally curated SSMS HPO disease model.

Quality-of-life impact

No EQ-5D, SF-36, PROMIS or disease-specific quality-of-life study exists. Nevertheless, case data show major functional burden: severe communication limitation, lifelong supervision, epilepsy risk, orthopedic restriction and multisystem surveillance. One sibling became wheelchair-dependent after prolonged status epilepticus with hemiplegic stroke; another died after status epilepticus at 17. Scoliosis/kyphosis, gastrointestinal disease and renal failure add substantial morbidity. Conversely, the mildly affected Gupta twin illustrates that biallelic disease can permit much greater independence. (farhan2016genediscoveryin pages 110-114, farhan2016genediscoveryina pages 110-114)

4. Genetic and molecular information

Gene/protein

Gene: EXT2; HGNC-approved symbol EXT2; chromosome 11p11.2; OMIM 608210.
Protein: exostosin-2, a type-II membrane glycosyltransferase of the ER/Golgi secretory pathway.
Molecular function: with EXT1, catalyzes heparan-sulfate backbone elongation by alternating addition of glucuronic acid (GlcA) and N-acetylglucosamine (GlcNAc) from UDP-GlcA and UDP-GlcNAc. The EXT1–EXT2 heterocomplex has substantially stronger polymerase activity than either protein alone. (mizumoto2021congenitaldisordersof pages 11-12, mizumoto2021congenitaldisordersof pages 12-13, jankun2017thestudyof pages 24-28)

Suggested GO annotations include GO:0000139 Golgi membrane, GO:0005794 Golgi apparatus, GO:0005783 endoplasmic reticulum, GO:0015012 heparan sulfate proteoglycan biosynthetic process, GO:0008375 acetylglucosaminyltransferase activity, and GO:0008194 UDP-glycosyltransferase activity.

Variant table

Variant(s)	State	Evidence/classification	Functional or population evidence
c.260T>G p.Met87Arg + c.283C>T p.Arg95Cys	Both homozygous on a complex allele/haplotype	Disease-associated in original family; functionally supported	Reduced EXT2 protein/transcript in fibroblasts; each construct reduced expression, combined strongest; historical ESP MAF 0.054% and 0.015%
c.11C>T p.Ser4Leu	Homozygous	Reported in severe AREXT2 family	Direct functional evidence not retrieved
c.679G>A p.Asp227Asn + c.1823A>G p.Tyr608Cys	Compound heterozygous	Reported AREXT2 missense pair	Direct assay not retrieved
c.1118T>A p.Val373Asp + c.2015C>T p.Thr672Met	Compound heterozygous	Authors’ final assessment: likely pathogenic collectively	gnomAD 3/246,244 and 20/276,874, respectively; no homozygotes; damaging in-silico predictions; segregation with two affected sisters

All reported SSMS alleles are germline. No somatic SSMS mechanism is known. No recurrent pathogenic structural variant, aneuploidy, translocation or inversion defines SSMS. Heterozygous deletion of 11p11.2 including EXT2 instead produces Potocki–Shaffer syndrome, a distinct contiguous-gene condition. (mizumoto2021congenitaldisordersof pages 12-13, gupta2019developmentaldelaycoarse pages 2-4)

Functional interpretation and caveats

The original alleles are best interpreted as hypomorphic loss-of-function/protein-destabilizing missense changes. Complete EXT2 loss is probably incompatible with normal embryogenesis, consistent with animal null lethality. Variant classification should be performed allele-by-allele using current ClinVar submissions, segregation, phase, rarity, phenotype and functional evidence. The Gupta variants have ClinVar submissions SCV000782709 and SCV000782708; the NDST1 VUS was submitted as SCV000782711. (gupta2019developmentaldelaycoarse pages 2-4)

No SSMS-specific DNA-methylation signature, histone alteration, imprinting mechanism or epigenetic biomarker has been demonstrated. No transcriptomic, proteomic, metabolomic, lipidomic, single-cell, spatial or multi-omic patient cohort exists.

5. Environmental information

SSMS is a constitutional Mendelian disorder. No environmental exposure, lifestyle practice or pathogen is necessary or sufficient to produce it, and none has been shown to alter penetrance. Routine healthy diet, exercise within orthopedic/neurologic limits, avoidance of smoking/alcohol and vaccination are general-health measures, not disease-specific interventions. Environmental seizure-safety measures can reduce injury but do not prevent the molecular disease.

6. Mechanism and pathophysiology

Supported causal chain

Trigger—biallelic hypomorphic EXT2 variants. The founder variants reduce EXT2 transcript modestly and protein much more strongly, consistent with impaired stability/processing. (farhan2016genediscoveryina pages 123-130)
Upstream biochemical defect—impaired EXT1–EXT2 copolymerase. The Golgi complex normally elongates HS with repeating [GlcA–GlcNAc]n units. Reduced EXT2 lowers chain production/length and perturbs assembly of the HS-biosynthetic machinery. (mizumoto2021congenitaldisordersof pages 11-12, jankun2017thestudyof pages 24-28)
Secondary biosynthetic defect—NDST1 instability and altered sulfation. NDST1 protein was abolished in founder patient fibroblasts despite normal transcript, suggesting post-translational destabilization. NDST1 establishes N-sulfated domains needed for later HS modification and ligand binding. This is direct cellular evidence; the precise patient HS sequence/chain-length defect was not comprehensively profiled. (farhan2016genediscoveryina pages 123-130)
Extracellular/cell-surface consequences. HS proteoglycans organize extracellular matrix and act as co-receptors/reservoirs for morphogens, growth factors, cytokines and axon-guidance cues. Reduced or abnormally modified HS can impair ligand distribution and receptor activation. (mizumoto2021congenitaldisordersof pages 12-13)
Downstream developmental signaling. Zebrafish ext2/dackel studies support disrupted FGF and Wnt signaling, with less evidence for a primary Hedgehog defect. These pathways regulate neural patterning, axon guidance, cartilage organization, organogenesis and growth. Their role in human SSMS is biologically compelling but inferential rather than proven in patient neural tissue. (mizumoto2021congenitaldisordersof pages 12-13, jankun2017thestudyof pages 24-28)
Clinical manifestations. Abnormal neuronal specification/connectivity and network maturation plausibly produce developmental disability, macro-/microcephaly and epilepsy; defective chondrocyte organization and matrix signaling plausibly produce scoliosis/osteopenia; disturbed renal, cardiac and gastrointestinal morphogenesis or tissue maintenance plausibly explains variable systemic findings.

Current structural insight

A 2024 cryo-EM study resolved human NDST1’s N-terminal, deacetylase and sulfotransferase architecture and proposed that substrate anchoring at the sulfotransferase domain initiates a catalytic cycle despite spatial separation of catalytic domains (Mycroft-West et al., published February 2024; DOI: https://doi.org/10.1038/s41467-024-45419-4). This refines understanding of the pathway downstream of EXT2 but did not study SSMS variants or patients.

2024 abstract wording: “Mature HS polysaccharides contain complex, non-templated patterns of sulfation and epimerization, which mediate interactions with diverse protein partners.” This helps explain why simply supplying nonspecific heparan sulfate may not reproduce the missing developmental signal.

Suggested mechanism annotations

GO biological processes: heparan-sulfate proteoglycan biosynthesis; glycosaminoglycan biosynthesis; Golgi organization; extracellular-matrix organization (GO:0030198); nervous-system development (GO:0007399); axon guidance (GO:0007411); cartilage development (GO:0051216); regulation of FGF-receptor and Wnt signaling.
Cell types (suggested CL mappings): neuron (CL:0000540), neural progenitor cell (CL:0011020), chondrocyte (CL:0000138), osteoblast (CL:0000062), fibroblast (CL:0000057), renal epithelial cell and cardiomyocyte. Only fibroblasts have been directly assayed from SSMS patients; the remaining cells are inferred from clinical anatomy/model biology.
Chemical entities: heparan sulfate (CHEBI:28815), glucuronic acid/UDP-glucuronate, N-acetyl-D-glucosamine/UDP-GlcNAc, and proteoglycan. No disease-specific circulating chemical biomarker is validated.
Subcellular site: ER/Golgi membrane and lumen for EXT1–EXT2 synthesis/assembly; plasma membrane and extracellular matrix for mature HS proteoglycans.

No primary immune, inflammatory, oxidative-stress, mitochondrial, autophagic or apoptotic mechanism has been demonstrated in SSMS. Immune abnormalities reported in other HS-biosynthesis disorders should not be transferred to EXT2 disease without evidence.

7. Anatomical structures affected

Organ and system level

Primary: central nervous system/brain; vertebral column and axial skeleton.
Variable secondary: peripheral musculoskeletal system, heart (septum), kidneys, gastrointestinal tract, eyes and male reproductive tract.
Suggested UBERON terms: brain (UBERON:0000955), cerebral cortex (UBERON:0000956), spinal cord (UBERON:0002240), vertebral column (UBERON:0001130), cartilage tissue (UBERON:0002418), kidney (UBERON:0002113), heart (UBERON:0000948), intestine (UBERON:0000160) and testis (UBERON:0000473).

No consistent lateralization is known. The hemiplegia in one patient followed a prolonged seizure/stroke and should be treated as an acquired complication, not a primary asymmetric malformation. Patient MRI can be normal, as in the Gupta proband; therefore normal structural imaging does not exclude the diagnosis. (gupta2019developmentaldelaycoarse pages 1-2)

8. Temporal development

SSMS is genetically present from conception, but clinical recognition is generally infantile or early-childhood. Hypotonia and motor delay may be evident in infancy; language delay appears in the first two years; seizures typically begin in early childhood but can emerge as late as approximately age 10. Spinal deformity may become more apparent with growth. (gupta2019developmentaldelaycoarse pages 1-2, gupta2019developmentaldelaycoarse pages 4-5, farhan2016genediscoveryin pages 105-110)

The course is chronic and lifelong, with markedly variable severity. Some developmental deficits are stable; regression, declining mobility and progressive orthopedic or renal morbidity can occur. Epilepsy is episodic and may include life-threatening status epilepticus. No recognized biochemical stages, remission pattern or validated critical-treatment window exists. Developmental biology suggests that prenatal/early-postnatal HS signaling is a critical period, but this remains an experimental inference. (farhan2016genediscoveryina pages 131-135)

9. Inheritance and population

Inheritance: autosomal recessive.
Recurrence risk: when both parents carry one disease-associated allele/haplotype, each pregnancy has a 25% affected, 50% carrier and 25% non-carrier probability, assuming conventional Mendelian segregation.
Penetrance: likely high for clinically relevant biallelic genotypes, but cannot be quantified. The markedly discordant Gupta twins demonstrate variable expressivity and/or uncertain contribution from modifiers.
Anticipation: not expected and not reported.
Sex ratio: no credible estimate; both sexes are affected. The original cohort was 3 male/1 female, but published numbers are too small for inference. (farhan2016genediscoveryin pages 105-110)
Prevalence/incidence: unknown; no cases-per-100,000 or annual incidence estimate exists. The total published population is only on the order of a dozen individuals, depending on inclusion of incompletely characterized “further cases.”
Geography/ancestry: reported families include an Old Order Mennonite kindred and unrelated later families. No population-wide endemic distribution is established.
Carrier frequency: unknown globally. The 3.85% local p.Met87Arg carrier observation was based on only 78 persons and did not include p.Arg95Cys double carriers; it must not be used as a general AREXT2 carrier rate. (farhan2016genediscoveryina pages 123-130)

10. Diagnostics

Clinical suspicion

Consider AREXT2 in a child or adult with otherwise unexplained developmental/intellectual disability plus epilepsy, abnormal head circumference, hypotonia, scoliosis/osteopenia or characteristic coarse facial features—particularly with consanguinity, similarly affected siblings and no osteochondromas. The phenotype is not specific enough for clinical diagnosis alone. (mizumoto2021congenitaldisordersof pages 12-13, gupta2019developmentaldelaycoarse pages 2-4)

Recommended evaluation

Genetic confirmation: sequence EXT2 with deletion/duplication coverage as part of a developmental-delay/epilepsy, congenital-glycosylation/GAG-biosynthesis or skeletal-dysplasia panel, or use trio/quad WES/WGS. Confirm candidate variants by orthogonal testing where required, establish phase, test parents and segregate within the family. Autozygosity mapping can help in consanguineous multiplex families, as demonstrated in the founder report. (farhan2016genediscoveryina pages 123-130, farhan2016genediscoveryina pages 131-135)
Variant interpretation: require biallelic variants compatible with recessive inheritance; assess rarity, conservation, protein domain, ClinVar evidence, phenotype and functional data. A single heterozygous EXT2 variant does not establish SSMS and instead raises dominant HME carrier/disease considerations.
Neurology: developmental assessment; EEG after seizures or suspicious episodes; MRI to assess alternative structural causes, recognizing that it may be normal. (gupta2019developmentaldelaycoarse pages 1-2)
Musculoskeletal: standing spine radiographs and orthopedic examination for scoliosis/kyphosis; bone-density assessment when clinically indicated. Skeletal survey can document absence of osteochondromas or investigate unexplained masses.
Systemic baseline: urinalysis, urine protein, serum creatinine/eGFR and blood pressure; echocardiography if murmur/congenital-heart concern; GI/nutritional assessment; ophthalmology; examination for cryptorchidism.

Biomarkers and other tests

The Gupta proband had low HS in dried blood spot (12 nmol/L), serum (4.46 ng/mL) and urine (0.5 mg/mmol creatinine). However, her clinically unaffected parents also had low values, so HS measurement is neither validated nor sufficiently specific/sensitive for diagnosis. It may remain a research assay. Conventional karyotype, array CGH, Fragile-X testing and Rett/Angelman/Prader–Willi testing were normal in that patient. (gupta2019developmentaldelaycoarse pages 1-2, gupta2019developmentaldelaycoarse pages 2-4)

CMA is appropriate when copy-number disease remains in the differential, particularly Potocki–Shaffer syndrome, but it will not detect most missense AREXT2 genotypes. Karyotype/FISH, mitochondrial sequencing, repeat-expansion tests, biopsy, proteomics, metabolomics, epigenomics and liquid biopsy have no SSMS-specific indication unless another diagnosis is suspected.

Differential diagnosis

Dominant EXT2-related hereditary multiple exostoses: multiple osteochondromas, often short stature/limb deformity; typically monoallelic EXT2; neurodevelopmental SSMS constellation is not typical.
Potocki–Shaffer syndrome: 11p11.2 deletion including EXT2 and adjacent genes; exostoses, biparietal foramina, intellectual disability and craniofacial anomalies.
Other HS-biosynthesis disorders: NDST1-related intellectual disability, EXTL3-related neuro-immuno-skeletal dysplasia and HS2ST1-related neurofacioskeletal syndrome.
Mucopolysaccharidoses: coarse facies, skeletal and neurodevelopmental disease, but caused by HS degradation/storage with elevated urinary GAG patterns rather than deficient synthesis.
Other developmental epileptic encephalopathies, overgrowth/macrocephaly syndromes, congenital glycosylation disorders and syndromic scoliosis.

No standardized clinical diagnostic criteria or newborn-screening program exists.

11. Outcome and prognosis

No survival curve, median life expectancy, 5-/10-year survival, mortality rate or validated prognostic score exists. Published survival into adulthood—including age 21 and at least the mid/late twenties in follow-up—is compatible with long survival in some genotypes. Severe outcomes in the founder family included renal failure, loss of ambulation after status epilepticus with stroke, and death after status epilepticus at 17. (gupta2019developmentaldelaycoarse pages 4-5, farhan2016genediscoveryin pages 110-114, farhan2016genediscoveryin pages 105-110)

Likely prognostic factors, not formally validated, are epilepsy severity/status epilepticus, degree of developmental impairment and hypotonia, scoliosis progression, feeding/aspiration risk, renal involvement and congenital-heart disease. Neither HS concentration nor a molecular biomarker has been shown to predict course. Recovery of the underlying developmental phenotype is not documented, although skills, communication, seizure control and mobility may improve with supportive treatment.

12. Treatment

Current standard: individualized symptomatic care

There is no approved disease-modifying therapy and no SSMS-specific guideline.

Epilepsy: treat according to seizure type using standard antiseizure medication; prepare a rescue plan for prolonged seizures and status epilepticus. No drug has demonstrated SSMS-specific superiority, response rate or pharmacogenomic interaction. Given reported catastrophic status, caregiver education and emergency planning are high priorities. Suggested NCIt concepts: Anticonvulsant Agent and Seizure Prophylaxis.
Scoliosis/kyphosis: serial orthopedic monitoring; physiotherapy, bracing and spinal surgery according to curve severity, progression, pulmonary impact and function. Bracing was used in the founder family. Suggested NCIt concepts: Orthopedic Procedure, Spinal Fusion, Physical Therapy. (farhan2016genediscoveryin pages 105-110)
Development: early physical, occupational, speech/language and augmentative-communication therapy; individualized educational and behavioral support. Suggested NCIt concepts: Physical Therapy, Occupational Therapy, Speech Therapy.
Other systems: feeding/nutrition and reflux/constipation treatment; nephrology for proteinuria/renal impairment; cardiology for congenital lesions; ophthalmologic treatment for strabismus; urology/surgery for cryptorchidism; mobility devices and bone-health management as indicated.

The Gupta proband showed some language/social improvement after immunotherapy directed at neuronal potassium-channel antibodies but tolerated it poorly and treatment was discontinued. This was treatment of a possible comorbidity, not evidence for immunotherapy in SSMS. (gupta2019developmentaldelaycoarse pages 1-2)

Experimental concepts

Farhan and Gupta proposed raising HS levels through HS administration, enzyme replacement or gene replacement. These remain speculative: no animal efficacy study tailored to SSMS, dose, delivery strategy, safety dataset or human trial was identified. Farhan explicitly cautioned that nonspecific HS administration would be premature because genotype matters and toxicity from excess HS is unknown. Developmental timing and delivery across the blood–brain barrier are major obstacles. (gupta2019developmentaldelaycoarse pages 5-6, farhan2016genediscoveryina pages 131-135)

No relevant SSMS/AREXT2 interventional ClinicalTrials.gov study, gene therapy, cell therapy, RNA therapy, CRISPR trial, immunotherapy or targeted small molecule was identified. There are no treatment response percentages or SSMS-specific adverse-event datasets.

13. Prevention

The genotype cannot be prevented by lifestyle or vaccination.

Primary genetic prevention/family planning: offer genetic counseling, parental carrier confirmation, cascade testing of adult relatives, partner testing where a familial founder allele is present, prenatal diagnosis by CVS/amniocentesis, and preimplantation genetic testing for monogenic disease after the familial alleles are established.
Secondary prevention: early molecular diagnosis enables developmental therapy, seizure surveillance and renal/cardiac/orthopedic assessment before complications become advanced. Population newborn screening is not available or currently justified by evidence.
Tertiary prevention: optimize seizure control and rescue planning; monitor scoliosis, mobility and bone health; detect proteinuria/renal dysfunction; manage feeding/reflux/aspiration and congenital heart disease; implement home and school seizure-safety measures.
Immunization/public health: routine schedules apply; there is no SSMS-specific vaccine, prophylactic medication or environmental intervention.

14. Other species and natural disease

No naturally occurring companion-animal, livestock or wildlife syndrome convincingly homologous to human biallelic EXT2 SSMS was identified; no breed or VBO term can therefore be assigned. The disorder is not infectious and has no zoonotic or cross-species transmission potential.

Orthologous EXT-family function is highly conserved across Mus musculus (NCBI Taxon 10090), Danio rerio (7955), Drosophila melanogaster (7227) and Caenorhabditis elegans (6239). Conservation of HS-dependent morphogen signaling makes these species mechanistically relevant, but induced genetic phenotypes should not be represented as natural veterinary SSMS.

15. Model organisms

Mouse

Complete Ext1/Ext2 deficiency markedly impairs HS synthesis, prevents normal gastrulation and causes embryonic death around E8.5; hypomorphic models survive longer and produce shorter HS chains. These models establish that residual activity is likely necessary for viability and support the classification of human missense alleles as hypomorphic. Heterozygous/truncating models can develop osteochondromas and are more directly models of dominant HME than of AREXT2. (farhan2016genediscoveryina pages 131-135)

Application: embryogenesis, neural patterning, HS chain length and skeletal growth. Limitation: complete-null lethality prevents recapitulation of the viable, chronic human syndrome; heterozygous tumor models emphasize exostoses absent from SSMS.

Zebrafish

The dackel/ext2 mutant has reduced, abnormally sulfated HS; disordered chondrocyte intercalation/stacking and pharyngeal-cartilage morphology; abnormal optic-tract axon organization; and disturbed FGF/Wnt-dependent development. These observations directly connect Ext2 to neural guidance and cartilage organization. (mizumoto2021congenitaldisordersof pages 12-13, jankun2017thestudyof pages 24-28)

Application: live developmental imaging, morphogen gradients, cartilage and axon guidance, rapid genetic/drug screens. Limitation: larval craniofacial/fin phenotypes do not reproduce human epilepsy, macrocephaly or chronic scoliosis, and strong mutant alleles may be more severe than human hypomorphs.

Drosophila and C. elegans

Drosophila sister of tout-velu (sotv; Ext2 ortholog) and related HS-pathway mutants disrupt morphogen distribution and neuronal/dendritic development. Viable hypomorphic C. elegans rib-1/rib-2 exostosin-pathway mutants markedly reduce HS and cause selective cell/axon-migration and morphogenetic abnormalities; cell-specific rescue indicates requirements in both migrating neurons and neighboring cells. These systems demonstrate conserved, partly non-cell-autonomous HS function. (farhan2016genediscoveryina pages 131-135)

Application: genetic interaction screens and cell-specific pathway dissection. Limitation: neither organism models vertebral scoliosis, mammalian brain anatomy or human epilepsy adequately.

Missing model platforms

No retrieved publication described an SSMS-patient iPSC line, cerebral organoid, CRISPR knock-in of a human AREXT2 allele, or humanized mouse. Such isogenic hypomorphic models are a high-priority research need because they could measure variant-specific HS chain length/sulfation, neuronal network excitability and rescue by precisely timed gene or glycan-pathway correction.

Evidence assessment and 2023–2024 research status

The most authoritative direct evidence remains the 2015 founder-family study and later small case reports. Reviews correctly emphasize that recessive EXT2 disease is “without exostoses and with an autosomal recessive inheritance” and that the EXT1/EXT2 complex catalyzes HS synthesis, but reviews cannot resolve penetrance or phenotype frequencies in such a small population. (jaeken2020congenitaldisordersof pages 4-5, mizumoto2021congenitaldisordersof pages 12-13)

Recent 2024 HS literature advances structural and systems-level understanding—particularly NDST1 architecture and HSPG-mediated signaling—but it does not yet supply new AREXT2 patients, prospective natural history, validated biomarkers or therapeutic data. Consequently, all epidemiologic rates, genotype–phenotype rules, surveillance intervals and treatment algorithms should be recorded as unknown or expert-practice extrapolation, not established evidence.

Principal knowledge gaps

Complete contemporary case census and longitudinal natural history.
ClinGen-level gene–disease/variant curation and penetrance estimates.
Standardized HS chain-length and sulfation profiling in patient cells.
Brain-specific cellular models linking EXT2 deficiency to network hyperexcitability.
Genotype–phenotype explanation for macrocephaly versus microcephaly and severe versus mild twin/family presentations.
Evidence-based renal, cardiac and orthopedic surveillance schedules.
Variant-matched hypomorphic models and preclinical rescue studies.

Bottom line: SSMS/AREXT2 is a recessive, hypomorphic EXT2 glycosaminoglycan-biosynthesis disorder with a predominantly neurodevelopmental–epileptic phenotype and variable skeletal/multisystem involvement. The human evidence supports reduced EXT2 abundance and disturbed HS-pathway organization; downstream FGF/Wnt, axon-guidance and cartilage mechanisms are strongly supported by models but remain partly inferential in patients. Diagnosis is molecular, management is symptomatic and multidisciplinary, and prevention currently consists of genetic counseling and reproductive testing.

References

(jaeken2020congenitaldisordersof pages 4-5): Jaak Jaeken. Congenital disorders of glycosylation: a multi-genetic disease family with multiple subcellular locations. Journal of Mother and Child, 24:14-20, Jun 2020. URL: https://doi.org/10.34763/jmotherandchild.20202402si.2005.000004, doi:10.34763/jmotherandchild.20202402si.2005.000004. This article has 21 citations.
(mizumoto2021congenitaldisordersof pages 12-13): Shuji Mizumoto and Shuhei Yamada. Congenital disorders of deficiency in glycosaminoglycan biosynthesis. Frontiers in Genetics, Sep 2021. URL: https://doi.org/10.3389/fgene.2021.717535, doi:10.3389/fgene.2021.717535. This article has 60 citations and is from a peer-reviewed journal.
(gupta2019developmentaldelaycoarse pages 1-2): Aditi Gupta, Sarah A. Ewing, Deborah L. Renaud, Linda Hasadsri, Kimiyo M. Raymond, Eric W. Klee, and Ralitza H. Gavrilova. Developmental delay, coarse facial features, and epilepsy in a patient with ext2 gene variants. Clinical Case Reports, 7:632-637, Feb 2019. URL: https://doi.org/10.1002/ccr3.2010, doi:10.1002/ccr3.2010. This article has 9 citations.
(gupta2019developmentaldelaycoarse pages 2-4): Aditi Gupta, Sarah A. Ewing, Deborah L. Renaud, Linda Hasadsri, Kimiyo M. Raymond, Eric W. Klee, and Ralitza H. Gavrilova. Developmental delay, coarse facial features, and epilepsy in a patient with ext2 gene variants. Clinical Case Reports, 7:632-637, Feb 2019. URL: https://doi.org/10.1002/ccr3.2010, doi:10.1002/ccr3.2010. This article has 9 citations.
(OpenTargets Search: seizures-scoliosis-macrocephaly syndrome-EXT2): Open Targets Query (seizures-scoliosis-macrocephaly syndrome-EXT2, 1 results). Buniello, A. et al. (2025). Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery. Nucleic Acids Research.
(gupta2019developmentaldelaycoarse pages 5-6): Aditi Gupta, Sarah A. Ewing, Deborah L. Renaud, Linda Hasadsri, Kimiyo M. Raymond, Eric W. Klee, and Ralitza H. Gavrilova. Developmental delay, coarse facial features, and epilepsy in a patient with ext2 gene variants. Clinical Case Reports, 7:632-637, Feb 2019. URL: https://doi.org/10.1002/ccr3.2010, doi:10.1002/ccr3.2010. This article has 9 citations.
(mizumoto2018defectsinbiosynthesis pages 13-14): Shuji Mizumoto. Defects in biosynthesis of glycosaminoglycans cause hereditary bone, skin, heart, immune, and neurological disorders. Trends in Glycoscience and Glycotechnology, 30:E67-E89, May 2018. URL: https://doi.org/10.4052/tigg.1812.2e, doi:10.4052/tigg.1812.2e. This article has 14 citations and is from a peer-reviewed journal.
(farhan2016genediscoveryin pages 110-114): S Farhan. Gene discovery in mendelian and complex diseases. Unknown journal, 2016.
(farhan2016genediscoveryina pages 110-114): S Farhan. Gene discovery in mendelian and complex diseases. Unknown journal, 2016.
(farhan2016genediscoveryina pages 123-130): S Farhan. Gene discovery in mendelian and complex diseases. Unknown journal, 2016.
(farhan2016genediscoveryina pages 131-135): S Farhan. Gene discovery in mendelian and complex diseases. Unknown journal, 2016.
(gupta2019developmentaldelaycoarse pages 4-5): Aditi Gupta, Sarah A. Ewing, Deborah L. Renaud, Linda Hasadsri, Kimiyo M. Raymond, Eric W. Klee, and Ralitza H. Gavrilova. Developmental delay, coarse facial features, and epilepsy in a patient with ext2 gene variants. Clinical Case Reports, 7:632-637, Feb 2019. URL: https://doi.org/10.1002/ccr3.2010, doi:10.1002/ccr3.2010. This article has 9 citations.
(farhan2016genediscoveryin pages 105-110): S Farhan. Gene discovery in mendelian and complex diseases. Unknown journal, 2016.
(mizumoto2021congenitaldisordersof pages 11-12): Shuji Mizumoto and Shuhei Yamada. Congenital disorders of deficiency in glycosaminoglycan biosynthesis. Frontiers in Genetics, Sep 2021. URL: https://doi.org/10.3389/fgene.2021.717535, doi:10.3389/fgene.2021.717535. This article has 60 citations and is from a peer-reviewed journal.
(jankun2017thestudyof pages 24-28): P Jankun. The study of molecular interactions during zebrafish tail regeneration for use in glycotherapeutics. Unknown journal, 2017.

Artifacts

Edison artifact artifact-00

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome	Count
References checked	10
Resolved	10
Unresolved (possible confabulation)	0
Unverifiable	0
References weighed for topical relevance	10
On topic	5
Off topic	1

References that may not be about this subject

These identifiers resolve, so they are not fabrications, but the records they resolve to share almost none of this report's vocabulary. That is a clue and not a verdict - a paper can be relevant in ways its title and abstract do not spell out - so read them before deciding:

DOI:10.1038/s41467-024-45419-4 (2 mentions) - Structural and mechanistic characterization of bifunctional heparan sulfate N-deacetylase-N-sulfotransferase 1
shared terms: human

Weighed against this report's own most characteristic terms: disease, ext2, ssms, clinical, gene, phenotype, genetic, variant, developmental, human, scoliosis, epilepsy, model, affected, family, arext2, patient, gupta, seizure, syndrome.

All extracted references resolved successfully. Resolving is not the same as being relevant, though - see the references listed above as possibly off topic.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome	Count
Terms checked	54
Resolved	54
Unresolved (possible confabulation)	0
Obsolete	0
Unverifiable	0
Terms whose name was checked	1
Terms named correctly	0
Terms named as a different term	1

Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

MONDO:0014731 (3 mentions) - the report calls it "if available"; MONDO calls it seizures-scoliosis-macrocephaly syndrome

Ask OpenScientist

OpenScientist Report

Classifications

Inheritance

Discussions and Knowledge Gaps

Pathophysiology

Pathograph

Phenotypes

Genetic Associations

Medical Actions

Biochemical Markers

Diagnosis

Prevalence

Differential Diagnoses

Experimental Models

Animal Models

Source YAML

References & Deep Research

References

Deep Research

Disease Characteristics Research Template

Target Disease

Research Objectives

1. Disease Information

2. Etiology

3. Phenotypes

4. Genetic/Molecular Information

5. Environmental Information

6. Mechanism / Pathophysiology

7. Anatomical Structures Affected

8. Temporal Development

9. Inheritance and Population

10. Diagnostics

11. Outcome/Prognosis

12. Treatment

13. Prevention

14. Other Species / Natural Disease

15. Model Organisms

Citation Requirements

Output Format

Seizures–scoliosis–macrocephaly syndrome (SSMS)

Biallelic EXT2 / autosomal-recessive EXT2-related syndrome (AREXT2)

Executive summary

1. Disease information

Definition and identifiers

Source granularity

2. Etiology

Causal factor

Genetic risk and modifiers

Environmental, infectious and gene–environment factors

3. Phenotypes

Core and variable manifestations

Suggested phenotype annotations

Quality-of-life impact

4. Genetic and molecular information

Gene/protein

Variant table

Functional interpretation and caveats

5. Environmental information

6. Mechanism and pathophysiology

Supported causal chain

Current structural insight

Suggested mechanism annotations

7. Anatomical structures affected

Organ and system level

8. Temporal development

9. Inheritance and population

10. Diagnostics

Clinical suspicion

Recommended evaluation

Biomarkers and other tests

Differential diagnosis

11. Outcome and prognosis

12. Treatment

Current standard: individualized symptomatic care

Experimental concepts

13. Prevention

14. Other species and natural disease

15. Model organisms

Mouse